var title_f28_0_28672="Subcutaneous granuloma annulare - finger";
var content_f28_0_28672=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F65614&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F65614&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Subcutaneous granuloma annulare",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple nontender subcutaneous nodules are distorting the shape of the fifth finger in this 10-year-old boy with subcutaneous granuloma annulare.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Copyright &copy; Bernard Cohen, MD, Dermatlas; file://www.dermatlas.org.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_0_28672=[""].join("\n");
var outline_f28_0_28672=null;
var title_f28_0_28673="Giardia";
var content_f28_0_28673=[" <h1 id=\"patTopicTitle\">",
"  Patient information: Giardia (Beyond the Basics)",
" </h1>",
" <div id=\"patTopicContributors\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <table>",
"    <tr>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?28/0/28673/contributors\">",
"       Author",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/0/28673/contributors\" id=\"au5463\">",
"       Flor M Munoz, MD, MSc",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?28/0/28673/contributors\">",
"       Section Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/0/28673/contributors\" id=\"se6247\">",
"       Peter F Weller, MD, FACP",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?28/0/28673/contributors\">",
"       Deputy Editors",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/0/28673/contributors\" id=\"de1811\">",
"       Elinor L Baron, MD, DTMH",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/0/28673/contributors\" id=\"de2799\">",
"       Constanza Villalba, PhD",
"      </a>",
"     </td>",
"    </tr>",
"   </table>",
"  </div>",
"  <div class=\"rcBottom\">",
"   <div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"patTopicTool\" id=\"patTopicToolTop\">",
"  <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"   Find",
"  </a>",
"  <a class=\"toolbutton printicon\" href=\"UTD.htm?28/0/28673?view=print\" title=\"Print This Topic\">",
"   Print",
"  </a>",
"  <script src=\"file://w.sharethis.com/button/sharethis.js#publisher=357881b8-c7e3-4c31-b7d2-242aeb1528e1&amp;type=website&amp;post_services=care2%2Cfacebook%2Ctwitter%2Cmyspace%2Cdigg%2Cdelicious%2Cfaves%2Creddit%2Cxanga%2Cstumbleupon%2Cblinklist%2Csimpy%2Cyigg%2Ctechnorati%2Cmeneame%2Corkut%2Cmixx%2Cfunp%2Cfresqui%2Cmister_wong%2Cfriendster%2Cfriendfeed%2Clinkedin%2Coknotizie%2Cgoogle_bmarks%2Cyahoo_bmarks%2Cfark%2Cnewsvine%2Clivejournal%2Ctypepad%2Cbus_exchange%2Cpropeller%2Cwordpress%2Cblogger%2Cblogmarks%2Cwindows_live%2Cfurl%2Cybuzz%2Cdiigo\" type=\"text/javascript\">",
"  </script>",
" </div>",
" <div id=\"patTopicMiddle\">",
"  <div id=\"topicContent\">",
"   <div id=\"topicText\">",
"    <p class=\"headingAnchor\" id=\"H1\">",
"     <span class=\"h1\">",
"      GIARDIA OVERVIEW",
"     </span>",
"    </p>",
"    <p>",
"     Giardia (also called Giardiasis or Giardia infection) is an infection of the gastrointestinal tract caused by a microscopic organism called Giardia lamblia. This parasite, which also goes by the names Giardia duodenalis or Giardia intestinalis, resides in the gut and can cause diarrhea and stomach discomfort (nausea, stomach ache). It is one of the most common gastrointestinal parasites, and it infects roughly 20,000 Americans each year.",
"    </p>",
"    <p>",
"     Giardia can affect people of all ages, but it is especially common in children younger than five years old. It is also seen in internationally-adopted children of all ages and among people who travel in resource limited settings.",
"    </p>",
"    <p>",
"     The Giardia organism is found in the feces of infected people and can spread because of poor sanitation or because drinking water or food becomes contaminated. It can also infect animals, such as dogs, cattle, and sheep, but it's not clear whether animals play a role in spreading the infection to humans.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H2\">",
"     <span class=\"h2\">",
"      How giardia is spread",
"     </span>",
"     &nbsp;&mdash;&nbsp;Giardia infections can spread in three ways, all of which can be prevented. (See",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/17/6424?source=see_link\">",
"      \"Treatment and prevention of giardiasis\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H1248645279\">",
"     <span class=\"h3\">",
"      Waterborne transmission",
"     </span>",
"     &nbsp;&mdash;&nbsp;Waterborne transmission is the most common route of infection. People who drink from contaminated streams, reservoirs, or wells can become infected. Contaminated water used to prepare drinks or wash raw food can also be a source of infection.",
"    </p>",
"    <p>",
"     Waterborne transmission is especially likely among campers and hikers who drink from untreated water sources (streams, lakes), and among people traveling in regions where water sanitation standards may not be adequate to eliminate the organism.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H1248645305\">",
"     <span class=\"h3\">",
"      Food-borne transmission",
"     </span>",
"     &nbsp;&mdash;&nbsp;The organism that causes Giardia is killed by cooking, so properly cooked food rarely leads to infection. However, uncooked food or food that is contaminated after cooking can cause Giardia infections. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?28/30/29156?source=see_link\">",
"      \"Patient information: Food poisoning (food-borne illness) (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H3\">",
"     <span class=\"h3\">",
"      Person-to-person transmission",
"     </span>",
"     &nbsp;&mdash;&nbsp;Person-to-person transmission can happen when traces of infected feces travel between two people. This can happen if you do not thoroughly wash your hands after using the bathroom or after changing the diapers of an infected child. Person to person transmission is the cause of outbreaks in families and institutions, such as day care centers and nursing homes. Person-to-person transmission can also happen during unprotected anal sex.",
"    </p>",
"    <p>",
"     Waterborne transmission is especially likely among campers and hikers who drink from untreated water sources (streams, lakes), and among people traveling in regions where water sanitation standards may not be adequate to eliminate the organism.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H6\">",
"     <span class=\"h1\">",
"      GIARDIA SYMPTOMS",
"     </span>",
"    </p>",
"    <p>",
"     Giardia infections do not always cause symptoms. Some people carry the organism without ever knowing it. What's more, some people develop symptoms and then get better without treatment, because they combat the infection on their own. When symptoms do arise, they can include:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Diarrhea that comes on suddenly and may be initially watery",
"      </li>",
"      <li>",
"       Malaise (a vague feeling of discomfort)",
"      </li>",
"      <li>",
"       Foul-smelling and fatty stools",
"      </li>",
"      <li>",
"       Abdominal cramps, gas, and bloating",
"      </li>",
"      <li>",
"       Nausea or vomiting",
"      </li>",
"      <li>",
"       Weight loss",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     People generally develop these symptoms one to two weeks after being exposed to Giardia, and the symptoms often last at least two to four weeks. Some people develop a chronic form of Giardia that lasts even longer, although symptoms tend to be less severe.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H7\">",
"     <span class=\"h2\">",
"      Nutritional problems",
"     </span>",
"     &nbsp;&mdash;&nbsp;Giardia can also interfere with the way the body absorbs nutrients, so it can cause vitamin deficiencies and other nutritional problems. In up to 40 percent of cases, Giardia impairs the body's ability to digest lactose, the form of sugar found in milk, cheese, and other dairy products. Guidance about lactose products is included below (see",
"     <a class=\"local\" href=\"#H11\">",
"      'Recurrence of symptoms'",
"     </a>",
"     below).",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H8\">",
"     <span class=\"h1\">",
"      GIARDIA DIAGNOSIS",
"     </span>",
"    </p>",
"    <p>",
"     If your healthcare provider thinks you may have Giardia, he or she will ask you for a stool sample and then send it to the lab. There technicians will examine the stool under a microscope, looking for any parasites that might be present. The test, called the \"ova and parasite exam,\" is important, because it can detect not just Giardia but also other parasites that might be causing or contributing to symptoms. (See",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/28/33224?source=see_link\">",
"      \"Epidemiology, clinical manifestations, and diagnosis of giardiasis\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     The test is not foolproof, because people infected with Giardia do not always carry the organism in the stool. As a result, you may need to provide more than one stool sample before the infection shows up on a test. In some cases additional tests, such as endoscopy, might be recommended by your doctor.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H9\">",
"     <span class=\"h1\">",
"      GIARDIA TREATMENT",
"     </span>",
"    </p>",
"    <p>",
"     Treatment for Giardia involves taking an antibiotic for several days. In most cases, that is enough to eliminate the infection and its symptoms. In stubborn cases that do not improve with the first round of antibiotics, doctors sometimes recommend changing the type, dose, or duration of treatment.",
"    </p>",
"    <p>",
"     If you do not have symptoms of Giardia but testing shows that you are infected, you may not need antibiotic treatment. However, children in daycare and people who handle food should be treated for Giardia, even if they have no symptoms, to prevent the spread of infection.",
"    </p>",
"    <p>",
"     Avoid swimming in pools, hot tubs, lakes, rivers, and the ocean until one week after you have finished treatment for Giardia. Swimming can contaminate the water and cause others to become ill. Anal sex should be avoided until treatment has been completed.",
"    </p>",
"    <p>",
"     If your symptoms resolve after you finish your antibiotic treatment, you do not need to be tested for Giardia again.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H10\">",
"     <span class=\"h2\">",
"      Special considerations for children",
"     </span>",
"     &nbsp;&mdash;&nbsp;Antibiotics are the most important part of Giardia treatment both in children and adults. Still, children sometimes need additional care. Diarrhea can cause dehydration and a salt imbalance, both of which can be especially tough on children. For them, drinks containing electrolytes may be recommended to restore what is lost through diarrhea. Fluid and electrolyte replacement are discussed in detail in a separate topic. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?0/1/27?source=see_link\">",
"      \"Patient information: Acute diarrhea in children (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     The safety of breastfeeding while being treated for Giardia depends upon which antibiotic you take; some antibiotics are safe to take while breastfeeding while others are not. This should be reviewed with your healthcare provider. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?30/54/31588?source=see_link&amp;anchor=H14#H14\">",
"      \"Patient information: Maternal health and nutrition during breastfeeding (Beyond the Basics)\", section on 'Medication safety with breastfeeding'",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H11\">",
"     <span class=\"h2\">",
"      Recurrence of symptoms",
"     </span>",
"     &nbsp;&mdash;&nbsp;After being treated for Giardia and seeing symptoms improve, some people experience a relapse. This can happen because people consume dairy products too soon or because they are still infected with Giardia.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Giardia can interfere with the body's ability to digest dairy products (see",
"       <a class=\"local\" href=\"#H7\">",
"        'Nutritional problems'",
"       </a>",
"       above). Even once the infection is gone, it can take several weeks before normal digestion returns. For this reason, adults may wish to avoid milk, cheese, yogurt, and any other foods that contain lactose for at least a month following treatment (",
"       <a class=\"graphic graphic_table graphicRef55938 \" href=\"UTD.htm?32/38/33388\">",
"        table 1",
"       </a>",
"       ).",
"       <br/>",
"       <br/>",
"       Milk products are an important part of a child's diet. Therefore, if your child continues to have loose stools or gassiness after beginning treatment for Giardia, have the child avoid milk and other dairy products for a few weeks. This is only to avoid symptoms, and does not help eliminate the Giardia infection itself.",
"      </li>",
"      <li>",
"       If you or your child develop symptoms again after being treated for Giardia, your healthcare provider will want to run another stool test to determine if Giardia is causing the problem. If Giardia shows up again, it could be that the first round of treatment did not get all the organisms, or it could be that you or your child were re-infected somehow. Work with your healthcare provider to root out the possible source of the infection and ask about how you can prevent future infections.",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H12\">",
"     <span class=\"h1\">",
"      GIARDIA PREVENTION",
"     </span>",
"    </p>",
"    <p>",
"     The key to preventing Giardia and other infections is good hygiene. Here are some good hygiene tips:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Wash your hands with soap and water before eating and after using the bathroom, and teach children to do the same.",
"      </li>",
"      <li>",
"       Wash your hands with soap and water after changing diapers or after tending to anyone who has poor bowel control.",
"      </li>",
"      <li>",
"       Dispose of diapers properly and wash any clothes that could be contaminated with even small amounts of feces.",
"      </li>",
"      <li>",
"       Try not to swallow water when swimming.",
"      </li>",
"      <li>",
"       Pre-treat drinking water when traveling or hiking. This can be done by:",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     <ul class=\"hyphen-block\">",
"      <li>",
"       Boiling drinking water for at least 10 minutes at a hard boil.",
"      </li>",
"      <li>",
"       Adding five drops of tincture of iodine to a quart of water and waiting 30 minutes. Iodine is much more effective in eliminating Giardia than chlorine-based (bleach) treatments.",
"      </li>",
"      <li>",
"       Using a high quality water filtration system. Information about water purification and a traveler's guide for buying water filters is available from the United States Centers for Disease Control and Prevention (",
"       <a class=\"external\" href=\"file://www.cdc.gov/travel/\">",
"        www.cdc.gov/travel/",
"       </a>",
"       ).",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Food preparation and safety tips are discussed in a separate article. (See",
"       <a class=\"medical medical_patient\" href=\"UTD.htm?28/30/29156?source=see_link\">",
"        \"Patient information: Food poisoning (food-borne illness) (Beyond the Basics)\"",
"       </a>",
"       .)",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H13\">",
"     <span class=\"h1\">",
"      WHERE TO GET MORE INFORMATION",
"     </span>",
"    </p>",
"    <p>",
"     Your healthcare provider is the best source of information for questions and concerns related to your medical problem.",
"    </p>",
"    <p>",
"     This article will be updated as needed on our web site (",
"     <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"      www.uptodate.com/patients",
"     </a>",
"     ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H2413285344\">",
"     <span class=\"h2\">",
"      Patient level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H257591\">",
"     <span class=\"h3\">",
"      The Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?21/1/21522?source=see_link\">",
"      Patient information: Giardia (The Basics)",
"     </a>",
"    </p>",
"    <p>",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H257598\">",
"     <span class=\"h3\">",
"      Beyond the Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?28/30/29156?source=see_link\">",
"      Patient information: Food poisoning (food-borne illness) (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?0/1/27?source=see_link\">",
"      Patient information: Acute diarrhea in children (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?30/54/31588?source=see_link\">",
"      Patient information: Maternal health and nutrition during breastfeeding (Beyond the Basics)",
"     </a>",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H14\">",
"     <span class=\"h2\">",
"      Professional level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/59/17335?source=see_link\">",
"      Antiprotozoal therapies",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/28/33224?source=see_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of giardiasis",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/17/6424?source=see_link\">",
"      Treatment and prevention of giardiasis",
"     </a>",
"     <br/>",
"     <br/>",
"     The following organizations also provide reliable health information.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Library of Medicine",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.nlm.nih.gov/medlineplus/giardiainfections.html\">",
"      www.nlm.nih.gov/medlineplus/Giardiainfections.html",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Institute of Digestive and Diabetes and Kidney Diseases",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://digestive.niddk.nih.gov/ddiseases/pubs/diarrhea/index.htm\">",
"      file://digestive.niddk.nih.gov/ddiseases/pubs/diarrhea/index.htm",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Center for Disease Control and Prevention",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.cdc.gov/parasites/giardia/\">",
"      www.cdc.gov/parasites/giardia/",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       American College of Gastroenterology",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.acg.gi.org/patients/gihealth/diarrheal.asp\">",
"      www.acg.gi.org/patients/gihealth/diarrheal.asp",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     [",
"     <a class=\"abstract\" href=\"UTD.htm?28/0/28673/abstract/1-3\">",
"      1-3",
"     </a>",
"     ]",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 16, 2012.",
"  </div>",
"  <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"   <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"    Find",
"   </a>",
"   <a class=\"toolbutton printicon\" href=\"UTD.htm?28/0/28673?view=print\" title=\"Print This Topic\">",
"    Print",
"   </a>",
"  </div>",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <div id=\"patTopicRefHeader\">",
"    <div id=\"patTopicRefHeaderHeader\">",
"     References",
"    </div>",
"    <div id=\"patTopicRefHeaderTop\">",
"     <a href=\"#top\">",
"      <img alt=\"\" src=\"./../images/top_arrow.myextg\">",
"       Top",
"      </img>",
"     </a>",
"    </div>",
"   </div>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28673/abstract/1\">",
"      Ongerth JE, Johnson RL, Macdonald SC, et al. Back-country water treatment to prevent giardiasis. Am J Public Health 1989; 79:1633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28673/abstract/2\">",
"      Bartlett AV, Englender SJ, Jarvis BA, et al. Controlled trial of Giardia lamblia: control strategies in day care centers. Am J Public Health 1991; 81:1001.",
"     </a>",
"    </li>",
"    <li>",
"     Drugs for parasitic infections, 2nd ed. The Medical Letter. 2010. file://secure.medicalletter.org/para (Accessed on February 17, 2012).",
"    </li>",
"   </ol>",
"  </div>",
" </div>",
" <!-- patTopicMiddle -->",
"</div>"].join("\n");
var script_f28_0_28673=[""].join("\n");
var outline_f28_0_28673=[" <div class=\"patTopicFancyTop\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <p>",
"    Contents of this article",
"   </p>",
"  </div>",
" </div>",
" <div class=\"patTopicFancySpacer\">",
" </div>",
" <div class=\"patTopicOutline\">",
"  <div class=\"rcbBottom\">",
"   <div class=\"rcbLeft\">",
"    <div class=\"rcbRight\">",
"     <div class=\"rcbBottomLeft\">",
"      <div class=\"rcbBottomRight rcbBottomRightBottomOnly\">",
"       <div id=\"outline\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a href=\"#H1\">",
"           GIARDIA OVERVIEW",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H6\">",
"           GIARDIA SYMPTOMS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H8\">",
"           GIARDIA DIAGNOSIS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H9\">",
"           GIARDIA TREATMENT",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H12\">",
"           GIARDIA PREVENTION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H13\">",
"           WHERE TO GET MORE INFORMATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#references\">",
"           REFERENCES",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"       <h1>",
"        GRAPHICS",
"       </h1>",
"       <div id=\"relatedGraphics\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          TABLES",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_table\" href=\"UTD.htm?32/38/33388\" title=\"table 1\">",
"           Lactose content of different foods PI",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"  </div>",
" </div>"].join("\n");
var title_f28_0_28674="Isometric internal rotation exercise for shoulder";
var content_f28_0_28674=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1140px;\">",
"  <div class=\"videoplayer\" h264=\"./images/EM/86820/Iso_int_rotat_exer_sh_video.mp4?title=Isometric+internal+rotation+exercise+for+shoulder\" style=\"width:496px;height:288px\">",
"  </div>",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Isometric internal rotation exercise for shoulder",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Isometric exercises for the subscapularis are often unnecessary, but may be performed if needed in the manner demonstrated in this video clip.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Craig Parsons, MS, PT and the Physical Therapy Network.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_0_28674=[""].join("\n");
var outline_f28_0_28674=null;
var title_f28_0_28675="Phototoxic eruption 2";
var content_f28_0_28675=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F76399&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F76399&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Phototoxic eruption",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 296px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This 11-year-old boy taking doxcycline developed a painful, confluent, erythematous eruption in exposed areas after a day of summer sun exposure.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Copyright &copy; Bernard Cohen, MD, Dermatlas; file://www.dermatlas.org.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_0_28675=[""].join("\n");
var outline_f28_0_28675=null;
var title_f28_0_28676="Endotracheal intubation lateral view";
var content_f28_0_28676=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F71498&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F71498&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 510px\">",
"   <div class=\"ttl\">",
"    Endotracheal intubation lateral view",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 490px; height: 610px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Note that a pillow is placed behind the patient's head to elevate the occiput. The tip of the curved MacIntosh blade is in the vallecula. The lips are pulled back to prevent injury during intubation.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_0_28676=[""].join("\n");
var outline_f28_0_28676=null;
var title_f28_0_28677="Pustules in pustular psoriasis";
var content_f28_0_28677=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F67402&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F67402&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pustules in pustular psoriasis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 325px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_0_28677=[""].join("\n");
var outline_f28_0_28677=null;
var title_f28_0_28678="M mode Chagasic cardiomyopathy";
var content_f28_0_28678=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F80211&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F80211&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Chagas' cardiomyopathy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 433px; height: 245px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAD1AbEDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD26Dxr4cnuZ4V13ShLFc/ZCjXcYLSYXAAzz94D65FV7v4ieELacW8/irR/PDFNhu0PbnODxXxGnwv8bz2KX8Xh3UZYJIVud4jOdrE4PqScZwOcEVPF8IfH8rBU8K6lkjPzIFHTPUn3oA+xtY+Kng3TTprXOv2Zt792EMsD+YgC9SxHQZGM+tXIfiZ4KluEiXxXojO3CgXa9Txj0z2r5D0n4E+PNQTUA+jm0ntfLAiuJFQylyPunOMBSWJz2xyap3HwT+IUN3cwDw3cy+Q20yRuhR/Qq275h9OnfFAH2vZeM/Dt5I8Vr4i0mWUAsUS7QkAdeM54qt4e+IHhnxFbxvpmu6fLKUEjxNcIrxjvuU8jpXxTP8I/H1jJZtN4bvojc3CW8TfKf3jHC5wTtHHU4A70a98IfHGj3vkSeH72eN7g28M0CeYkhzgN8pOAeuTigD7B+KfxT03wBoljqUkA1RL2SSGFbaZcFkXOc8jbkgHHIz0rc+HHi2Hxp4M0/X7WPyluQwkhDbvKkViCpP4Z7cEGvnH4f+AD4/8AC2keFNcvZ9Mk8My3cl1bLGDIGklTCHPTgMQeevGa5Pxn4d8b/DfxNrWkeEJPESeH/NW4jltVkMboyZG4qMEgEqf92gD7g/eKTkPgDrg0NOkbIjlVLuEXP8TY6fkCfwr85LbxR4wkaZrbWtdd2CiQx3MpOM8cg8c1ot418dapp0MQ1jV5otHD3QkErl4gxCFmbOcAnHPTJoA/Q5X+XuB046flTsvggqR6cZxzX58Wvxh8fW1kltD4mv8Ay0feGZgzj23EZx7UkHxg8dw3KzL4jviFZ2EbSEoNwIIx6DJx6UAfoPHPuj3IxZSSNydAc4I/TFHmjaSCRjt/n6V+ecfjfx54O1GaxOuatZ3EQ2vBLMWA3fNnacjJ3bs+9atz8dfiDM8xGvSxo8m8IqL8gznaOOlAH3usxBwCS2M4/wA9qUykgfXgE9eK+AdX+Mfj/UtQXVv7aubUrGLbNquyLj5sY5G44ya12/aE+IcN2pe/tg0W1WjNsu0lRg5Hv1Pv6UAfcfmMGwW6HoOCacZi0akEg4zXw9rP7QXjTWtP1HT99tbC92JE9pHseEB8kA5Odw4NSW/7SHjuBZ1EmnSh2JQzW+5owegBBGQPegD7d8zLDLkAdOw/GnGVsqfXIPf8K+Gx+0T8QFm3NdWJC4BQ2oxwef8ACqn/AAvnxzb6zeX1tfJHBdXL3QtXTfEoYbQozztAAwPUZoA+72dgo7Hdg4pol3sRkYx9a+I7v9o7xw97cS2kllDA5by4jBu8sHpjnqKS/wD2ivGt1Z2MSGytbm1m82SaGI/6QABhXUnGMgk4659qAPtx5Cv3hlh6/SjzMqG/hIxjFfGiftOeMBbKjWGjvMAAZPKYbumcjd14P51dl/ae8RpqkLR6ZpcmnhkZ0MbrIy4G9Q27jndg4oA+vGkdmQxPtCn5h7Y//UalDc5Yk5Hc/wAq+LNL/aQ8aaXMy39rpl5HI5mKyxMrbXG4AENwBkY46Vfi/aj8Tq/7zRtGdNpGAJFOT0Od3b9aAPsN5cAHGOO3ekMvynaevVTXxxqP7THiSWbSZraw0+N7cO1ygDeXOzAjGM5AHB69alj/AGofEaxQBtD0lpEDCRsuAx7EDPy4/GgD7AWTGzGSM880eYxZSpJPPevky3/al1QNL5/h2xC+U3lmOVsrJt+UnPbOM+1R6P8AtOapY2NlDqWj2upTRwfvLgSmNmk5xkYI6YoA+u/N+RDkeuBRv4XPGQTwM4r5If8Aao1f7LGE8Oaf9pDHc5mfZt7ADrn1OaS+/ag1NNcM+n6Lavp5t40MM0jbt/3mOR7ll6dADQB9eCXLEHvxj19qElIXlW+9XyXd/tTanFdRNbeHtPe2eJWaN5X3K3O4bh1GenFQal+1Dqk+l2wsNCtra+S4jkmZpS8cka5LKBwVJOBnnjNAH10JySewAzkcjPpQ9wVZS2QP0r5Mtf2qL5bY/bPDNrJOZG/1Vw0aCP8AhGCCSQeprQ079qQG4sU1Dw4gjdR57w3LZiJYgkAjkYwcfWgD6jeXIQKrZb1pXmYqdoPPBOehr5R0j9qV4rkjVfD7zwNPK+6K42skZPyIARg4GOTjNX0/arsfNbzPCs/lLu2AXYyeflz8vp1oA+oxJyRn5vpSNICFPOCe39a+VdX/AGoSLPSbnStDjW4M8jXcElwWGwDCjIA5Od3ttrtfC/7R/g7U7CFtdW50ed2ZCrI0qDA67lGe/cUAe7ecPlyCpbnBo8zjgZY9PSuL0P4l+DtbuWi0vxLp9xKkTTFPMKsEUZY8gdBVTTvir4HvbZJV8SadGGaRdksuxgY8lsgjjgZ9+2aAO9E43nIYDjGRVeSY5UPlS2enHNeZan8ePh5ZRiQ66bncSM29vI+SPw4//VXn3i39prSbK6tT4b06TUIZLQySCdjH5cxI2ofoAc49Rg0AfRjS7oyoYk54yaQS7SSu44xyTXzNH+1PZNcs0vhm4S3EPyotyGYy5HU4AC4z2z0rJ1P9p+9udE1OGz0KK1vZSUtJ/NLBFz1Yf3gO44zQB9XpJlyrAqOo9vrSrISNoB2D+tfJ9l+1Nfi1uBqHhu1luPlEPk3DIv8Atb85PTpitvTv2p9KNu39oeF72ObcuBBdqylc8nJAOR6d/agD6TkfnOd3PY9venlwSQd2AK+d7T9pvw42pXsN7pmoiy+1KttKm1v3WAC7DIPXccDtjvXZW3x3+HbC5L+IWURuB89rL8+e6jbkgfhQB6kWLuQN3HPepQ5ZsuOcdCK8f1j48+BrKOzmtdYW8El0sE/lQybo4jy0mCucDj3POM01/wBoL4fpaLOmpXMrGUR+V9lcOqk438jGOM9c0Aew+YOeSSDnOcUiuAvIO8++cfSvGtO/aH8CahqlvaCS/g86TYJpodqIc4BOOQDmqmlftHeDJ9WurK+N5bQxSssN6Yy0cq7iA2B8y8c8igD3TZ7L/wB80V43/wANE+AP+gje/wDgK9FAHp+d3OcKV7HrzwKQbmwGzkdmOc1gr4x8NFFH/CR6Mck7sXkfTv3qf/hJ9AdE2a3pLITwy3sf+NAGwOHYbsHsKkC5UdeMcH9ayBr2ksTs1jSzjJObyM4+vzVZGs6Y4x/aWntxj/j6j/8AiqALpZR/DxkjPHHvSFm3HYXA6cdqqpqVjn5b+xO7g4uY/wDGlGoWLAf6dZjGeTcIP60Ac74f8PSad8QPGmtSIqwauLJYiCST5cRViffJ6V10cjBMKzDGSMH3zVWO7tSCVu7VvXbcqQP1qQXcLthLiBgfujz0/wAaAJI1XLEAc4PyqOfSqqafaxyTOLaBJJ1WOQ7Rh1BOFPsMnj3qyJ0z/rYGwD/y2Xr+dODrvAEsWPvFvMX8s5oAoQeHNEhmvLldJsPtF2Atw/kLmYL90HjnFU5/BPhq5hMU2g6aI0cFQLdFK4Ibg445A6eldAWCKMmNlx3YHmpVJwwYKPbI/nQBiaz4Y0PXo5o9a0iyvVmcOzSxAlsEYO7g8YHftVO88CeE751e78M6RK+cgm2UHqW7f7RJ966d1MsLKBwoxw2P89uaVch8bTuAxQBzUPgTw1Fpw05dEsW09bmS7WB4wyJK3VgD0/kOlYs3wg8AXErySeFdPZt/mMQ8gJJJJz83P0r0GONwR8hI5NJsk3M+G54B6fpQB59Y/CDwHp+sW+qWPh6CG6hLbAJHaPJG3lCcdM1BdfBn4eTzI0nhi0j2liFjeRQ+fXDduwr0VUl3ZYMRyCMHgZ4pWBBHytx14oA83m+Cnw8mEofwzCrSoULrNLlf9ofPweanuPhF4Fu7Wytbvw/DOlnbC1hkaWQMseWbkhhk5Zjn3rv2jkwflIX9ev8AWhhIFUrExB65HNAHmjfA34dmPafDkSgLtJW5lyffO7rTrH4L+BLK9u5IdDQR3VqLaSF5WZFUZy6nOVZuMnPboOc+kuWBOI2I6c8fjTcAMd0THGDgj8qAPKv+FCfD5tRkvDo0xjkTH2UXT+UpyPmXB3A8epHPSoLn9nn4fzxMqafeW0jliJEu3O0kehyMDt+teuMSZdrKwO36UYbI2525w2QaAPMNW+BfgHVLdIpdLmhlS2S3W4huXV1CAKpIJIJAAGSDms66/Z1+H0jRMLbUoVCCM+XdnDHA+c5B547cc9K9gYHuuQT6dRQCDjHB64I7UAeWWHwG8A20V/EdLlmhugi7ZZ3Ji2jqhBBBJ5P19OKzrz9nPwHKhMcGpwFgoHl3f3cdfvA9c89a9mUZbcAcHpTST8q5POentQB4jdfs3eCHktzby6nEYmRnU3AYTKD8wOV4J6ZBGPSpda/Zz8E6ne+fC+qWJkmeWRYJkKkEk7QCp2gdsV7IUZnOWOCePb2p6sVBZs8dSTQB4ZL+zH4OkSJU1HW4ipwz+ZGd/PcbOD2q3D+zf4OOl29ndyal50UjubiOYK7gnABBUjpt6DqPSvai24oQcr9Oc0qyMWzkBQeD3IoA8G0/9mPwim83Wp6zcfNkDdGgA9Pu8/WtDTv2dPB+n6wtwst/PYvaTW8ltNKCxd+A4YAYwpPHrg+1e1uwUHLHceTgcGkyuCB2xj1IxQB4Le/sy+FZ7qMwajrMFukezYHjYlsk7txX0OMYqne/suaH9gmWx1/VFvSmYXmVDGG7bgADj6GvogvuQNtweMjvQNpkU5weoHp9aAPn/VP2ZfD13ZxeTrOpW15Hbxw7yqPGzqoBbGARk84zxVOL9lvS3t7eO58TXheOMqxjtlAZiScgEnjnp+tfRYwpIb5hkk5PeheN5yGI7HuaAPnuw/Zg0eGw1O3udXnmnudi2t0Yx/o6hwzHb3YgFeuME1x2s/sv+Ircztous6deopHkrOGhZhzn1APTvzmvrlcjBbkc84xgUxGURMQo45/yKAPgfVPg34/0uCKW48O3abpFjzEyPtLkKo+UnqWx7d6uX/wF+INvOUj0VrrM5hDxSoQeAd/J4Xk8n0r7tIyULjcCccjgelKU+Q8H8u1AHxhpn7NPjm5VFu5tJs42IJWS5LEZODwoOSBz1rsPDP7MSzaJcxeJNSktdRW9cRTWqh0eALhTyf4j83Y4GK+n32owYgrx0H9BQ+AFBG4kZJH1oA+ddB/Zc0K3Mx1/XL+7+c+WLRVhAXtu3BufpxW5p37Nvguy1myvRNqlzbRFjJa3EyFJOOOVVSMEj8q9uOBkjsQRxTUA8w5PAyf8+1AHhGp/sweEJ2lFjqWsWbscxgukij25XP61Xh/Zd8KBgkmta4z425BiUFsdfu9M9q99B5B5yOeuSaeuGwGIyT3H5UAfP2o/syeHZtDt4rTU7yDVIrTyzPw0cs27JkZcZxgkBQRwBySDXEaj+y1rseRp3iHTLh9oOJo3i578/NX1zlRGPVR0x3prhQGxx2AxnBoA+ONH/Zp8TzXmpW2rXFramK1WS0njffFPMf8AlmTjIxzk49MZp1v+zF4tMri61PR4YVj3+akjuC27G3G0HOOc9O1fYsoUOucN6fWhwpiKkjCjOfb0oA+RD+y54iWG5J1vTDMqgwoA+HOehOPl4z688V0N7+yvCXk+w+JmVRCBH5tvnMnctg8KfQZPvX05HtVznk9uM0gbHH5+9AHyx/wynd/9DVbf+Ap/+Kor6twvrF+f/wBaigD4PHw90n7TErHWdvGQIohnHUf6zrUkHw90TA8z+3CA2DiCPPX0D19BeGNN8K67f3q6NE97b2+B5tvdxTLu/wCA/MMe9a1rovhSWQy2d15rQylGEd2jYccFSBzkenvQB862nwx0WWeEb9TjTeA3nxAcZ68GtiL4Q6FJKNzXojHXA7Z6nmvobTbHRpciwiEybijlmDYcHp9R6VmtcvpVsn9reJNMyJHiLDSwFVgfuA7uo6YNAHgK/CTRZLhUilvsZ2kMh/OoZvhFpjTFLe6u+uCPLYle3oa9t1++utbtQvhedp4lmCG5sWSMsw6qcMDx3FWdNg8RNp9s9trWnQ6kynzke1aYqFJG13Vzls5yKAPBrf4Mw3DELczIFkOT5LkFM49OtWD8E7bzQovJm3MVGIJBj25Hp3r2SXXPFkc0qyaXbanZxP5YvLa/dDIQRn9yiEqRzkE9q3NN1S7ub2a2u0dPKkOXt9T3HbtzlkKbgQeMdRQB4E/wTtEkZBd3DHIC5hfk55HT0rTf4DWCcC4uy/oY2wPXn+VepP4l8RjVDD/Zm/ShJsEq+eZxg85GNuRW+NXvprzdBAYrPYTOzzs0qEfQ4x656UAeQQfs/wBqN268vY0ByOGHy+/P1pJvgTZJtEVzelj0I34PX36dK9X1DUPFsL2qaHaaXeQyhmU3V0wY889GzgDHB9aihvfiibhUl8N6Elupw7jUiSPwBJ/CgDy6b4J2dlcxtcapf28bcKXkZC59AS1TzfB7TYllEWvX0UoOfluTx/4//OvT/Dlvq2qPqFxqekW6SW87LGizNKTgZIO88HnGBWw2nSXEavFpGlozgE+dK5OfQgDPegDxW6+EdrG0X2fxLqXLYJ+1kZAHX73enS/Cpw7Lb+L9SUFzgi+b/wCKr1vSvsM6v9shtEuoZGE/2OKV44vnKqcsAeTgHAwPpWpbWdjeRtOtt5AJ2lZ49pJ5zjHFAHhVx8LtRFwfsXjPVk7EteOM+556Uxvht4gjVjD471UqDnK30oH8696uINFQt9rlskUHaWaXAHb0/CsxNY8OXkj29lfaNHMHxLbXEBV1VeuT2PcHpQB4rN8PPFcYcwfEHVyoAJY38wz74z2qhd+CfG0F1LHD4/1ho4x1+3Tgn07+te46+1z9ri/4RePwZdWrbfMF9OySbvbaCCMeveujfSIvMkWGO0hlZQWK2e9SfxoA+cR4O8cKUC+PNcd13BwNSlIB7Dk1I3g/x0rsF8f6wSoAO7UpB1HTk19IJpkW/wCb7J8oySbNRVSMabJcslle6Y9xHJ5cirboTuAyUOcDPFAHhcHgjx2oQ/8ACwtYQsMk/wBoucHGfWornw18QIbsJF8QtV2CPcS+oYJ9cc17po+oajf6hcWmoeGZdPgj/wBVcyvDJ5wzgfIvK5q/NZCNmcWMbHHQW0fIGaAPnhdC+JW8CP4g3x3fMG/tAEHn61afw98TotgX4g3wbaG+a6HX869f3aZf3scGq6RLazwxllVw0WU6gqIxtIJ7k8YqlNq/g+W4S2vSVlHybF+0tgjjgheR75oA8ru9I+K8MsCr49umdky370ELSLpvxZWNJE8fTkEk4IyevXpXsEC+DL2+WCymMt0AcRrPNuIHPTPOPWqmu6bo+nQI98rafETtjkmkchz6cHOcetAHl89h8Yo1Bi8cM655/dgBfT+GqR/4XOvlgeLWYsAT8iYH5rXZ3viDwYtsETUrssOAfsk+1m/3s/XmtU6GnlRXUNq0lqE4fYT8p78nt+lAHmkt78aoFUnxQWOMn93H+vy/5zST6x8aYGUDxDGy/wB4RQ559QVr0S7stNRUiW8iYrjOFBPXrmrEXhyHUSYLJo7nbF03KGA74HXv16dKAPLZ/EvxkjKbdfikL8geTDgD06deM4qOTxl8YosMddtVJP3WggB/Eba9fuPh9NJLbtDagqq8gTBe3Qcday9a8NzaPbJPP4fa5it13ymG6ZpGUZJwuRk+3egDzr/hOPjH5aSnXNMIIyp8mDnn/dpw8dfGWNBu1TS3Ug/eghx/6DXb3LLBY21y2iSXdlKMpFDBJBLEucjzCXx9cZ5plx4j8I6ZFB/b+m3ti7p5jIn2qYKM45ZFK/rQBxbfEf4vxbB/aGikyE8eRFxj14qQfEf4vx4AuNDYtn/lgnH+ea7+LX/CM9zZWtmhAus/ZpZtPmcOB1DHHb3rpLizs44oZY9J0K6BJ3GSN48fT5DmgDyRviX8YVVSU0SUsxHFvnoOe9OHxQ+LyxeZ9g0F0AJz9nbp6/eFdjrninRdMvhCfDFhMyqWXyFZDnPJBaMAcc5JGegyakuvGXhdLID+wr4lyNiyyqvpyTvOOtAHEP8AFz4tIiONG0VgSc7rdj2/3xSN8Y/izHb7pdB0NgWK48hw3T08yuqtvE/hW+geOTw/f26wkqGjuBLu+hBFaFvqHg69s/3OnyFM4ZHuD5sfT5nVclQe2cZ5oA4eT41/FCCBZ5dA0PbyAQjjB/7+Yqofj58RViLPoGhhTxjD5Hv/AKyvRdX8P+GdY0qSDR9X0WKUMHWX7eswUDrwQR7dK5uHwD5UlvJZeLLAzTy+UpsYkmZmxnHyx8d+uBQBzbfH/wCIxII8OaN87YVVhc8+mPM69Kt/8Lq+KxHz+CrckNznTbkZ/wDHq6258A+JoYgdH8RWF1c5yRd2n+rOMgqUAIOe5rJbw98bIpGU6+Xw55F8QMdR1U0AZDfHT4mgAt4Fh9sWF0Pw60f8L7+IiKPM8EW/ufsl0Af1ropPCXxmSx3yeI1jkU/M41GR2xj+6Exmq8Ft8X9MiWS58RWt9JwGikuZNy5HGVRM0AYbftE+NY1LS+CbfbnkmK4H4ZzUD/tLeJ4xifwdYjP97zhjn3rpZ9U+JFppMk97b2eqKHwscV/PE6MB7quR19aZpPirxJc2MkWpeEPE8F4zBgbAG4UL25eTkn0xxQBzg/aj1pUzJ4T07I4/18g/SpB+1NqYB3+E7EjgH/THGf05rpv7d1C1sWZvCPja7lVgWjksBAGUDpuBYr6d/WnaN46sZJJBqXw+8VQRAHdLFuuiGz0wAMUAc0P2qLzLbvCdpwMf8f7f4UJ+1PcMJFPhO2HHBF+QR/47zXoC+LvCr7ol8J+M2yMEHR5GI/8Ar+9YB8dWVtNJax/C3X7psZYyW4RgM8cFPpQBgf8ADUs//QqQf+DA/wDxNFdH/wAJxB/0SPXP/AYf/G6KAKOvDUYbSSG5+JGo6ZopaNYpZLBIJrg8lBCyBF/vbju6AZAAqxALTTpze638QZE1CNFluQNFsg6j7qvJIqnAJOMs2e1PttNufB2qW+jatb61B4dtLZ7ey1X7a7QXErMCqSxIp8tTkqSemPTmrXgP4U6frEI1/wATwPc3Ny2+2E0rM0cRyBz/AHSp4UrkfeJyeAC5fwajJOE0vxP4ruHhjIuY1s4IrVM8sJWG1Y5QpDZzu24PerPgeyF7rl+pu/Foe3iWEm7vF8h+uJYtrHdn+9xnFVR8KBBJJDpkcGi2sUQe3vIZGad5lLYEke4xshATOck9+mK1tJ8L69q9vaTeJ7xvtEEXlW/2djFuI/5bvtwFJ4bZg4xigC74es77S7bVLWLWEvNPIBt7m5yHE7Z8wyyDBJJC9McfWsHWtc0+01ezW8aVr64ItYJ7L/S4dOmAx5kmTgFs5IIJ7niuvl8IJM1xFFdSOkzI3lX+J4VCt98KuMs2FOCeAB71y9v8PY9O1fXL+zsYJH1G4UzRSzmM2qE4YxrGTy3ByQvy8GgBNA1vxBJr9zDpd/4Xl0RZ2VHa2mgmeVfvgLnawJz849M4rW0O91+8gSXVm0RB++lm/sp5cJydoZunIB5PJIrR0jwoNHFzcGyuLq5ecCMSSDO0HAPJIHBJ98epxU1l4av9QiY600kFq155kWnADbHGmR8zqfm34Dc9M4oA4W71TwsZrWxXR9Q1TWbsC5KaPG7IysxxJvYqH9CRzkH0ro9OtrCxsr3VrLR/JeBt6JJJDi5YcEeYjEKc8Hd3NdM+hWms6JcW6y3ltZ3h24tpPIYRrwNpAyAcex+lVr3wTo9xZi2+z+TbLkvGshVSegLKCAe557nPNAFjwrY6LBbNqOj2y2UmqL9omXneWOCcrkjOSASKqjWmtrJ547Mp8++QSqPvltmSUOCc4z7etbek6Lb214boRbWKeWgK8qPUEHlT2BAxV1bQM7SJG0eV8oq33WUHqoB6nPXrQBhanrC6Zax3EVxY2LlnluoJoiplPAZgQMg55yQcjHTrUNhrWqX8Ec+jeHVtbZpHEyakxgkdgeXRVB3AnucZreh0yGGKb7HDH5qqI9043MwUYGTnPTv1qVElESCS3MSxhUSMuoBOeSD/AE70AYeq2EuoM+lm0t7Oxn3SNLGglLTbg4baw29c5z1496pQ+GF02W3e3jklltXb7O8b+WYwxyVCnIOeSTxW3qN1LJDKZLG4CxSEAxOGeSMHl1Ud89jzjpUWm31reaObjUJVs9rtHI0jvGOTtBLSBSc8YOOp4oAzNS0XTLjUvPGX1SAGUQFiAm7ucevPPqKz72LUm1OO3OiWZ0uGcSw3eHF1GSTmXccrnrx0NdZBfabpumL5l3bW9pCqx+bJOoUY4xnPXj8ap3/iLR9Ja2m1jWLTTUuYi8UF66xo2OT8x9Bgj2+tAHNt4b8MSajJHeNo11elvOYnTkebLEne2ck9Kgv7iaMXM+hQSa3PZv5dpiMRKJScuoZeVXBI5549K6ay13w34stZBo+q29zAsjI8tvMY9roecNxkcj2IPes3WPHngzQLp7a88R6fYXbkvJG7FnLdNxxnH3Rj2welAHPR+J9YsLk2dr4e1KSZXcndLIVVifmGdpydxPHoK1vCVnqE9nqF5q8lxCbyQ+Xp9wzSJDhiSwDKpXJPbg8U208UeGNSs7S4tLq3vLkykTSWc6oInT++rSDCtj3FYk/xC8I/2iUtfFGlQR3cwikEUkjzo3K5BIKIAQPm6YyfSgD0WCwtoLk3cNsq3a5BuHjy4VuWUEngEjp0qbybe23uLm5VZGaRyZCyx8ZJ56D/ABrgr74g6LYRz/2Bp+uazewkpHCttMyzqv3pFJ6jJAEh4JPGauaR46sbhvsuo2mvieSEtI0mizeVG+T+6O1Tll4GRweuaAN6fw/pkzXhm+2zS3biRp2kYPggDYrZBVOB8owPzrE1TSdc0m9sk8Kak1to3Ju7MwvNO7E9Y2ZsKAMYHAHPWtLT9attVaa5stTt9OnDpAYtRhaORVAOQY3ZcMTyGHBGOuKsXlxdQWUc9vfm/wDMHSNUXy9inc6KfvqW29+Nw5oASOKTVopLa+g1UW6yCSaG6t43W6BH3M84GecDHQ02TQvItlj0OK2tnVi2by386Paf4FA5VfYGsZ21PUrKC61rStOtmhhkje1GoytO8hP+rikO1STjBPJByBkHNUZPiRpl7p8LaE2rQhZDFOf7NldoiAMEFtoCZ4JJ6Z6UAW/+EdumuJEuLfQLpbt2lMEsEzpnHAwQQqgjIB9T61dk0jdJ5pgmS+jAcTNGGic45VQcnbjPGBgVj3fi64e2sZ7Gfw7rCLIUuEGoR2RtpB0lcb2yuMgqCT0IzzS2PirTpbG6mtbC989g2Lq2t7l4JFDAySCXYQoHJAPJxyBQAlnoVheX1+ms6FpauzmS2kjgjlZUOBtIZAFAxwOepq7Fptr4VlW40uyvb6SclJora2t4AyseCxAXIHIA981JaeLtF1C1+36bq8ItgmFjuZkhEr+uSSRj+IYyKBqNlqV/b3Ca3Y+WjYlitdSV7dnPyrEvQkk5JPHI98UAYs1jfXuox3MGmWk9pIWZPPadpIlJ4HyjBxyB7AUW2n6zZ2s0ptreVuTbPbW5kuEUkkDa5XAHIB9cV1Vk39sSRXMWvyrCqPFtjUQlpg5BDIckMoAGOM1zF74l1xpQ154YtLiOSNrIapZakHDqTn5UUBgAy8jOcjHvQBaE089tIj3Piu0gl3bZnVInjYEnaXzwBjAxyR35rmlha5SO4vNVvpLyQjeIxdPCi9dq5dd2Bzn368VvT6stnodtcyWL/Z7r90sF7eI8RkjbJczKWRW3cctnIIGSKn1DVPGEsFhenSNJaWLcXsm1OUytyQcMi4cYBO1sntQBBFqusWfmrJqU8tqkuyOVrLYVQjCKFb73IPzA9Ocmo/D2vvpkMcmoanrupXA3BytriJATwOfmIBB+bueKV/Emo2WpzxaNp/8AaGnvCq2+28hto1kI+ZJHkfcpBAAG0deOKtLKmoXUlxEG0TWhFI3l6hbh0hmcjaCwfaQpU8989u4BalvriXbJNrHie1iuAZo0ksYMRgcfxR5H1JzzVIarf2jTNd6vrUUEp327NbWUhdOBz8nHPPXHzCrUukeOF+zrf63pl9cxnIhtNMVCyg8gF5AuQOTnP0PFWbe31+6kvI9RstOkmJKtFazK4ghIBVZCWDhgc5IGDjgUASaJ4hV7SYvbajqcu8kTS2MUbJx0KoBnoTmsCZdO1K0vdTvkuIpXYCTy9MEMjqPlDZycr6EtVvVrvV11G1OueD7y4d40CXGg6i8pixggSRnbxnb8xzkHngVlat4q1/wtqrHVtEuV0mRgZpZbjzJYozgE/KPLznjYGJ5yM0Ac9r/hLSNP+1RWM9jbSZWR47mIxSQRHHzEhWBUn+L3xWYPBV9FoV5dxa6baxmIEU+muWUg4GJGCL8uc49wK7/XNYjlFrPomoxRxtc+TeRXKTys0JxlY1jBK5B6tgqQMkd8XWd7WFv/AMIpos+uWwkeKO7kmuAYJuhQwyYZgRzub5RnigDmdN8DavqOkyWepeJvEDyxyBBbT2PneWGX5c8k/MOQewNY1r8C7iSymddamQxS/Msts0bxKeFDgtlckHH6V6tZa7rN67fYdFvtWmtSI7uOGKXTlwSBtZZRl2GWOQSMA47Vbt/CVnBq6/23aaVCkXmm3uoNQcXDNxujeIKqPgELvJzyKAPDB8KdWur+NLfULG2t5JUijhsr6eWGRypxhmy29gpJx0B6dq6bQ/h7YaNDd2+vf2Fdz7zFLdMXuXtvl4V23cfNlQcdsdjXVSWXxakW9bUtD0+a1lJuII7N4YZ45BkIpfeCOucjJHY9RUSf8JzZ2mlXFr8N7G61Wyjcu09xGHYP1IKv8zcYywJON3BOKAOX8XfCnWLezgfRZLiLSJY/Plh0+IsjgJgEpI3zTNk+gxxmuT1LwXqypAuqDxPJcKsb26zxx24K9QEYFskcZA6e9et6fZ+MptOspIvCfiDQ57R2W1lg1G2vpI1b5mIFw4ySeCCOAO+TUemQeNbVrm1updd0+Npiyvd6PFeLK7HJlJQyBDnAwPl+Y8cCgDz+HUfHyMk0vh++eKRlMJlaNlBPQkIFY4PQDH40nm+N3uJ2vtSVra9lUPG6T4tGBwSEV9y8kdc8dq9nju9RitktbjwzceI7mFN17rX2VbEo3IJjRl3SFeeUGemBVV4VvpobPStGm2yKxmk1G0mVxu+8I5DCMsQWJO7OVAGM0Aeew2NtpjajH4p1a9kSOIeVd211Pbtkk8kjgA9ADz61ZuZLe3tlTSxpcs5tzLFJe6pPdajN0zlo2CgAFcc16LB4V0Ox0+yhuPDk+mWKsICzyOwZRkg+WhYnLBTh8Y4JJIxXL2nhDwxomoz2em6F4g0++MZa5msYJb1JG3KwxKccqeoUYO8jJxwAc7/bemf8/h/8HN7/APF0V0n23Qf+hXv/APviX/4migD2uaFJI3jcK0cilHjbBDDHIIqTyxH8u0AY4A+n+FCARqQzMdzZBbBOT2+lLGjKqqGJbJI3HOc84oAay/L03MQdvYE1GIy+SzHcRggdPw9qljOExuJx1Joiwq43FsdS1ADkhRdxReXOWI6fjUEWm2cDztDbxI9y4knZV5mcDALHvxxzVqNGC4LMxBI57j8KavyxkFix/vNgHrQBkto+lRGdWtogtxkygu2X4579MelGl6Jo9gsX9nwrGEQrEqXDkKuOcAsRjFYXifSTJdBYLnxYZnL3Bl06ZVjiYc7fmGMnAAXnPeqMvg1PErWepx+JfF2myQxmNVTy7aRSCcllaPOSMDI4OBQBr6/438O6DfwW19r1jbTkq7xTM7t5eD90KOGPHWrGl+LNB1Z5IdPe5ll4JVrKaMsSeMblANYUfw8vrOAkfEDxlGGctue5gxk855j/AK1S8L+CbCaAonjzxBrwsrjzUZdSVmtpTnOSmeSCwwxOATgA4wAd5rPiHR9Ciil1a+jtUlzskbOxsYB5AI4J6VkRfEbwWFwniXTmJJUfvS/J/CsK0+FtroEdxJ4Q8Q6x4d85zI0cUiz24Y9xHLnB981bTwNrEzMJviH4kC5JmS3jt4Q2euMIdufagDpNI1XQhpLajp8iQ2M8ju0zxNH5rLnc/IyScE571Q1Hx34RsbqJbvxJpsLScrAZwzOcDnaMkfp3rnrz4ReGNRa0tvET6/rVwHkkiubm+mJjJbcSSpCg9BnqcVZtfhFoKwKl3f69clGYxSNfMkkK5zgOuG6cZJJoA3vDPjPQfFN5c2/h65kvjafPNNHbusUZJwBvYAEnBIxnIFP8Q2Oi63K1pq6PewwJvmtBueAqc48xBw3IOPQio4vB9nFNoZkmu2TR2k+yxLKyRjfx86g/OQMYLE85Pc1YPhixNpBb2kt5p8UDMyjT52gUljkkr0J+tAHOW/gX4c6bJDd2PhrRWlLKY1MYZhzndtc9uvTtW3fWPh0mLw7JplpewJFv+wCNJUiTJ5MROeSTyBVvSfDlvbW8i3d1dajJIro0t2VZ8Nno4UMODjrVK98C+G9SCvqmjWtxdqgj+1rujnIUYA8xTv6YHWgCnc/DLwRdxqX8IaOgHIUWwj2+gIXFYguPAeiT3+h+GrHwp/bMXzTWdw6Qxqx7M5UjOQMqMkcZFdnJ4eWKyig0m7l0maMqGkt0D+Yin7hEm7II6nrnnNadpp9tFb+SlraiNDlQkQCgnuAehxQB5Dd6T4SvZlmvfhQ13fuqiYae1nMqMP4eJR0x6ZIxVr/hLdE0GG8kX4a6/pcEUaozSaXBHFJghQAwY54/Re9eoW2n2lujGK0tY5WJYvDAqbiT14FRS6RZXOo6fe3lvHPfWO/yJDuxFuHJUHgEgYyRkdjQB5xc+PZfD2pXOpax4W1eDTJioj1cXKGKSIDIbY5V0JXHynqRW8PHttqVtDcaKI/JZPNNxf3UcERTGcBstnI/Ku3I8zKzLFKGBDjqMZ6YPtWC/hHw/cIyXXh/RXaQkyFbJBkZ47dcYoA4OXxJLrm7U7PwGniGDJR76xMM4MYP3FMu0u2B/DkDoCadZfFLQ7eWOztvCniWS7jzFGlvpTouT/Cu8jaPrjkV6wIA8SpdRoyocoqjAXB+X6HGKlHmbhvOSCQeTjH/AOr9aAPM7vxf4hvjbSab4E1uR7cs00VylsqSnBChXMp2EEg9ORVIXXxBmkmgtbS6WQxNOU1WK3lt27iFZISCGzxhlIPrXqsQzHjy0UAk/IMfQ/WkQEnLoqNk4CsTx2/HGKAPELPVr4ztFdeD9T0iWZ9wstM0QPCydQ0zNGdzqc8AhTWhLe6xJMdX1PwV41lgidZIbeO/iCvtPEhtlYbW7lTnrXr8JmUSGQAckKFbORng/lUawh3WW4hRZQzBeckD2PuOtAHlr+OxHem+l8IeM7eFAEGmy6RGRK7HGU2gnJJ+Ylhx61VXU9b1GNr2PwDqV1bsGS507V/KtxufAAtUPBAAYncATnr1z666LNC8cowGyMK5B259RyD9KcikwqZY1XYThQ24gZwDyOuKAPGrmXVr6Ox/s/xBqPhKE73k0uPTfPeBU4k3Ha3z5XKndgA11WmaV4gPg8S6T4rk1KeeMvBLMiGGYNwGY7dyjHJA75x6V6BC8zIDKoiJyNoYsAM+vHOMGmws0kaNNCI3PVQ24Dn1H50AeT6h4U8YwXVrPZ3X2mFYxFLpodPs25jl3IdT5gyMjODnnPaoovBnimOWOWXxb4jeGViksQvQiwMfuhCoGVB6k9uma9gj3OoMqCJgcYB3YAPBz7jmljLH5nBjOem7PGeDn3oA8f1f4ayHRo7aCfViJZPNvUWG1uJLmUnLyM0gyQzAHr07Cq2qaTLpOnReHrTwfq+sy3EJgW8lgiitF8xefOCNkgEDdgdBwc17RCGYuzRlCCRyc5GcZ/HrTl5BaWMxkblAznIz149QM0AeLeFfhn4i03QL+3OrizmlcXFsNPv7xYkfjIZHO7HAUYbpXO23w+s4onijuZ9b1GU/br9Jrd5bhX6gR5kVSdw2kMWGAMc5J+jIWaQEvGYwpOMnO4djx68UiEOTuUqYzsy2M49fpQB8+6N4euNWEw8O6jNpelCQfaNNkhmsb9pzn7spPyk4GDllHoK67TtO8Q6FYXaWnh6/vPOYiXzdW87AwNsqls+Y/HPAxwBXqUEcgeYvLLJljsD4AVew46j3PNSxFsYVCuDgsSMH6e1AHh0vg7xBNp15cXWq6zZThzJZ2Om6kqXUhCfOJS/yvIwVSMEAjGeea2vCvhq5udK8+7tPE9tHJIxl0+9v9kkzfKDK7qzN0B2jdjr7V6vGELPmEqyt95gBuwB82f0pY5NwOVZGQkYYdQOM/Q0Aeaat4RtzrVvFpF94xtMXAN5Np2pOFDEAgyiXIdSNoymSPauyv9AGo6SbN7+9s3Zw73FjMYpnZSBy+O4ADetbfDbsqww2OeM+4pscm7dtR0KsVw3G7Hf6e9AGfNpls81xJAjW1zcIQbmM4k5AHBOecKPyqMaR5898l+8Nzp0+0pa+ThkYDBYtn5icDsMVrI28sMEMp9MZxSr8wIG4dRkjBOKAMe/0b7Ys4i1HU7T7QiZNrKF2Ff4lJU4J6HrnAqXRNOk0rTxBLqN5qDbs/aLsqZWHQAlQB2HOK0YiGB2hgVJXlSuSP6UqOJMjoeh4Pp+o560ARBfv8EbjlizHj2A7fhS7RvdlzhsEkkkccUI4ZpVw2IyFO4Ec47eo5FAIZ2CnlDtIKkZ4yPr1oAqXdssqtywDsvmKQGDgfw4PTPqOeKLaxt7aJ47dTFE4w0aZCjJJJA6Lks2SOpNWcJLKUyd6EbuCMcZ69+vamxshneMFiYwpYYOAD0+vTt0oAof2DpX/AD6H/v8AP/jRW15i+tFAGZG8c0YeIiRWyAQePQ0sbrIishDr0yDTyQQxySCcf/WppyDg5xj1zQAxCkijy8Nu6EYx9KkiUOhKkBcHHPBoVgSAc7vp6dqd07AZHUigBI/3kII+YHgYaqWp6tY6bp8l9e3MMdoBgSM+0Mcnge/Bq1BNHOrGFw6AlCVXgEdRWXrWhR6tqGm3FzcXC29kzO1mmBFOxxs8zjnaRkD1JoA57wL4l1LVLzVItbtmhtT/AKbp96IDFE9qf4TuJO5SCcsASCDgdK5m78V+J/iBNHY+ALWXSdGk3CbXruMhwqngQjpubjB5wOuDxXoeu+HrTVryKaZp45YzgvGxAdMnKMOjDPIyMg8gitaCG3s7eO2hjighjTbHGg2qgA6AD6UAeLWPwOGrSm68b+KtX1mR0y8UN24j37uWXOcA/wB3HB6cV6N4O8IeH/Bum3EXhu0W1gkAeUqxcyFAcEnvgE1sS6xbWdrHJeywW0M0vlwESf60nlQFwDuPJ2gEjHWgT2Goy32mZV2ji8q4hQ4KCRehx0JB+tAHKeIL3UL/AFGO38Gzo1xewb57m6k32tvbg582OLOHdidgPHIOelVPDug+KbS+sNZm19TLd5jvdPubmS7tUXICG3wVw5C8ls8k1b8NeHtD+GVuUsLS9+xXEm1HjjMohPJ2nGWwWJOTkA+ldTomqtf3E0MFi0MdvgyTKT5ZZucRnaA/8W70OOuaAJ7nShc31teR3l9BLCT+6hnxHMOmJF5BHfsa461+Ikuqa4tromiXV5oxlaBNZbiCWVD+9RB1wAGAc4UspHvWdq93r/hXxTeWVjYtqGia1K7IIFH/ABL5XAG8j7xRiSW4wpwe5rQ1fV/DdnFDZanp2lQeGLMpb/a7p1Eds5GQnllCqngDlvqBQBuaB4r07Wddn08SAX9uHZIkcuroDg/MPlLccqM7fWs3x1qHiIumieEDbWF1KV8/V70jyrfeTiONeS8x6gYwB16isyW7g8SeGrC7+Fd/pMUmnXTWyTC03C2jZirkRgZwRyOxGD05qWx0+bwhaRLqbS+KfFd7I8qsEWCMlVCgqvKwoF2puA5z70AcvbJ45sYJ1m8R6hqGs22blg9oRZ3USnLpEdqjO3GPmOTnoK9ZGr6ePDy61JdxR6YYBcm5k4URkA5J57frWDpOr69GtudW8L22kWMOEuNt6kqpk/I0RUAFQcbg2DzxnBqr4d8K2ujzzx6ZrBbw7ZXLTHTJgSLa5UliFkJ+WMbg2wgjIyDg0AbL+LbETWP2201OwS92m3kmtG2tuOACVzsPGSGxgc10aOjKrIQ0bruDDkEcfMP8a5i31LStFjury61KG30653TF7u4KJkAFvKV+CpXBODj2qfwjfJdJc29rYJbaREIptNuIG3Q3NtIuVYf3SCDlfTae+AAdDImcDBU9ODgfjTUVvLOSM4zkHr9azPEOu6d4Z05LnU57e1tg+wPcSrCik9tzkD1wOprG8MfELw74k1qbSNDuUuvs8KyCWKVHibk5QEEncAM+4+hoA6tlwzsq/MxwxzyBzz705AWfIXOPm+tLEvlOFAITOVBye9EEapGqxfMm49Dkdf6UAIQwcbRjndzzkelOdW8nI6HHLcUkcawgRqCFHJBJY88nrSgIuAOm7IB5oAYVOcEEZHPOTSleNoGDkHP+fxoSNYoysYJCkkbmJIOff60RjYgAY9d3JyQTzjmgBdpD5AwOozwTTAuACFYc9/c08HYRgsRkg7iT3psOIlKgScEn5jk889TQAKoAARR1yAPzpdgO/OfcDrnrSBRt2x5yeRu5zz0oiHlosYZyRz8zFiR6E0AOC5ZTngjnPalRSASOg/IetNhjMe0MzSEZ+Zsk4+tOj/cwhNzNtP3mPJH170APAK7slivJz7UjjOBgYXGMn0NOUbYwpYuMfebqabGuwIheRx6tyeuaAJFVQNp2k5BpcA5Lc9wKbEhRAC7MOTubr1p0YZY8bi5znJwOKAAIcjHA7/0pAq7iePfnp/jRCCq4ZyzZP3sfl9BSxKyA75GckkgkAYBPTA9KABcKQO+KUrkDpTIVbktIX+YkHGMAnp+A4zTowVzucvliQSMYHYUALjkkg88YpDkZJB+lEakAhm3ZJIO3GAe1ESyKCJJA53E/dxgE8D8PWgBduUwMYPApF5fBXoM59D6UqblGJGDHk5xjvSRK6hvMcOSxIIXGBngfh60AOZcngDnvQeCemTSR7hnec5JI4xgelJGH2sJHDEscYXGBngfl3oAeCD05pF6fLjFMjEigiVlLBiRtGPlycA/hTo9+CHIzkkYXHHpQAHnIPIJxRt4HXjuTQgkGd5XGTjaO3b8abHvBk3lMZ+XHZeOvv1/SgBGZSTkHPQD1pnJIBb+venAMrSbguN2U2jnGO/456VFEX86TeFVARsPPzDHOffOelAE2I/7xoqDcfT+f+FFAHinx71HVb+XSfCfh46kupXaTahdHSWzNFFGpWPuvytKyZ9lNc2/xb1G40bQm/tu10V5dEuHu5J7cSub6BwmwAnqxGccnDevNfRRG1uDk+n9azpdF06TxBb63LbZ1SC3a2im3MNsbMCy7c7eqjkjNAHg+v/E3xrZ3tit0thoc7adZ3ot75AiXsrgeauW+YYxtCJ8wPXNdVZ+PNXk+Kp8Oy31oNDF68Y1AQH55hGG+wB/ueYCSd3UgY+9Xd+Mby50XUNB1NZWXT1uxaX0ZPylJ8Ikh91l8rnsrNXTFhs4O3PoP1oAYkmEUzbY3cAKpcdcdPc9aR5TFBJMyncqltnXoDx9eKo6pf3FpLhLF5IQhkMwwyqw7bQdxJGeRRBqllf6Z9pt5RPayxmQbTyy5I9fUY/CgDm9B8bx3FsY/FtifDur+S909hPJvPkrk71cDDcYyo5HpWdpfiDVp0uLrxjGNE0+SJDayxSOySq+OCNoCv0HJyd3FW7DwTqcN6kmpeIXvjFdx3Ye6gSQSOOP9XjEZXgKynOM5rXttFbUFhfWreK4ELPsNzIZHbc3O5eExkKRwcY7UAc/J400W41BIrDSrq91q2LmOO0i+1PChOze0kYZIy2OhO7HJ61W0Vm0fWNE1KXStT0wXw+x3VvMcovmsWEr7eDIrhV3EYCvjNd5caRZKluTJJbW1mfMWC3lMMWcdXC43AdeeKwfiSZH8Ki9sF+1RxyLIfJl+8pOVYMOwcITj+HdQBvy30GbWK5doJ5XYLbS43ykDJQdicEHjNYGtRai873ekLrNtrJjYxJMxezO3kCVVbaCQOMYPzDrUfhDXm8aiC+nsP7Nlht8IRIXeGZyRIFJA5AGDx3rqtH0uXS5RFaTp/ZwXC25U/uz/ALLEk468HPbGKAMbwprkup6Ct7qVm0F1CjpcCRBG6kAMPl5KhgQRz2qPw6uoyeGrabxDaWqrdfvJ7MWhYRsxJI2jPf1HqScnFZY0qebxV9o0y8WxlhQxXMXkllubbe5ijOTs3KSwBHzD3BrrbjQodQ2z3r3EV20YVpba5khZVzkDKkdM0AY1iY7TxFE6QrbW1+gRoxB5LB1G6MsOnKhkA9gPatGEM+r3l21lKJBbpGsj/eKcsUwMnOScjvgVi+LfCOlXWkRWK2ieTADNuuEMkToXHmo5LDJYc5zkEbhXPR6nZeCPCesan4cs31nTdEjMkUVvIz+fJIVUMHOcqsfLEZwCSKAOl8SyJqFl9oRNQtms8SpNPbyJHLEeJQ6YAG1SSN2DlQRVez17T/FPhaS21C3kSZJVs9SspgY2SYAHZIDyVb5SCM7lP1qt4J8Yy+PPDutk3OhXMcUSMkml3MkmdwYlJI5EVkPyjk8MG7YNZkfhm8N5odxdXL6jDYRCPTDIQBFK3yrI7A5lwjHgjj8c0AUb3whrutWqavp8umavb3gWc2uvaeYjA8eRHNDGpAAxj5H+8AuTzXSeANX1e/8AC93Z2ulW+m6vpsqQ/Zrt28l4zgh1A+ZEYbtox8pBHOK7LT9Fsbe1t4kWV1ikMweSRizSHksSTznPTp7V598R7JtN1+DxPpySS6pYIYEt0V2aRWG5I1UMAxLZ5fIAZscgUACW9/498R302q2VtHommMY9Lhu7QTLdTrgTTujjgAjYnQ8sRVqfQoNJt9P1ea00tHtbgNL/AGfZ/ZFW3lwjFu+5S2/8DXS+H7O9vdL0yfXSEuFiWWS2idggmI3MW4BOGyAOnfFaPiKB/wCwNRjt4VlkeFkSIIG3MwwMg4yOefagDC8b6pqejaDaW3hu0fVdXvGFvbRTTeW2wD55WY85Uc59xXDJ8HilnNc23iO/0u7mjJaS1uJo0Dt94vukO7OTkkA5OeKt+GdS8TRauug6hqVtq2vJEAlylo0H2GGXDu8u4EF1G0KgJyAN1dLZfC3wlY6vFqttYTJqCyGVpmu5X81j1Z1LFWJ57fSgDY8ERww+G7C0tmkZbVPs5852Z1KkjDFvmz6Z5wR61zmufFjw5pMxjWS7vHF2bRktYGZ0cHb90gEjdkcelZ2urr2h67fP4Klt40u3bUr6K+ieYZUCElSuWy2EO0DjZnvitQaxonhfT7aa9+3QpHMRJcw2Ejrc3BUCRztUnGSTk47gdCKALXw68dQ+MIrv/iU6jpbpIxhS8XBnjHG8HoGz1Q8gYPINdDqmr2Ol6XNqF9OkNqmAZHbaBzjJJxge5rhdS1Kx1CWLxx4LtW1G+s5jaXSxwPHNfW/8aRg43EZV1JGDtxnmq9zqsnjzUNLvPDenP5mmrKWOqgxxWsshMf7xBnzHCqSFBx8wJNAEjfGrwbPHOmk6l9tvEkCCMQSxxgFtolZyvEQOMuOBXpUbrJGrwMsiuMgqeD7/AM64eHQ9Z8MxXWqarreqeKIRGyTafDYQKWUjB8pVAIxx8uTketc7Y+Krm08Kt4d8S3GmDW7qzEOnae120l3cxt8o88gAKxU4wMnqe1AG34g+Kum6ZqU1tpeh69rtvZS+XfXmm2bSQWjZ5Bb+IjgkLnjv2rvNMvrPVLG3v9PmW4tLiJZIpU+66kZBH4EVwNt8PdCkTSE1RZk1KygSKFodXuEdFXnam1h8o+6CRkgCp/ANnZeENe1nw1Z2s9vYllvoZnJ8jdIx3RKWJw2SCAOozQB3j3UCwo7zoqSEBGZgFJPQVJGyTRLIhVlIDBxwD9K8t8dave654ubwn4b1K+tdTsYxeXE9vDG0NvkAqswkBWTdkbU4OQTngVm+E/Hniy18b2vhzxfYrc2U4MSatBZSW+2YdBIvK89Mg46UAezB0kUPG6tGwBBByDRDIskQeNw6sMI4IIasnxb4i03wnoE+sa1I8NhbkCRlUseSAMAdeTXhzfGHxjqMk+mafoNxp8l1IRper3djIIHVm/dCRcEJle/PbIAJIAPolJEmVWiYOh/iVsjrSqVkLMrBlI4IOQaw/As95c+EtLfU5Hm1AQKtzJIFDGUcODtG3O4HoBUGs+LtN0XxFZaTdPFHNdRNID5qgoN2ASn3ipwfmAIBHOM5oA6VJFdN0bB1PQqc0I6tjawYdODVewura6t1eyngmh7PE4ZT3zkce9SFV5UAAk5HYfpQBLndwMEZwaRWBxjBHTj2qKSSO2DYUAE52p1JPU4/U496kjAVQFCqp+bAGBn/ADzQAuQQcfgQc9KdnPQg03hBhRgZJwo6kn/P502NAseAgXOWIAwMnmgB+eCQO/agnHYjnFJGiRJtRQi5JwPfmiJVRMKAoBPT3NADsADGM0A9wR+dRwxRwII4lCKCWwB3JyT+JJpUjVAQOBuLY7Ak5P8AOgB2TnOKXOPp0qFIPLjVID5Y37m4znJyfzNKgji3KpABcsctn5ic96AJSfw7U3IDYwc/5/xpkUKQqwiyu9i55zyTk9aI4liL7CcMxYjJbk9evT6UAGGL47Y6elIw2rjkjPPvSRxLBJIVJO997bmJwcY49BwOKZHCkUsrqWzIdxBYsBgAcDsOOnrmgCXA/wCeZ/M0VB8v93/x2igCjatMqsk6sCmArN95hjv79elVUubwTKkVhI1mgIluZ5gHGP4goBLA9c8fSuMbx/ofhiwj0jULlLXVlDQafZYkuJJowD5EhOCSHUDnOM8V5h8WfDOh+EvB0ni86xrzeIrpYzBNa3JRHu3G7zWAHy5Ut1PQYFAHu+tQ2et2+o+Grl3LT2bK0gcEgMMZ4OVcZDc49R0pvgTVJ9U8J2cmoMF1GDdaXmTyLiJjHJ+bKSPYg14Z+zD47a9kbRNQtbFL3y5ppb1pi13cyx7eZQ3O0RnAP/TM+td9qPiZPDPjjVbDTX0u5Gs2K6vBDcXyWy+eqiNgGIIw6iJh/uufWgDsr2aZ797e81DTrawjQRyW1wqyTXAY4353jaHG5QNvXNcp4Q8KX+ieLJ7aWCAaJbsrQOWPmSEZCtGowEG04cHIJAOK1/ASrq4utZ1jwnp2jaxIVzKlzFd+dGF4cSKeB1AHHtXaRbZAjja8Y5BDfkRQA+MFIl3sztgAyMBlvfjj3p0aEQrHK/mkjBdgBu98DpQpXIkUqQedy8hh6jtinL8y71O48HK9CO1ABs2RBHPmHbgkrjcfSoWUwW8aeWJdgwFVQu4fTpVnG6MnlgV4wM81BqFxFa6dNdSndDHGXcp8x245x60AZXhiyurW5uVu55JkMjSJ5kSIVBPbb2JJODyPeughBVFDncehYgCuX8Aajd6zHqGoyW32fTfNFvp0Z3eY0CD/AFjhgCCxY/L2211vB5yNvXNAGPd2c3nRTNOrWy7WeMx8vJuADAj7v/161YlcRIJXEjqMF8YBPc47VVvLC1v5rSa4jVxbus0TBz8rDoeOvWry4xkYx6+tAHOeL9Uh0bS4JtVvIrSwdvJnvnACwFlwrEHI2lsDngZFVNKsIPEHgzybS+ltLa5YGC90ki2bYjjY0fBCghBxyCpxyDXUTwQ3FvJDNEksEibHiYBlZT1BHcdaWztreytILW0ijhtoUEcUSDCooGAAPQCgDmfB3gnT/C+oapqFvc3t/quqFDdXt4yF3CAhRhFRQBk9FGe5NVPDnk2+pHRHjhTUI2kvZhE4YHnYsm3JK7htIB9PWu19Ace4qtb6faW15dXdvbQx3V2ym4lRQGlKjC7j1OBxQBKA/lbcqJcYzjAz/hWJ4ieG1jt57sySAKwKqjMjPjK7gOnPTPfFb44zyTzSL90jBx0we9AFO2S4WytvtIVbvyl3iMfKHxzjnpmpJI2NoTMvnOo3lUGNzDkbcnjketWAq7hxyPel68DnmgDmfCkurXUUtxr+lxaffhVDJFOJEbOT25BAwDnrj0xXRIrbF8xRuHXH9KSWCOXIZSB14O3+VLDEkAcK0h3OWJZi3J579B7CgDjPEFm0VzLdXWptpsgYTWz25bBkIAbeufm6bQDgfN64rsLf5beIMuwgD5V6DjpSXEccuI5STghgoOOQc5qbII7nvzQBg6uqvCq3+BFKfKkCOVVj2QHrhumeKzPCelGK5nkAjtolK+ZbW+GjdggCndk5IAHPBPGc4rrpYkcYZQeAQM+/XNV7KzgtoyltEkcbtu2qfl9OB24oAliDkIZFUTBcNtORn2zXnKeGrWa5W71LUork3NzvtLbylYWtwGPmGJiNx+bkZ4XHccV6JALlZyZngMJG0IiHO71JJ6e2KqR2NyLmOeS6kbyZJWWNcYYN0DcdB2x+OaAIbfSbQ7GaARXPlkM8LndnGOWGM8eorzz4paBa6rf2F1qFuly+nWb3M8LXLiOIJnZOFC/vnU7gFJA55q3qmkfFK8kvLyDW9CsC+6O1sIopHWIZ+Vnlxkt65XaM9K6fxhpms6jYpHo909tcGJldkcAg7ccEqR1PXHbp2oA4bw3c21j4IvJ9YS21uW/f7Vqj2cR8yaWTp+7GRwirjnHBxjitHX9Ss7/wLC+hsZLzTbiOeCynZo908Q3iFy2MKRkZ6e9TR6XPo2g2WmXOonT7ohpbu/2oogXIQsr7dokOVK7gR972q8JdcufDevHVf7OttRtZn+yzwbmUQbcxuwB+ZiPvL0PTpigDx3TfEeoa7e6Rb6lrFr4n8yZ5reO6s2js7a+YHEbEgmaNQx2NgDOGB4xXt/h2/juG0+3vG1Zb14ydk0BCKw+8dyjaOVIBJ5zxXOeFPD2qy+Izq2rT3vli0KxTGNII4VOFCQRAkoCoyd3I4wR0G5HdaPb6jrF3DHaT2dvIl1dyQeZLcCdY/lZv73yqAAufw7gHIzeMP+EO1TWn1jV7d4JpZ7qy0m1tyZxhj5zSNyBhs4Y4HBOD0HnesfEPwjqfhu1PiG0i122tkCysIZ2uYGboY7kIqq2cnHAbruHArqfHeh6zrPifU5rHQbXWdFnhW+bUNRdljjhRPMW3iVNrby5J3HOC3tiotP8AE2p2c+ixavqt3bQXYSa1gskj8q6SQDbCxeMKqKik/eDfOSTwKAKXw88R6P4Hmtb7SdUtbjwlqluUhhunP220nzmO2k25DLuZgGwdoJyduDXUaL8R9O1oa8PEHiuwstIaA77VUaG6sWGEeMTcrKpw2GX5jniuO1ePT7nxGNJ8LaRp8t3rVwbby723JlgicH7RhBhYwqKxEnzZyRxgZv8AxN8GaBosWky6kLmHSNNVohZWkSylRuO2VY3zv358vDHjJI5oAuWXjLQ7ib+ztL8Z6tf2gXY8d87x3VoFODOjGAbvL4bqcjr3r0++8baR4b0LRpPE99JYyXjC3iN0o8yZ1yN7BRgBgN2eB8wrw5rYXGgWF/rml+KItGljkb7IuqGRtO8tcRSQIMcgd2PAyDnNZFpaaxqWnzavdeH7LxNfyQf2bH/aeSlxbRgBfs3ln/Wv94u2CAuAOpoA+hdb+J/g/QLpbPW9etLG9JYG2kJZ0APG4KDtBGCM4yDkV0emaxYajpo1Oyuo5bIguZQ3yhR3z0xjmvm7RrzSNDjk8IeOi/iezIjSRZrSOI6ewOE2s2xpSysQXUsQyDjBqje+ILHwt4dfQPCupre+GNSufLuIvNd57OTJ328MZ2kpKNqhsnG5z2oA9Tg+IWo+JDBp/hrU9DS6u7gzWt5GfMAtQxCiS3kKPuYrtJTIxk8YxXqlnLM9un2mHypP4hnK5789cZ9e1fOPiTwHZalNc2mmfDywW1gAt/NsNX231pN5ayELETsLr1wT8w781FoPxB1n4XXn2L4gDxJdaLdWrLb/ANpWsbMJUyFCOjnCspAKtkg47EmgD6FbxNpCatY6XNexxalfo8lrbuCrSqp5IyPqRnrjIzg1qopdmc78Nj5W7Y44ryjwPoVj4s8OWmv38E1xe6lLFNJLLvtpYCm7aqYOQELME244wTyWzY8ZfDC11S0Y6ddajZX9uh/s24hvJAsMnBDzAsd435JOCcE+1AHf6zrNhpOkXep6rcfZNOtY2knlcHCKOOmMnnoAOeMVhajf6nqukaPqPw8n0e5glk+0Sm8L/wCkW+DwhHIYnHJ4H6Vz9jBeeN9Ts7zUbKB9L0i0SW2tbhWWO41I8icHHzRKuNpx/wAtCcZGB5n4x8P6JD4jF1Z+HL7w14quLjznvt0scNtMOS6S7jA6SHICkKTnnaaAPoXRPEFrrMU/2RZYp7OUQ3UE0TRtE+MleQAw9xkHsaZp/iTSdS1zUdGsdQhm1TTsG6tVyHjDdCcjn8PUV876f8SNW8IDVbPXINfvPGfkm00NtStQrXMTsGHnIrkbkfcc7uVI5qbXvANvpVuuqXV7q2qeMJJNms3umNJFcRNMm792UQqny/JhlwQ2BtOKAPd7P+228R3FzFqlleaEzNC1o1qY5bV1xkrLkiTkHIIHseMVf1PX9M0zTLvUNTvYrSys2C3E0oKiMnGMn33L+dfPWk/D3xnomnT6r4N8ZapZACP7Fo+pxOjYyNsUu4bckA4wBnjpmuqu5x8RDdeIb+WI+HLOdbfw/p14PKiur3bhnuVwWx5n7tV7fMcd6APaPtdv/wA/cX/fxf8AGivG/wDhA/GH/PZ/+/0H/wAbooA6XxpHqtvoNu2iaLZ+IvECIlrHc3CpGF5BZnYkELkbiqnBxivK5PgjdeMm+36z4zuzb6hMb67s4bJlj+0HcD5W5uEGdqkr09M19ASwvIJmhMgk8l1MYk2rubHOfUdj2zXgfx/vtY8OeCdDkk8VarcbtVS3uZrJhby7FjYuoZerHI65GVBx1oAyF+DP/CG+I59S8I62s+rWkIay0y/EfmXb4AkU/Mo2kE8cdcZPNReNrfT9H0yDXviUtnb+Jp5Ldl0uIx3GYFJSWJAARGuxpTzlQxUZO0VofC3QtV1vS7/XdJUXMst+X0tvEv766vrQRFHSSRfmXG4bHXoS2ODWj46+Ecvirw7qE+omKz1uyhRdMs7GMm2togSBGTgl2c5LHPy5B9cgHcfAq88G6t4a1G/8CaPcafZtetBOLpAHd1RWHRmGwBxgcY54r0pEAVI8ZUgg4GABjpgV4V+ymJdA8Bavp2q29xb38etXCNDIhUK6wQDaxPCkkgDPWveyf3YypDjnaT046UAINqrtUKoXoFGAo9BTlARNoAAGMLjjGKbG0jx/NHhgM+WSOD6entT1/wBWWwWJXO3jP0oASNcbQAqgDAGOg7dKSSCKdHt5Io2gkjMbxsBtZSMEY9KkGQA43ggdP6VJGMxo+3DYzjvn0NADLCGK3s44IIzHEg2JHn7qjgAegx0FSqqqFRVwqjgL0ApQf3OQh6Z2Dr9KNxERYI2QM7O/0oARUVQqKqiMDaFA4A9MenFAVRCsQjUR7QoUcAD0pQxMYbaQ2M7TjP0+tDMRDvCNnG7ZjJ+n1oABGgj8vaBHjaF7Y6YxShFaIRlRsK7cDpjFNL/uTIUf7u7Zj5vXGPWkkkCQNJsZ8KTtVck8ZwBQA/auzyyAVxjHt0poiQQiPaPL27Qo9MY/lSu+yJnKscDdtHLH8PWkkkCwNLsdgqltqrljx0A9fagBGjTyinOwLt2gnpjFL5YaDy9p2bduCecdMUO+IjIAx4yQFyfy9aJHESOxyQgycKSfw9aAARIEEYX5Au3qenSlKokYj5C7doGTwPrSsQIy5B6Zxjnp6etDSKkTuQ21BuICknGM9P6UAMWNVgESg7Qu0DJzgDHXr+NCIgjSNQdiqAAT2x79ac0qiIyfNtA3cA5x16dfwpodWi8xQdhAbBBz0z0659qAGhSFRMYQDBBJJ/A/1pyJhFRWbao2nJJP59c0rMBC0mcKVzkjnH0pgniMXm5ym3fyDkLjPQ80AK0REXlBnKbdnJyemOtMso2itIYnV8qoXDuGbgYyT3NOZ0eAuGwjJuJHBAIzmkhKfZEfduiC7wT/AHeoz36UASRxKqqBuIAADEkk0xI/KiCGWQsFxuY5J7Zz605JY3jEof8AdFA4Pt1zSNJEIfPLgQKhct/CBjOfyoAIVIhWMM5AQDe33iemfrTfLcYTc5UphmzyD0z9aV7lBCJt37krvMmQAq4zu+lE0qeQ0jS7I1HmFwcAKBnP0oAie0BhkhkZ5UkTy28wK2eMZxjBP1FVzYtDbQw2g8mOF1AC7eVxg8dB2PTtVsTosct1M/lwhN+5mG0KBnd7cZ/KlnlRIGld8wbdzMSNoHXJPpigCIwBo3TcWL4DtnBJxwT/AJxT4oykMcYkDbBtDEDk46+n9KB5ce+Viqg/NuPp0yfbFPDYHmBlEQ53DpjH8qAKytHbQIlzPubaF8xsbpD64A5OTzjika0gmshbXMUcyFQGEsasGIGMkYx6HpVXUpbCOS1u764hh8weRAZnGx2cZAGep4zx6U+VJrl4g11LbGJhIrQEFJ1K87sgjB547YBzQBzGtWekaNqU2ttEg1lIfsf2jb8qq3zB2xgKO5I7ZFXfDl4L/T5Qbu31TULRtkrQwhVeVcZwG+6Mk4OcZB9DVDx9rMzW66fosRvNTuCDBCsqiGWJWBkZ3weAobj1wOpFZfhrQ7bSXldrPV4knhiMSwu0okIbfvJH8bMWPz8jccn5sAA6n7Dba1YTpdTS3dvMHhy0DQNtAKyqcBTg84P4jjFc8+p+Dfh5oejeH9dvrezjl3vBuiZQ6qc7nIzjAwNzHnFJaX1ne+L7S8t73WrJbi5EAklf/RdTdIySAOdrgqyEfKDg4B7Ou4NAtfEFxqHja4ga71l20q0triUTW6wDJ2KCMAsBufPQsB0xQB0n2PSfEIkiumsNVW2kXzQERsEjcA4IIwVZSB3HNcTN4G0/w5rsfiW+eze1traRbu6mT/j3Rct5wU5XftymQM4Oeuc9ToVx4Ok8UT3GgTaadantgshtnC/aY1YqpJHyuVKFQeSAMdKo+K9IuPFEum+G7+4xZw7L3VmRSiXkQ3BYhjopcZYZ6L3oAl8DaRaWLwHStdlntrYO3kxBRFKshJVX43Ep0BLZGMH0q34o8H6d4g0yxtNUjmnitiXEMTlUlbjbvDE7scEZ6EfhVHwxZWL6hY6v4Ru9CTwzIjrstLUeY/U7RKDjlyWIIzkD1Oe1tEkiijSadp5QOZGAVm54yBge1AHP+G7G80Tw1AmpXFul6EKxqUVYLUY+SMY6gcZbOScnPNZeo/8ACb6S9ldpf6BqKlglzbtA1vJKSxISBi5XIGQA3J7muN+Pmh6n4z1PRfC+kaTLdw+RcXt1MZDAnA2RKJSCCQ7Bynog9a5y7vfGuo+GPDqapp3ia0ax0qeFF0+zZpm1WJgkMkg2k+WyjcG4Uljk8UAem6ho+qPp89l4b1CfTJfNF2080xYW8kjF/Lw4YGJc5MYIByAGAroPCsmp3Onyx+ILU29+TmaHeJIWx8u+MdkbG7aTlScVSv8ARD4m+HdronjGVoLm/tIob3yJQhM5QF1jPIPzBuOhA9K8cux8WfAUputca48SeEbNli2WU226EIOUl+UBtwwN2cg8g8c0AeoeMbPw9oOmWfiDVNPa+1XS3kbTo1mlaaWWQ4WKPJLEkkYHO08iul8NvbtaiCx3QG1kMc0aFmXefmK72++fmGWBPIIzxWF4b1LQfH2kaLrtvK16thdkxSXUflSwXG0qwdBxvCtkcY5Brz7wzofxR8C6aV062s/Ec99uluIr682/Y5A5CbDuGQVIZgP4s4PqAejaidEu/FltFeXMDa9iWKGGO/w6QMGXf5eQGOR1wSpPBrL8XeIbyCf+zNB0e1u73TQt/Nd3bZt7WL5vm45adgHAVQcbtx9D5fql/wCLtP8AJbxT4H0fwxp0F0LhNcsEVzYzs4xIw3EFHY7H6ZDk5yK2pfDfjHxxcXUGrwTaHpkUkl7EEfy5jMv/AB7RkNu3BXBYt0ICYxigA/4Wfb/9CJP/AODN/wD4iiqH2j9oL/oHaJ/3zD/8VRQBqa3471HTxd6BeS33/CQ6a5K3620jwTQPki5cIuNqKVQDOS/uM0z43afPcaRo9vqEV+bLSZorxNTtII7l57kALse2LKQDnO7JGTgjGa6RNQ8YXesXXh+7totMNvG1yviC2B+z3iYCxx4I4kBYllBx8hxwRXiP7S9nfWmjaRBceNLnWomuFJ069iiWa3kMXMjOuCobPCsBjnk0Aej67e2WnaSzeJbi7l13UJ0MS6HqC24tAsaoIIpNwRMKWLDjILHkLXXafr0emXCeG9GgFzfpahrXT7Vy626CPK/aLggqN5yQx+9g9Sa+Y/hbeaNo5ikhkih1mF3t76S+dW024hc4CFhnBK7yHPG5VHANfTOjvDd+DJrGwm0mbxRPapeCK6Cp++c5gaRY+NuQuzHXANAHVaFZ3154faPxFHYw6pdxFLyTTydjSFdu4ZAPAC4+mM8Vo6A97/ZFuurIUv408uYght7Kdu8Y/vABvbNV/D9zPf6HbPezxtfPFtuZbZWWMTD5X2bueGzjPpmtZwDEVLtkrt3A8g+tAErE9yc9QTXOfEyeaD4beK57eSSG4i0i7dJUbaysIXIKkcgjGc10BRliZQ7gsu3ePvdOv9akdT5LIsjI5UgOMEg46/WgDwC58VrqnwZ8O654Z1uW+1rwlDYX2qW8U7FpE2BZo5c/eyFcnOfuGvQ/gtPe61puqeKr6a5MevXr3FlBKxxDaJ+7hAUnCkhSxx13V3TIzRsqylZNpAkHJH+1g96m8kmIp5hVtpw4Az0646deaAJQSenQD86UnDAYPIzntxTShMW0MQ+0jcBzn19PeldWMRQOwcjaHAGQcdcUAOPUAgHNLzt564pmxjEVDkPtwJMDOfXHSklVzbsiSFJCpAcAEg+uDx+FAD8kDkfTFAPcn8qSQO0TCN9rkcNjOD9KSZXeCRYpPLkIIV9udp9cd6AHHkEHr/KjJ3c4xSSAlGCPtYjAbAOD602YOY2SJ9ku0hXK5wfUjvQA/n/IpPYZ7/jSTB2iYROEc/dYrkA/SkuN3kuY2COeASu4Z+negB+eBz+tBPp19KZu82MmIgEjhiMj/wCvSTbxEyxELIc7WYZGfcDqKAHknHPODxikUnlj69K4zTL3VLb4g+JbC8j2WM0MF5p1wzFk+75ciMM/L84B4HIPJzXVXE6QyRQiRFuZ9ywq4OGYDJ/QZoAsBhuPzcE9AKa5KnGc8joOc1xvxa1i68PeD5tXsgss1hPDcvDu2mWNGy6j1O0Nx7Vq6RrsHiDR7XU9Cvbe/trmPIaEhlUgHPOcj5hgjr2oA3Sx34GFOeneoLO9iuYxLbzRzwlsLJGwZTyQeR6EEGql1PJHpssy4WYwkhpMhVbHcjJAz6V85+GvE/jnwHZXHh6y8O3+rwzxGfQ/Jsw8S7yJDvdSGOCzhs9/TuAfTu/cc52gHBPf6Vn6lrmnadqen6ddXccN9qPmG1SU480oAWAPsCOO9ebfCn4h+JfEmvaho3ivQP7FvrezF1bpLDJE0679hf5iflzjOO/esL49+H08UyX++xluNS0vTYry0+zSFpULTYcbR1JCnA74oA9y84bVIdCrH5SWGGPoPWsTxfffZdLuXuG8rTEs7ie8uskNFEq87AP4j1Hb5e9fLFxrOuad4cW7XWtXOjNCJbOw1Pw9m3zEcqUZXKRYbHzqQACPSva/izqd/rfhPQtE0K0a5vvEXlTyBoS0PkJsaRZH6KDkDJzxmgC74Y8eX2s6NbT6WulXmnjy8apd6gka3EXSTfGBvilUdmBXIPPIr0eOeKa3E1vJHLAVDI6sGVlPTBHUYr5n8XfDLw1qkbam0umaRf3En2FomtDDarIDlRIFOYpX4KuMqw7fNzp6H4u1v4eWN14J1eZb3XtNlT+ybeFRs1SOX5Y4c8eWUZlYjj5MjBxQBveNviRFomt6vpLeKBYyRThpTJo8lzvR0UGKNwwVWUkfewo3c55pngn4zLqHiLTdD1DRZ7P7ZJ9ns3XU4rtmVV/5aKpyrnHfj+uj4c8IXHh2yt7OWG1165lUyagl9MkYknYmSWRWAPzFpAu0/wACKaz/AIl+CrP+xhbzzw2t7qymCw063soxA90q+YqvLjc2SvBY9enpQBm/GCDUvFviGKzjeXw+dOnZNOu5mIjnljO4kDIUsx2qiDJ6k9QK5DSfi/4u8N6lFF4isJc2mV1OxvJSssg6b4VIC7BxhVJOc9sV2vgPRb7xLcHxFrCWVxpptXey0syOEsJ1PLqrEnzGKFt55AavSL6Kw1FrjStRhi1qS1hDzW1zJA7tGVynmJ6MQQGI6gk8UAUbHxhpV38OW8U6Ppy2ttGM+VLCFaJ92JBsUZJBzwOWOPWvnPUPiJ471BtTOhalqFtoeosf3T2ZMsFtypeLIOFI4Ow8EcY4qbxvoC6b4mvfBllZ3E97q0sV2k73DhY7Vzv2BAdu6PDR7yeRtwAM17ro2qC50uyTw/FqF1eWRjtorEERwlNoXMoHyiJcHBH3ivGaAPKPDXxQ13Rde0ldbvtQvfCsSnzpta0mOxMYRdwMOwku4UZA6k9OTVHWPDl78T9fk1rWdRSy0e7Pl6Nahxm2tmb5GKg4RnABy3HPPbHo3xk0tvFYi0ueS2a+s7aS7gsraDzHZ12EjzHGwY7pnkc9qhiS7t7qW8tW0zw/pLWSRQ39zOGCSFRiGRQwSMoST1zx05GADida+DutaZb2j6B4o8SKYyollVSEQ4ChgqONoC8ZycAVH40+J+q6n4A0zwTYJdp4htibbX/soEIEURMe1ZG4+f5TkfTviu1u7DxrDYXV61nNJpsQH2m1j1ye3ms1KBpdjONskZX+FslWDYOKztX8JRppt1ceHLS+n/4SOW3SUNFJFcXMJQS+Wsp4UZT5j7be4oAd+zNqdpqV6yRSXEV0IG+1WsOor9jmYBV80WpAYEqFBZcjIOTnivcbHWLRL650+5hNjLZweeFlYEG3yQXDAkYGOQeRxnGRXh2q+AjcXWoakLvVPCPihbdoZ7y1gIsb1CowqqfuDG0HkDcG4yM1yF/qfiGzi0q08ceIF1jQ9Rll8nVtPkL3Me2LbLZnbwTKuxdrZ5O7OQaAO4b4gaZFplxqfiaO5u4rkyy6RptsJI7lUBPluCp3JE6CNQ44J3k56DivH/xF+IV/pOh6tY6BqXhXw5pkwZ3WZ5PMKsAizcK+BtxhuG3ZNemaN4GvLjSoPEPiaTWdI8SanIqOPDymOWygYBUtTgHEKoiZ4+Vuc55r0P8A4Rqe5tbm3OqXyaZPZrbxWkqLIYztH75mYbzJkcgkgnnvQB83+KfF2o/E7WtMvNAtr+Oz0+1LDT4Z3RosZ828WYcYVtsa9GbDcAZFen/BP4qS63bPpOuTWs1zZCOCO9jZhcXJLbQZLYjcmONz5K55OAc10XgnwZpnhnTHs9E1S4l1bUJXuZby4jVp22gKyuBgKVJAOeQSfU1yn/Cy/BKa5ba3rvhq/sbuwdojqzWy5im/1ciuqNvH4gjn6UAekW2gy6R4x1TVrdlj0q+09FuELM0jXMbMBKc/9MyBnqdo9K1La/sLLSpppLnyrW1XdLLcyEBcgMcu55+9jOcdu3HD6v8AELw7H8PbjU2103thetPb2tyECSOAxVlAOCSgycnGQM14f4s+L+r3umHTPEnh2zEV+Rc6TeavBmOC3GVSQwhWDvw3tkjAxigD0Pxb8WUt72y0y+8KM3hLWgITqOoXibJVlJyy7d6lAB/eBHtivKI/H3iOXxDey6jrl7bLpJFtbrb3kbww5ZTulmXKyr8uAg+ZwGGRg5v6r4Kg1LwXZ61fX9zqFre5uLjVJLpnNnECq+d9k2gBFf5SAchSeMCtLw18JbLXdFMn9okxwrLcwJZbRDcTR7h5phIyVZsoOMhYzx81AEP/AA0V4h/ueHP/AAFuKK1v7BX/AKEzwh/36H/xiigD2Dxhqo0i21K4tvtF3NYWrXQsbWFWaPcfmlDNwzck7M5PYc15N49g8I2FxFqHj/wzczyXk7CfVtQR4XkJjDRqFgbIA5TO052V6N4r0KS4uNch0XWF0LV9XaO4urmFnkc2cYWN3APyxSEnbkdQB9Rwfxv0bS7L4Ivbm6vYpEnha2h1QfabtpSAFiU7vkbaCSRn5d3BzQB5rBfaVoF5rD6bpV/oVosMsLKHeZFkbHlLPGyl4fMC5A3EgqvXmn2nhSC9RPFHinxDYeGL9xHdW2+dpLox7QEkKl87yQGxz8p4UACqnwa0O3uNc1WPX9Rv7fWbabdPZrGzTbw6qJGyfnwzkADkMQ3YZ9O0XUvCus3MsOraXp+p7Pmu7q5UTQWkrApCDK3zsXYKpABwxAwKAPYfCOoXVxoNnJqOrWGq3KRhpr+1CiKZjzwF4AA25I/IV0ryxwoXlZVjHJJ6AfXtXBeAr6Wziksddv8Aw2r/AGxrDTbTS1MaoqrzCysB+8AXlR0AFd+QBkN09DzQA95VSN3lYIgBLMTgAevsKe8qwxPJK6xoi5dmPAHvUUYZ42Dhck9B09qeUUBlOSr8kNyPpz/KgB7NFFE0s7rEgUsXdtoUepJ6Cn7gqLIxARRlix4A9zQ6h1YMNy7eVIzkfSlWNSMSKPmXacjO4fT0oAc8ieSZJiI40+bduwMeuc9KfLLHDGZJZEVByWdgAB9aPLDIVYblI+6Rx9KHiSSPZKqupGDuX8Oh/GgBZHVEZ3YKoGdxbA+vsKHdFjLykImOSxxiszxBaz3dnHHAjMUlR2WOYxNtBydpwQemNrcHoSKLK5uL2a8iurFooY2CrvU4kzyTg8EAY6HrmgDSkK7CW2gDk5Pf3pd6iMuW2qByWPSkZA6FWVWQjkEcf/qqPylkikSZFdGGCCAQfbFAE7MFUs5CrxyeKazBV+YlRjOT/U0yZUljYOiyIxHysMg/hSXEazQtHMiurDlSMqw9KAHqyl2JG0g9TxSySKu3cVGT/EcVzl7qd9baz9g1DQ7q606ZN8d/bBZE3AZ2SR53KcjggFTkcita6gh1K3WK5h3wttkw3UMCCPoQQDQBcXIds9B6e/alJVOWz+NVrqCG7imtrpPNhk4dSSP1/D1p8iJLFJDcKHR+qn+IUAc9e6OuoalpuryRn7datLHGGclWgkI3oV6Z+RSDgkY96dqNwbjWdFbT4mukiupGmnhdfLj+RkKsT3yR8o54rbKebG0coVkYYbAwMZ7VV1q1W706aI2sV3na3kMSgZgQeSPz/CgDK8QTQ3uv6LpMjbpSZb1lUjcscaFBx2BL4/Ovm7VvhRrN3401RNHt7z+zb07WnS4FpbQxqx3CQAcMNnC7SDuz717jcLYW/wAVYLS/luLrUtX0+d1gAURWlum0EEjDHc2eT6V1Os6HFqcVzHLJdxw3EflTLbvtDr0wfwyKAOU8F3unQfCJHhus2FhYTwG4mO0hYdy7n9DgDP1rH1CzsNU8I+FrXxPKf7Em06OW9klJtI0ZUXy3Egb93IS2NmfmB9q8z8XaLrqeLdft9Tfyvh6dSa4NqtyYUunfbiFQCOdwBPbnvX0bp0FpqnhuCy1Czt5AsEST2rgSKjbAcZ6Hg5yPagDgobnw7aeKPBF9pPlQ2jmTTbZlmLRhZYmKJnkZLIABmr3grVIPEXxC8ZXmmXkd3p1pFa2EM0bcO673kII6qGIXI9D1qD40eHtI1bwzoOnXk50/Tm1WKJHtQFAkYMEGQPkywC7u26ovgvpsK6NdyW2oQ3lusotmawVordgEKkIOCyKcKrZydpPegDbt/h74du2urvUNEiS6meVpIRdSNbndkFlTO1QwIJwBz9K85+H63fj/AMO+HLfUZns7bS4ZIEImy2oJG+zfHtO4x7doYno2Bzk17nNbW18jxzMjojbHZXw0ZK4wSOhw3f1FfN3wr8BazZeIoTJaXOkqt1581/8AaET7Yqu22C3RfuxkYeT1KgcUAe42mnX1jrUMkUVtcxH9xLJMhT90hLQsgXIyoLJ68A1ieLdGg1LxtpNzDafaL61jmSGVk82GORvmCSgA+WSrEq59MeldX4q03U9V0i/s9D1ZtIvp1Xy7sR+Z5XIJIXIwSMir7+ZHNLF5IJMAeSRG2ySuMAYHYe+eOlAFT7PFNb3/ANgkRbmKRgZ3jD7Zdq5JHfAx/LpT7TRrWxvJ7lLm9eedvMKzXDSqD1+VGOEHPamaNo8lloMdob25e4Z3mmnc5kaR33Mc9gM4A7AAdqt3ljbu73kiql55XkNcx/K4j3ZwD25OaAOb1Wzu7bV7KyjnMlhqEksl1LIQAiqvEQUDhWzguSO3c1V1jUL6xvdFh0DQrie7BbTp4knVYbaFdgEr8EuASm3HYnOOlbtlYarca3qlxfXXk6Z5a22n2sa4ePqJJnPIJYgbfQdsmrviDRY9Y06eyuJbmKGSPypHgbErKeCAw5HrxjkA89KAOH1dbfV9XhMqwS3FrbiJpLcglpJW8tEdwOM4YgAbQuTnHNYlh4z0aGC7fT9P8QEwRy6PZ3llp73CEpySir8hG8jaDjoACQeNXxkF8IeHIbDRHgi12+aLSrH7Pbl5EiyVVwpOZDGsmSxOOSfauoi8Iru0+G7Y3EFrGkrTFiJJLuMAJJ+A3EdsnkYAoA4bTfGNrfwR6NqviG4u7sKJYb+bSW0yKSVTuEA835ASpIwT2P0qTxDo1x4iSYm20y3tJJGlgiS6VJ7lFyTIwdTH0dyQw6gc4Ax2XiDwlcavLGuq6zPd2HRrJ4YxHL2weOQfQ+nHpWx/Y1vf6DcafqMIniuYTbyxy7WJQqF2tjHOACQOM5xxigDxLwb8PfFXg6S31OCCy0yBFV9QhglN/NdDcCyr5mBF8qjJDMMnjjivU/slzD4lh8m+WTS7/wAwXdvcSkPsZMxmLbwAuChXg4JOTgVvaPo8Gh6DbaVbSXDW0EZiSS5kM0hBzyzNnPXvx26VcS2RYm8ogcHLKAct/eOO9AFPSrNoEBlkuEigdo4IX/gTgYJyd44yGPPNGsaDp+rx26XlvCfs9ylzGfLVtrocg4I7HPNXJLAPMLkTSrcrbmBX3Epzg7jH90nI/pU/lFoApZS+3G/b1Prj+lACwKY4EAZpXA5Y4yx9T2qQDGMDAzzTCshtyqSBZNmA+zIzjrj69qUCRbcBpFMoXBfbgFsdcf0oAhEIRiFiVWY5LYAznk+5qpreg6ZrsKRa1p9pepHnaJ4Q+0kbSR6ZHFX03iLbuBk6FsYGcdcf0p8e9Y0WQqZdvJUYBPcgUAfMHiz4KzSfGPTNP0y0ePwjeKbu4dWciFVKiSPJyAzAKo77SeuDX0kbGJo0SWCOUR42eaocjGBkEirMZmWCMXIV32DzCgwucc4HWktlk8qM3Ji83GGEZyufbNAFPVbCLUbKS0nj8yCU/Mmdox/nt0qrpmkWejWUcOmWqIEiSIZHzOF4UM3f61pxCYxobkIkg6iLJUc9ifakQy+QGuREsoYg7CWUDJxjIHbGfegCDz29B/32tFH+kf8APCH/AL7/APrUUAfJXiv4kX3jK5sdE0/SIzZ3t0biCK8laGG4txHty8jkbvmDZA7qQMk1U1S30VvD+p+JLnUS95cqs9msGlSP9lut4wkcjc+WqqFHmAHONtYVxPH4csLG80fVdL1m0uoHFrp11bs5hPmhWWLKknEhZ1JPAU9STXXa/qHi1tZt9Kg8bX9xY2UbXD6xaxm2RpJlG62JJVGPGVZj8u4jtwAcnbyeMxqurXq6fpr6texlb6RrRR5bOCiQjacBsLvG0ddpJxXcR/DOXU/Bt1e+LNZiGovD9oNpNJHaWkU+0Ll2UZJ5yQOrNnFYPh3WbrwzYa/o39pPdXMCnULy40h/m8xeJBNJMvzAryNmPTO44pLy+17xZZR69PpltdWmnt/oFyrbBJHDnz5xG4LOXyoBCkowXjIzQBvC+1bwsdEuPGOo6VJpyGM+H302FXiLoyfPJJjzAdg25Ykncdx45+gJodWm1LTbtJ9kEMUhmtUIRJ5WxjexJwoAOAO55r4/1BH03QoydFWHw/JOJ3s724ae6iDALI8K5UDIKhmxkFlzjFe9eHfiT4e0S4sdOv8AxYb2wTT1khuJI9pC7sKrqF3l1VeTjjaS2M0AezzyOqHyVWSRSNoY7A344qWZ3WNzCnmSLkhC20Hn17VlnU7byIJ3nj8qXDROSMOMZyPUY5pLzW9LsbX7Td6jbwwZXDvIAGL5KgHvnBwO9AGrcyOltI1vEJpByibtu7/gR6U+WRlhd418xz91CdgPtmuE8PfE7wxrmpxaZp+oS3V67MpEFjceWmM43uyAKcYznvxXTrq9sZoLcufOmkZIkII3MozjPTpzjNAGxLNIIWMSGWQKCqBtu72yeBUkzvEjGOPewGQu4AE+me1Zuk3cV7apd204miYHBU/LkEg44z1BH4VbaVmOQTxxnFAElzK8UDvDGZmUDC5xu59aVn2oSibiSBgHH15NQvcIHdE+YrjgHoSM4PvTkbAUgDd1OOxoAtBgWGMdT0NeT/FD4qXXgvxXcaVa6Vp1zDbaMNZmkur427SKJjGYoxsYM/AIBxnn059Mgnj+0sjSLuQhWB7ZGRz+VYOo+CNA1Hx7D4p1JFutRTThYx29wI3hVBL5gkVSuQ4JxuBxg9O9AHAeIvjdJottr+/w+xvLJbGaxtmlKvdRXEZlYkbTtKKj5HPK13HgPxwPGGu+JIbK1VdJ0uSCGC8EmTcu8Ydxtx8u3IHU5z2o1v4e+H9a8eWPizUPOk1C0tXs1h3r5EiMHXLrjJYCRwDkfpVj4b+CtH+H3h06Pok9xLbPO9w0l1IrSO5AByVCjgKo6dqAN+4mMUZk2SSfMq4UZIyQM/QdT9DXPeOvGGneDLC1vdWIFpLcLBK4kVTGGBwwVj8wyADjnnPaugfJGBy2MciuX/sO01TxN/aet+ReTWGUsrcxhkttwGXwRneTkZJxge9AHO698cvCGk6o+mzzXb3Y27kFuQoZgp27umQG5A6YNaur/FDwnYeDn8Trq6TaUJfKSSFcyTOGAKIjYJIyM+gye1ddFZ2wCrFbW6tncP3YOG/vfXjrXE3vwn8J33ixPEF5p4knQlzaEgWbTH70xixgyEAZPQ4BwTzQB5LpHiz4pJ9ptv7MHlzTrqEGpam0duxhYnyo352KSMEqegB4rr7z4parpGu+GrLW9JDWuszNb3LW91DcLacqiFJIiMgs24+YBjnGcV6BPoOieIL43OqabaXiR+ZGtvewh2jZsE4HTaQAcYPY5FVrr4eeFZ9O1LT7fQ9P0+DULU2lwbKFImZOoxgYyCAQccEUAfPvifxcuk6tqGteH/EX9p+LY9WjL7bZ5bVoFR41tUkxlwTtyQQMnjn5qr61b+ONWF1478V6/NoKQTRGPTrVpFVxtJSOIKSCW2Y5J5zmvUobG48KXk3h7wnp2m3um6JZtdSWvmIJ/PKgwLKWwSZMM25RjOAcCuXmbw/p4tNPvtK13w94nube4mmtbG5Evlq+WEgjclZRwcheU2sMcUAQtqEeraZo/jTxV4rtY4omm1K1tJ4A8VvOxIEbKmGYAYG3lienGTXc3XxVh1SY2/gvWtCns7SOJ729vVmdgScMEiABIAGd2cdq8+t7a9vdV0ey1uPQLrNuJ3GmBjbabbSAosysT807kA7zuAVTmqmmfBG2trmIFZCpiUkrdPF5jOcSIpHACqM99xHPFAG94z8Xz6jq39g3RTxn4ZSJpL6TToxbyI2dpRkB+bGCwxydwP8ADmvQ/B3jXSbZ7rSr/UNOs7uE4j0+3XasESIM4GOQOpPP4CvGfF3w/wBL0LxBZw+HrDWy93bl4bqS++e0lU7fNz0ZMNgr144rN8QeBLLRfFFtpVtrCajqewNaWWtyv9mmeQfvcspUp5nJHPzYIPrQB9E3Y8LStFdtJZTpamS932l3vd5HYM+5EYlwSqnvjA6AVkeB9O8LWOuz+ILC9mu7zVIWu7ZZJJGWztpXG+ONCcDMqknAz16AV896jpF1pySXsWl+E7JrFxIdT8L6hI11ZFRkuEMzb0XPzYU8Z5GMjpvhnruo6p4tsfEsH2zXrTTWaw8vyFjuZGnUl7mNPuKm9VXGTjcScc0AfTS3slnaTTzx3c7KSiQNGomZsZCrg4bPrkVLcFlumuJlS2h2R72kfc2OcjaM7TkgZ+vpXD6FrWqy+KLUXeqWkP2m2ZrnR549kkG0g70ZSQXAO1wTtyMrxS/FTxdq3hu202XT4dKS0nl/fvfl2JiA+baicnB28jPUDHOaAPRWMcFucsI4oxtJ/u9hSXzRCFzdMwhxhgehJOOoGax49YeK4W3uNPvQxtkmBQeZsyDlWA5BBXGe5PHetM3cSSssskcYCgLIWGN3pjruA5/GgCVWW3iZpHwF+ZmP14qxNIsMLyHCooyxJ6AdTXH+D9bvNV1jXRcXtpJBbeSkNkm0z2w+YFpSucF8BgvVehrr1b5XDEnPfGaAILi3tzcRXj+VvhVsSMgLKp64J5AOBn6U4SJJbpO7eSgBdsOCu31J6Yxg0y6kaOMoIpHeRThEA/rxRaWyxo53vIshbarYwgxjaAB0GP1NAFtygjEjlDGo3lyeB3zUDPDEANyAKpk3s2PlHcn096eNrQjgeXzuBH+fypn7sCJBykhxgnII96AJJHjaJi7qiAb95PAUd89KcXVEZgyBMbtxOAPf6VCRIYykyxdGG0DjHYY+nWpZIwQoYAxlSpGOo9KAHhkCZLZG3JYnjFOyAu5mGOuc9qj2xSo0bBWXG1lI4IIxjHcc1x/gbxWviq18UC6tIbS30XWbrST8+5ZI4QvznIAGQ3TnpQB2WFQM3y4PJNOBJXk/iDXl3wt+JcXxAm1jTrzSRp4SNZ7WORy4u7OQsqyYIGPu8j/aFem+XG8HlFF8tl27OxXGMUAPIztz/Cc9acox29qieCN7ZreRQ0TL5bKehXGMUscUaRiFBiJVCBB0AxigBZBuHTGDSnaR229PoaYiJDCsaLiKNQqr6AcUiQpDCkcICrGoVQSSAPf1oAGBXeQQD257Uxg23jg9KdDDHbxRRx7tiDA3MWOOe561Hb26WlskETSFEJOXcs3XPJPXkn8KAH/L6n8qKzf7NuP+e7f+Pf40UAfAWj+Iltrm0t1uho4ijMdrfi3WZ7RJMs6jADfeLDeSWUcAck1o6n4rll06fSNQ1eLULWecagstvpAlNzcFQoik81kKBQqgbAeDXSvqX2yWx0Txzog0+2a2aCKWyjBjvbvzcxurR5BCq7DIJBOcn06qfxL4qk8Avr19qGnWmozBks7O00R5Z4mVdvU/cOBkMeO4JoA84hvNBOgNpmpaJZWF+86wwC5SVG05cb2kklbJcNuOIuwycgkGup1ae11nRdPifXdS1u2Ty7ew0nRLaIKJEQFXmXOUU/3cEjbyaor4+8SrYXF1fwf2odQh+xAXUMflR3OVTfPGflQlT/FgtuzkAEVtSTzeHfC1tFo9ut1d69AllFqmlTorW0gkG6OSRcAOA2AMjdj2xQBz8kt9ZRanqfiSG3N0ZFtF0+zQCKKMPmfMi5wCN4OTg7zzyMYSzaJcpLdeF9CuV0vT5opJY55nN3fxytiS2d42wsW1HAIXOBknJrv9Su5vD2ntp1lf3kFv5UNvLeXUQ8uaY5DRtCOVxj5nyQWG3vmuX1+00xtZlvZZEtYmMLG1spDEZBKoA528qRz1J+Y9qAK9z8RrnVfB2m6XqmkQyy2l7Elrc3Fy5byAxYI0eVV9q4Te2MqceprZ1n4jy+KL6yk+z6O5tlNzFJe5zaJGwJKxBgrSFFVgozgZVeck4Wi+FNL1fV7HTbyd9PsbiDb55LkPP5m2KTZ/CHVkHzAc7gcV1OjaBY+HdDt01m6tP7Kvr9biGZ8LFbNattwxIY75T18v+7zxwADQtvjGxgubifU7+2u5Q8cB0awWV7gFsBy88jGIFkHyEE47ciuPtfiNrtnp+uaW2rapd31wB/ptvIHzMFYsiowBVMElmXnKg8A17Lpvh9dIa71yfxzFpeqXs0b3sjlDaDOBugRjgyEBV8w5Iw3c1xHiHwH4Yv2nW6uYbdWlhMN3bBXuL4lWVRgHA8xiCWwfmx2oAo/Db4k2OgeHrSPxKuqi3j3y2V3a3eRLKu0yRqCAV4YE53AkkDtXZXnxym1K9s9PMOp+HWmlHm38zAxxfvM5JK7WjbCqCAMAt1zmuK0PwRbxWi2t/ZaWtxvha4eMs88EeSoSMfMBLyGOQBk+9c/extqMltoOoXWsRR6fKtkvnjdaKofAjAXHDAbwzAcg9etAH0pf/EvQ18SLYaRrlhK00EU0ssckfknY583bIDzJtwMHjBzk9K6O28YR/wDCFL4h8RW58P2+S4VriOXcqthQHHBL4wFHOK+WtM8G/Da5M8M2ratZQxSK3228dYFuVLf6pI8FiAArbuSc9OM11uq/CzTNGhZNbn1648NeQZrK1F6RBBdscLEhwdxb5zu2jjA+Y80AdT8SvjAdF1a3S21O3t7Ui3mksraJZrt0JzIrk7ljKjDAEYZeODyMzUv2i4/+JhDoOm32sXy3DG3nt4vKha33EqGUgtnop4555FR/D3wr4I8MaDBrawzSXbLHNJeX0ikpFI+Agj4GGUlTkAn5hitrV4fENro1u2kajeJA07futAEMZaR2Hl267iCFRQMKOuTjAoAw9D+OcV/YSWXiGS/03xMHWRXmVViDZx5IBA2K2FBPXBPIxmu9+EHj+fxVpuoNqV/ZWl3DdyIArx+WqqqsIkOf3gxuyw7c1wACeJZrmL4gaRPqEtsskNu+oFEnSdVA8vzEwqq2VwrE8nPODXnEWm6l8O9WgN+FiuLaZbm0Qy74YJj1lyI2DRbW8ttuDv2npigD63u/FmjxRmVNct45nMQNtJcKjR9chkPKlgD19Kx7PxbpX/CV2WmTzyR6xeRFLcrIkrXUSHc29FOFY4OD1KgkV8reONVupdEinuNJvrzTXuCk2q30cMNxcyDG6EvEMmMMOpZssAcjpWJJDHa6Za6/qFpf2d5cyCW3ubdfIjlx1VCPuAjIB24O0n2oA+6tWW11zSZoXnf7KskZnCxsCwVg20YwcHHUVzPjT4jWmhaHLqEMNxPd/amt4bEKBPcur4IRDklGAb5gM45weleEeFPi/qNtFfNrWtfaljs5Ftb3eInTITEagja7jaAcRtjkhvmxXL6VceJPiFq9263o+z6Oj3HmSwRxP50hUbI+hjLOAFGeME9SRQB6nYfGSx0m7utP8XWV34X16GQSFTCbm2Dbvm2hcMAy8HkjPOa9D8N/E/wn40ulstB8RCK8gX7RIlzD5Kug++PnxnAyeDwOe1eKeGvH+kW93qFn8QNL/te1gULPepYmRTIhx5csbqSGydu8NztWl8Saj8IvG9paLBZR+G5IVeR2hhWGUqADsHlqySMwGApwRye/IBmeKvGE/jPxYt5odvJptx9nmtdP1CQMkmpxbsFFO35nxtRVOVGWPUgC7a+CNM13R5p7u/ntdcupN+pWSFnhW5TJkBz0kIzJgkYLEZwBVjTNMfxd4cu797VFjtXgi0iNLkBoRGm6OO3YcAt3I25ZSPSren6brj3pvdK0221W2WN0fVpY8XazkFZYpZFOZV3hly3AHtjIBR8P3Or+FGis9KuLe/tGna5v3gtmC3KKm1YVhA3GAAgkqPvMfSutn8Ga7fgJ4elS0TUZRNDqpvyZ9Ot9oJjCowMilsqD09fblPBKau2oT6pqtlDFp01q2m7btvMaO2Ul5EKx4MYMhBzjhcADvXZ+C5blNamuo9Lnu9Tisvsc8cckcRt0RycJvfJUnhTnnAPJ6AHP+LYtQ8DWsGnav4jg1G7u5lZ9X1Eu7xwIcmONCxYMSCDjghvWsrx3odpc28mnTXzXUt7OGSc5ZjKWUlWA6FlZmXI27jgHkiun8S+FP+En8QDUrmKb7Pb2RmmN9EPOeJsgQhWY4IOSDj73UcVy9hc28+r6Xpdu07JAZLHabwAgI4MYhnIGVB4G8YQnAOMUAXZPBvhbRpbJtNj1vRtbt2hExlh84KobLhT1ywLLjgHdg8Vhap48v7bRtPuhoaWbWM6/Z4fPZLW1dnZhOUTneudvJ+X0OeOi8a+HbHS9VmvZNA1yOVIwZLi4vVuomU8HzIhllwCWG0kZA61yU6am2ha7aLqSRm7kW5CsnmKIAmwF3PUkMByOvp0oA9m8MeLNL8ZaolvaxPpd8YX0+VmDSpJgMZVK/cYqcujMCpyQeeK8W+MWkXf/AAs+4VL46/cQKtykcdwreTZov3ZOMeYeeAfTjkAYOm3154HkZfEVlqCmcRtBqFlKkU6qrAoVcq4YEIPlO0gBh3Nc2l/eW2oS6zHcz2Mz3n22GYRASPLy6HaOAuSD3HXrQB9T+CPidbaJoNjHIdQ1bRbhmXT75EaSdFQhWgmjzuMicnI+8CuAea6tPHnhK68L3nibTgWsbNjcMZ7OSHzCWwZEBXLnOVyMjJwa+WfCnxE8aaxqF/pthd6bPdatH5U0t5EkW0fM7MCCFGDn5sZ6fhN468QfEC9u7fTtbmlLySf2nDNAhcI8an54GVmGwAZ+XAJOcZwaAPavhP4/spvFd5pUWmadaT3kC3NpfNKu+ffI0jRXLDgS5ZiEHI6V7yJmeOQwBXOcASHaM5xz+tfn/pviC0OnaFpdt9khEFyLie+uLVpJmfeHBITlkBDdMtgkV9XfDL4mzeJtH1jWdQ0uPQvDtjlLe8lnaQT7dxkPzBT0xgdckjnFAHfrNqa6retLHasoRTaQiQhiuDkM3TO7kEdvpWszvHBvihDOBlYy2MnHTP17187eEPi2niHxfqc9k15cJLHustIuWCCSVEDFg+SIuAdueGwTxXsvh3xfoWvW9tJoupWt6s7+WBHOm5cAgkqTnGR2HfNAHR3Usgt5WhiMkiqzIjMFUtjhSfr3qlPe7LW5mQNNPBETtgYMQ5wNvsc/gK88+LfxMtvCkVvbacLa8v5bmNJImf8AdpCSNzE/dz0ABOc1u+GdR0jT7bEd/a/bdWuTd+UJgPtEzou4ReoxjpkZBFAHaqZo7XeyCa42EhSwG9u3PQZqR5CIXeKMyPjcEJAz+PSqUlz5Vt5kqMI1PXOMD1P+e1I2oWsEKNcSxRh2ETNuygfqBn8O9AF+U+XGzRlnfGQoYZNecS/CayiPiJrPxH4ohtdanurm8sbe4gEUjzqQ+AYsjg8ZPG0da9DRwW2jDKRu3D/H/PFSbsgckEfrQBwmifDHw34Y8RWeueH7e6srqzs3tHgt3Gy6RscOGBJIIBGCOa7yaYx27TGORmC7vLQZY+w9TSKSQAcfUU5WCZBHTng54oALiQwwySFXkCIW2IMsfYDuaQyhbdpdr4VN+0DLDjOMevtSHcSAc8nPymnJwwzkBvXmgBEk/c+Y27bt3bSPmxjPI/pRHMssAfawUqGwwwcdeR1zSvnB46jn3pC2GYkAjPU0AQ2bpd20N1CHEcqB13qUIGOMqenWktbmK/s4Lq2Y+XKNyl1Kkj6EcU9n3K3PQc80jMrKOcjqc0AYv9u6X/z9XP8A3w//AMTRVn7bpv8Az+2f/f5aKAPgqxuIV1C2cXX2M3MQmW9tG3x2UcaZKrExyzL82OV+ZuOtd2fEHijw6upXmmXlvHHqkET6uUjWNbCRUCxokm9hHcOoIMZGEJHGBkYurfD6XQLyxtNDkPiTUpE+13sVuoBSPjauTnKsTkgjlSOvWqer+GtcsdOZ9FsZoNLuIw+oG4kMDh3wzW8nz4dVI3AgbsNgnPFAGRd69dz6f4ruzqAY3zhZC9w7zTqxUBGfdhwgXjIJI3HgGuv+FOq+JdBEgu86D4Zuw8cs72R2JKqA7sZyp4XEjZAPQZzXCWun6TDol1LNcvPLaushikcRoC2MCJeTKSAcnAG3aeOldr4c8K6ZrVrbiTU73UNYlXz4rO7dWENrggS7C2GII+6XUhWDc0AY0Pipjq1zJMUn027XzTHDC0ccT7vmUSOMgEYZ5AMk9q0tF1tNFuTcqJY4rgMvl2aIUKFd4WJSckY3dlznrWZq2uHVL+3NrrmrXkkN0Y/MnCRvIqht8pc/K3HlgIx7sP4s1Z0qeXSLbXrmOwj1WKVoyb+36Q7DtK88pmQgADrjjIGaAOyuNZ0uFVa2eSKB7lWQW9xHcwzxY+WORYidoXPCk7iQc9KTw5rl/pXhPVYfDlpBBqiTA/b7aATtISWyyQtwNq5DsMhe5PFcBaa9fW0FlHqOjxG8+1x3VrdIqQZYE5wAMSE568g8Zro7O6PiCfT9MbRrr93O4uZ7aVfNWU58wB9vKnIGM9fTFAHUaPb6dDqWoalquj2/iHWIAl1eyW1nGbmJGXAZYI2KM+7BYsV65xmsKPWtUj1G5S70Cw1zVknXytWl22f2dtpO1lAxuOAQCeqjAotU0y3mt21HRp/D3lt5qWVxO2J4VyGJcBWmJbbiPgt24qlot3NPqoJ0e105bh13WZcBZTyd3l7doYAKy7sAYPU4oA9JsdQ0TxJosUN1oNpLr8w2XaT6lHYSTMcEyxO/zvvIBAwB8pzir+qw6hZaemmHS9YbV3jEUtzcq4RyCQWHytGQFK9CPUGuesdGtpNKuDeaIuvLHaQQyz3kqfaLeDJL7JHyrYc7QBtbrzXG64kk1kI9P1HxHexQOiyxX+qB1UHJCoUJD4CgAYyGb2NAHpdj4Ftbhby7vFsdS1JnEztcuHZZ094DySMAHHG08EGrOmWHjXU5ryOfS9QsILRVi2C9845ByGijkRRuHPOemeteeST6pb6XBdLHLY2M0iRE2Vs0H2eZT8yzxJ9/PyYIPXr1rsNX1LUbjSGOpQ6rqsNzF5jPbayY4pYvusAhRAi9CVyWyxxkCgCxdfZ7HRplv/7BttWv2XY2pyCNi4BG2WLkAY5VmGBnJAGDV1oIdegistZbQ9Kv2mS6iguL5J5ZJAuBIqx/LH8pA25OB0riZfDmnwaHHBcWmpz6jvQX0sM6zyPESTGCpPKg4XZnJXIJHStiXQrDQbLRrjUTpMdmLr7Ky3lx9mkVeS7pMWYuAcYTBA6BiOaANaTQ7jQ3iaeLT7uWO43rBPq5hWRSp+ZYpF2t3wQQQcmtz+y/DvjPTriw1GCzljdlnhSObdjKqSYpe54GWXP5V53rOjxT6rNNoV1a3tlO32kTGWYTpDtAbNyMlE3AHaqknnOFyakTTNd8OW9pqej2Fmmk2riWC/jInW33LkhC330kBXG0cE/XABral8JLSTUWgjdtK0C3iCLb3Fulyi5PzsJCdx68f3TW3ZjwTPb6XpuptZ3ltaoLP7RP+6mVogYgQq/MQACN33cE1gax448VTXDWljdT3DOpjTT7axRLmFjEWZZMnBOCD8hIHPIxiueQ6vPYwWem2Gn6jNANtzYieO3ukO0gyh1O0EHGCrZySCpzQBa0jUluNEFlrml6Rq0dtLJJbvfblhsIiAqpAiqBjAzyTjA69afp+n2GgaubfWNVtbSzhjt7hrg2cYCPjMTgpzcHcpUdCoz0781Lpt5KhF14FvJlYBYJd/DJz88rADLA8ZwBjtxW7erb20dlp93pmj3N7BEn2XTbO8cRQB2IMspjBLyM2FI3EAKW4B5AN/UfDLatbCHTLqztr+6P2601KS4MdtJcuVLPbvkgNgD5Mkj9aWb4U61f2O3x3dQXGqzSboriJ0yx3J/HtUlwisFXGDuOazbS90XR5muL/QvE2nX12DEdLjVXtkuGcAy2+V2RkMABtJ4fGAKvan4i1iOOe40i6g1xIcm4ttXRAbfGR5iyxuUTGSMMRkgYHFAG3a2MWlRywx2qWumW6eWz29mXEeG+SVATmTYc5PTJz25XRtaiu11nRbmbTrkKnnLG8PlfaG3DaS3IJGd3AJHeuE0yHUNM8ZA2U+sXN9FcLHceZbvJG0kgB3HD52EuAwyeMYB61vXur6sifarsaNa6ezpbGK+06EzxAfu/MRvM8zZ1IJ+Ye/QAFq7t0sNbhinvBdWsdokEEVlEgRGjG/zJOR5i7sY6BiQM8VBqemytpH2NtZNkkVyP+JX9kntYZEWRmDb9rDfuIbcuQduO9Z2qatcppar4fQy+HIZEgke6ga5maR3I3lT96DO3amcd/rPJoetaDbHTbgeK0KYa4n0PVokW8diSJBFJyi9V3A9RyvcgEeuy3U7Si0VJ4vKV4ZJLyRX3q4JWFpQBwRuZjnYBnpmsC1a+Vbp74LdxXsu5Zf3UimWMlkdocAOONxCtzk/Srk/iS/8AC9y2l3Y1O4tr4hG/tuZbya1Z1wrxsnDfLwwUg9cgjk0NItFuLm5ur4/2qlxIIHt7pRGwQghHhAPlQMpAAJJ+nJoAj13xhFe6AulXUGhWWnxybpbnS5JPPV+fnMLHdtz1UHgZrMe6srokx6c0lu07PHdTQtbKTuUybodzKF3Y+vAwK2Rr13cRz6dayPd6npjsfLlmMszqMg+bE0XluoXdnZJ06VjSW9rqBtvsF7dG5VxHBN5boXjZQSSgJURAgLhiOACfvcAHaeFNBfxHM7+EtQ07XbSCUTz6Rqu2MBhkA+WCCRk/eYdQetebNdXepajZx6gkrQaUpFrJp9v5jRsknDErkEDkAnj5VFdX4f1i68KaxAyppVpDvktXuptOZRHKyjOJAQ5B2glQcA/WuC0/Wr+LVfN/tGXZM0iyrE7RRZYtliikAKcbuoyTn3oA6rw/oug3tksmdP0wCdoYbm91FFuCQQzJJHgcHJ53ZwcelTfEDw7ZafrNpe+E/Dr6J50cg41JJ0MmQQAwYiM+ik/MprA8NXa6YXuZLRdRuL/PkrbwrNuAzgAFGKHOchsk45GMGrWqi91lobvxDdMJzbtILWbTZYAGHCbvLGwIcZy2PUgCgDN8O+BtROpabNFLewTF2mS4it+IpYwWyrHGcFQcLnp61H45PiF7J9R8Zzs7amTcwW8TLEnmtgi58tRtbcAwJwD8wOT0remvdNmm05tLi8TIYVRZLk3DqXnYYdItqbIxknBGM55xWi11bqlql1pFzYJFAAyanEXik28Kd+H8vnA42j1oA85v/FOr6jcC8jR7a8SGG1c2cIjUKgAjJ6ncec9M/jirsPgjUpdCj1q2m0yK3mfy4LT7Vi580ttEagjJcEBioPAPOM1Pe3txp+tGS0uLmKS2WBbidrQBoRwoGe4HYnrx3rr4dM+z2Ftq2qXun6vaaxHJFFeXs522JJ2u6pg4Ln+LAwUPqKAOFvtR8XaYG8P39tLGGsvscdkbcBVidw24KowSWGdxycknrUujwX2ta3ZSWGnSgaPaxwSnzzAEkUlQwl6RuXIK5x82Bz3L5LjTIJdP06xlskniMclwbht00JZTkoQpI9MDHPfrUMBnsdQS8VtVu45XH2kwOYcYICZYAjcGAIyCOnFAHRxePfG9po1/H/xOAttM0TTiZ0a1csWZHX7r/MckuucnqOK2p/ibql74EVrq5id4lfNvNKpZpixdJkODuKCQ/IcduTiub8U+Ik1y2kW6sdYtb0KsBuLwwzKWLDeZX8lXBzg7wSRkjoa5aYahax3ctxKqSQTmSW3WZVKSZ258rGOqqTxyMUAfb3ws8WN4j02+tbq8uJry3EU5u2tBFC0UozF5I7rhWBJ7966HVvE9m9pq6aTdpcajZKw8m3dHcsoDFVBOCQvXPSvlHwd4l1TRdBu7FrWK9v8AVxHJstLuSPesbPuR0jGUG2VcRoMMDwDmpBrMei6hb6vMJdIv545LIRaTZK0TsrfPCsT/ADxTsCgO4H5Tz14APqyy8R6drEjDTNURFdUWItF8nmEnozYDMQQNmfeoF8Z6NqWmwTaXqlsguy6RyzMqFNrlCTG5BPKuB64NfMWmeIfFej2j6KNJ0LSxFeRXqyapPGy2ThN/mSRyHcJj8pMmBgnAAzxR1vxlF4i8RxudO0vXp7dLuzvL24mhszqQlAVNi9E8rqjknOCRtJxQB9e6vqj24X9/b2Ebsojublk2tlSdoUsCWzgYq4lyt5bz/YpYzPGWi3Ebgko7EexxkV8cJby6pFaa8+qLpmkaJefvLe7ka+trS6JCAtKG3SOdgf5QVxtAI5rVi+NupeHU1D7RfnVb7VbIzOt1p7WDWc2MR7SC3mAocg8cbec5oA+to5WmtS6Ao7L8pmQp83uPr2o85nWeMRkSoMbmBCsxGflPcZ618zaH458U20WkpqWm6hqGow6Ylwba3lcO1qXGwzsykAjAOVBctleOlaOr/ET4q+E4NTm1fw5pt1YpMrw3cs4QRBnyU5YM3DqgJAxtzQB7jB4l0k3C2D6rpjaiiMZoEuFOxkGWyM5AGc4POKLHV2ktraHVFtLXV5UdjZpcLIdq8F17lcEHnoCK+P8Axd8VdY8R6nb6hp/hfTrVNJib7ebJROkgb5dzOB8q84ByeT1OcVy1zqvjDWvM1SLTtSKXbfaJJbWGURXCx8O28c9QAdrAcevNAH1956/8+vhf85f/AImivK/+F1eGf+gfcf8Afmb/AOKooA800y78R6fI8GsyXtkb1/Ju0t4UlnvFDKVtwFwUGd205/iwD2qyfGNor6tpsd8+iW0alprea1kaS8LNue2RGYiCMdOu9gBknOBV0bw/ea95Y06TS9MNqmYLCeZpV1AISZUmkBzuyVCIQCVPynjcdSC28JT6paap4v12+1fWrm0NytxbbWt2ZAV8kBk42hdobdyRxjigDBttMEWl317p9zczaNBePJp/2u3jjaaUKPOJt1y7KVG04ICg5PTFdimlavq/h7TNVN2NavNVl8qU5gh8+JGGyGVz/q23bkKDcGHGRjNYWs6edSuIrnw1p1/ayzXS3sSahNHLCqhQrRkr86IC4AyQHGRgkCu90ufTvDWn22t/2bb6XBLcvHdXcVsQtlcbQJY/nOWicbhHtGFJJPJ4AOHv4Tqc8Uz6L5Wl21ys5FhiaJyF2h1LH95GqxspVAACCOeK557SbTZdSuNXtzJe/M1np08beXgqVWVlTIHl8fI3RiM8V0+pWt5Nq2n3c8V3HcajfGXSL6zdLQ27ysn79yNw2SDEgj+UqcqOpJ5mS4tbPTNW09Ta213FcM7j7PK9vOkqKiMkhYumBl/m4YsvHy0ASy3GqrBa6dodpqdx/Z8yzPbtEkiLtyQ8b43AnBBXvj1r1fw8994n0JrS4sZ9Uu5pcObrTzbMgAAYTvFxH1+UgZIGcDmvFnum0+4t59PY3FoXNompNG8Ee0RIGV1UA5EYXdgbiMEHdknsdYtLXWRb22r+KpUe2hE0UtvpzxzXERICssZxu+VgzHdux/C3WgDq/GSTeHtdWLx9qulurzia3shYtIbdGbAdH3Ltk4xuZSOMnnArh4dag/4SKW3W2k+zuB9pWWEQFUONypJu4DFV2luSDjjNOuR4duFlXVNM13SJLWHZcXt4JZ2ubgjCo8xxsi6DaYzngnFY/h/UTbJb6zqOjm70q4uXtkS5nwHO0mJM4JMcefmJ4OFx93gA9T8NXZv9EWysW1CCG4+aBnCxfZoHYfP8uRkbVGH4681R8QS+dqgvTdR3aF47OO8s0WOKRw2cSEDCjlfnXLZ6gU/xCL+80i9m0WRNHa3KvbKtwGkup3XY0TEDAUqQQDwSMDnOOf8AEdm/huS1s9fu72CK3c/ZY0YElioO8LnJVT97IJAKYyFxQB12nC6sby8t9Onhcxn7MrGdfMtyMlmCMMOvPU4wATip47fUpLjUktrCSdHugEuUVFC5PdgxjbJ5XjJHYVStY5rK8tmknjllhLCORwSk29ApV9uCPlbJYgg5GatHTbfw6kssZSwkWRngWa+LW8mRjDRqMrgjKnJIHSgBNLsLieC6mvbsQTi9dUuI4QRblmKszKPvnPO717Y66VhYQaPfWV/c3mmvBcxm1VLmCNpZSDwpMhKxpjawIXPOCO9ZFvax3nlz3Be2tLX5op7aaTMjN8x3A5BAJJXgj5vmzXQtodhe6PbzLpNzqF6uyddKs7hU4kX77FxgjnPpnp6UAY2owwfaltbmSOb+0JmidXQQxwHcMRxoMbmIOS2cnbjGKZqkviXTrEWGia80941z5MYeZUnAXpGsYTymjYZOV6bRjuKl1lLe3uIzHdJCdPdYCt2GmdC6YClRlfMUglcdSADiudS61HToIFtI5dPKFliEDzpMqhTvVpCzqgwflCADcB/CTQBo+I/EHiPxPBDpK3N2sIjadrmzWOJplXBYQMhG9hxnJXjd14rnpryzsL6Se3Y6PEQFXUYMTPGGUH5oznzQ6kMQgIXryea0Ncvbm7MVvc30tv8AZYP9GiuYyJJWOATJKrMWTjgDqw+ZWXNXdBn8Rya2tvbfbLG7lybYXNsZfOkkCggF1ITH3huwB06YFAGbpfhLQNN0x47lL3VWdBMsljrAiR0YFt6xcEDaQW3YwM1uaHavYkr4cs1hYWavbEEtHcKxYeYkrfvAnQjI6gYwDW4dCgn0aGYatokMAnkuVNhYPbnUREMyCR943YOeANvselZEOoWk93dTTLfW8qxwSxokglluC2U4lxtjjXlgu3ORuI7UAdFaRWUTLdtbahIL20jjksnQNbwSBesYLZYknaSGznHfBrnNR8KeGbCSK70zRzFG8bfaGubaRWt3BKkeSzEkMx++SVABwc4NdJpnhmDxdbzEXYu4kWMXRvNyy+aE+RW2fIQFIcPHjPGe9V7zwle2K2A8U67PeuswaO9tULSmMAjyZGI4jGAR1J5+lAFXwjZW+oXt4LyPzrKeDy714bvzI29MliHABwBg7jjjpXQappt1pmj6lcPo+h2qW0KKojBdpwMBZGVxkKOSFDZY8+1ZWqQ6m9i6Pc/2k8zK7RWiRIq3KghAJT8yoAAc4YgjgEcVpPFBe+CpLNbm/vXsJQ13FdP5jzOXB2u7DgguGUrjAA4HSgDDispJdOW9AuRfpEArbP3hQkZDDoc/exgEAgcYq1ofh6XXbtbvVNB0e5tJActfSO0rMgARwhOA3qAMYwav3Ulw2pWRcrbTaa8VrfCGUs0wV2bZgn5UOVy/U9DwazdQsG1FYV1K+v8ARWkt4pRatCEjaY5wIwrblPPIyAAvfNAGJ4gs7nRpL+COy02w0wq800dkm9hyAZI+wcDAIz24qh4UvZJIrqze8W0sr4b7GAoi+aw5JZ2XEecMO56/WtySBNRv4rHSbuS3+yyMbwXFvJHG0arvYEMWDqWwc8n61JqtiZJtMtdXt7eS3uOLSKKfzpLhcHeMBePvcE9PpQBzXiHVtKNtb2a61o82pqPMitI2aRLYYOR5oUBj2HPOelcTciVbvyLSSNopDhYVkIRS2S0b4wXV87mI4AwK7zxv4aa3tUubO2sIdOtbhJtj2ylwFwNjEZzjHOM5x06VxK7b26/4l8Mmo3RcpqUSwkIgdsJ5WPuoeMnA4OKANZpotJ8PSTx6fBNbNA++FxLKjXOVU7TuJVVztU5HAGa5bw7cRGG3+xaibN1Zo38+RLeNQVO6RQcltvK4P581ptFdaXbz3djqF1pYnjIn0yy3PsZCVdJGbOQeCDkgj1NUfDEc8v8AZDtGXsWVkZYYfM8w87N4Vd4Ax859McnsAb/w60a/jvJdX8NX8eo3hmknkitFDTxkbgjS8ZRGJGdnPJ571HrGmppHieNdW1LU5b2/V5byKVHV/NkQgMqnPnRjvzntg1qeG9Pi0661C51ddS8PPK5ElzaGWQToUO4QgFWXjBG7dnOKz9ch0e+e2i0+O8WFY1sQ+oaUbZ4Ac4+ZZMtzjLODgd84FAHYx3Muu+Ibf+17W2nsdPjkhM1vpZUzXHlYMKRbg2/udynbjtmsk6Z4T8u6+02V9ZyWpWUjU4UtEXICpGCzDcBhgT1weScCotD8Pao+s/8ACO2qWmqWOnTfbbt7CeZLqOTbtcxznG5wcEjJx0rYjV5NxvtV8bW2k210sbL4ghhlWLIPKs5JdcZyMYA6g0AYujNpOlS6hb6/CLGWQ+ZaWdxbZ8kD5k4VjlizKV8zcDxjFSahqdvDCLef+2L3T5flH2azVmgmYhlgiAYK0J4JZgSSox3rN1RNJtxDILREjubtGifULBSZkSTDmOWN8EDghSowOM0yXRI7f7S9vpXib7SSskDu/lWxG8bJMjlBgggcYxgmgB3iGbxZrWtPcG0v4byaeFh/adjBaKpiwYxIM5VFH3QDz1Oeans7Qm41GPxNfWNm9yy/bFj1C323oLZKbEJKxhlLAjBzjgVg+K/D0i6s7+JY7Fb+S4T7S1xfs8qx4GMgBiMrjDEke1XfDVh4I0jXb0a+LjTmikRY7ZXeYAZ5DyBVDZUgjGBzzjrQBbuvD+i6ncRHVPGOk29lZP5dnbx3wYoCc7m3IoxkE9eKzR4N1DTLaKe50G01+wDiOxmis5ZklBJO6V4XU9MEcsPpWv8AEEeAku51Xw1caevmRQLN/ahV9rBWZnhKvj5TlcEg+1c7o2jXK2kd14cuL5LLULmS3hhttSAkV+qzIisnVUZSJAOmfSgCn4j0KCxlt7u40i1tZWlVWsdOvpCJ1OTnexby9pAG0jP0xWD/AGQLW9MmoW8+pvcOWja2vwCjHsW2ElwcZ49K7P8AsLxUht5rmDxLCLmcRQNb2yXBaQfK+6EsGU8N8xJDEfjTf+Ec1W2WKe/g8VosFyrLDFYqWkZmBZwVfKFkGeQQGXBPSgCvZ+FrLSowNSsLK61qYZii1e4mQyscZCQphnbJCrkgMcn0Ak8YeF7bS762u9Q0ePT4ZIeLCWCWKNenmSjExfcoKnacDsanvtE1vXrttQWy1HVoLi5WHS4tXu/LuieMgJGxdwBg53BV57mszX/CclnrEmlXsFqmoyXa82VvPdeazY3xiVnOdgySBgnBBPSgDnNS8JX+lXCrey6dE8e14reS4WOS7iLZVwM4+YMMZIOPWu7k8SQ6ZogsvEXhkWMd5G0J1ZZP7SjljGTHEquxX92MAbXBXA461kahph0C5EEGmaBbattERjvC7s6P0JhmDBGII5DfKOODVO/ENg9zcjR9EFtcIqXIWaG+8iRT1ijjZWiDEY78d6ANvwt8RL6TxBBqWtPpd3c3EsNrMTOLZ7gjJjeZtpVYQDtbaARgdwTXS2fxC0PV4J4fE+kWuqG/me0ktNNupmkkgjbchUMc+Y0jKqkbSVD57V4Za28U10XV4wsbDaXhYRvhh9/H3QQea6jRLFY0lt9Cv9YXxKHJNpYwlomaN8qQwb5l4DZIG33zQB0/jLxTpZvXt/CaWaWGsaXFb3kMsX2KO0kSVsKUBK5GBnO4MRmtjSPiDPoPhDw9Y6LaS6lvuZH8y+unkiicIFwrKVUOFbJjwQo2t1bjyfWby9u72a//ANDilkKvPDbIkcTuvPMXQnIyQVxnPGK1rK31Ka50C71OzSe0luGubZbWNf3zeYplQhCNpHpjPAA4xgA+0v8AhGrb/nmn/f5//iqK6TMX/Ppdf+Abf40UAfOUPw8WcXWnSXloBZTWv2V0siNk1w6u0zDzP3jKCyqHzgHHOK9A0r4HeGNDtNU00m4v4L0K139pIBlKkMgHl7doDHOB1wO3FFFAHBeLdAl8J3+k6Rol8IZr+6gkuNTaBWu3JfaRvzjaRt+Xbj5fc1c1zTdX8O6wJLvUdO1q8unWKKbUdN8wW0wbYZ0TzNodlxnjGQD7UUUAc1rGiteXt5pOgyw6ALS6eIzWcb5mDAK5dd4XJPIwBt7etSv4a0hPDN3b2Wj6VbX0VzLCl55MjsEX5T96QncwXlieCTgDpRRQBo6b8IhE+g3FtrXl2+rRpFcWZtN8O2RWYjaznoVXk88V2+pfBnwx4VtrjV9BF3ZajawSypNFMdysowSpOSmRkcHIzwaKKAL1/p95P4E1bSri4tLmEpDAklzBJNIzSSbS8rPKS57/AMPNeaW3w71K2vJYk8V3RnSZ4EkNqoCdeQoPX05wMn1oooA3dA8D31rbTppOs29rarOLeO3l05Zlify/MWVdzZysgLKCSBuI561nWXhWGa4v9QkSwWaziSCcpasTducHzHLu235ixwuMjA7UUUAdzD4LTSPDcs/20z3tyWmNw8XzK+0M2Mk/Kw4K+n0pbnRLPxJpmpWUmn6TbFJWbzY7VmO5V3AhWcjPT8qKKALo8Lrd6DYXTy28VwskgZobYKGEYwOCxwflzx+GK09E0ua40+bUpbpJLsrGHd4icrt3BRhgRjNFFAGPa+AzqrXsTagluQ+y4kgtsPcepYljjIGDjB5PPNVNP8KQCawsrqVZYLt1wscZi8tFU4jyrZZfl6MTjPsKKKAJPF3w6hgt7iTRtSk08YAVPJWQKznBcEnIbAODnjJNYth4UuoonubXWJrbzookeOLzNnzt1w0hBORyWyTnFFFAHYeKfBL/AGOazvNUkvrW4dZdlzFux5Q4Bwwzk4yRjPt1rDsvCwWxugstqqXLKyolsVWIjceMPk8YByeQOeeaKKAN/wD4RafUtRtP7Y1Fb3S/s6zR2Rg2eXJv3Ah1bOAeg9ODmrmq6NI9xq0dnd/ZVltlYBUJCHgcDd36/UCiigCXTPCH9m6jLb6ZqM9taQtHGUC7mc8PuLE8HtwOlRXfhjy9H1FJ7+WaS9uxHI23aAsbFwQoP3iykljnOfaiigCg/hyIX1vvaKVnVof3kRIGAH34DDLcgZ9BVq50b7bFdTO8KyQzKFdYjv8A3nysd27g9MEYxiiigCvb+Bbia9vp7jWnuY4Xb93cW/mbhGMRpu3ZCg8kDGemcVJa+DRpsdvqdvqMqNaRsI4VjAT7vzfg3cD8MUUUAc1qHgd5FuLsal5aqWjjjSJmKPuB8zc7sxbsMnA5wBmnaD8P4tXxfXt1bxvJA0rraWxgMj7sfOwcswx2yM5oooApWvha7kh1KOx1mbTWtkBiNoJNuBxtKvIwwcZIGOaoeHfh5Z34nsoZltJHk8g3MayGQM6klgTJgAknKY2miigDoLf4ZyDw9YXGreIbq/SKLZbQrAluLcnqVePEnIXHLcjrmqV78NrO4lvr+WW3LxWjQxp9mJAVuWY5fJc4xu64oooAn0HwJqM+oWSr4nuYvLYyho7dVKfu+AgB2p+A57881R1/wDqUd9fyy+JpNSHlS2+7VLJLiVY1USALICpHJ5PUgdaKKAOd0zwfNqF3JBqOoxzRymGR9kDIWCZCrxJ2456nHOa6yTwteSW+m/adWEyzXrNJvhct5axbygJkP3gxUk57HANFFAGTe/DOHS9Jn1zT59OXUpbi3+zzTaaJTaFow25MvyQW4ByOBkGsS08LyapeyTa5PYXsTJtuVWyMTzsCWZ9wkwu9gpYBcfKAABRRQBVl+G8V/ozXCtolrPnKNBpCrsGD/wBNOT71nXHwqVL60fVtRttTe7Vg7vZtE7cryxSUbz7nn1zRRQB6n4c+Cnh7VrKC71K81Z9WAH+mw3TRMqqcbFA6Lt47nk81zVv8DdKhh1a60fWdU01Vun0ySGKQstxH5ygGTJyw5yV4BwOBzkooAm+JPw102wsEubJ1gv0nWN5ERwksa4Hlsu/cE+XO1GUZPtXn/iTw1qHiSWOeXUNPsGigEBFjp5jD7cfOR5pwxwASuMgc0UUAWtH8M/ap7LSNeOm6rZm6aQPLaOs0SMdzRxsJcIpIJ+6eWJreuv2ftJuNBtNX0XWr7TXuojI0LxrMqgEfKD8px9Se1FFAHK+Jfg1aaTawNban5sF1vAS5tyzRsrFdwZXXOeuCCPrWn4Y+B0Oq2nmvq8UEa4t3SGzdfMBHJY+bycjPpntRRQBnePPhJc2+stHd+Kby/kh3QQzXMJd40Q8AHf70/wAOfBexv9f0fS11a4hdnEslwEJbhQxCAMAuSDzyefaiigD6a/4Vlov/AD/eIP8Awb3H/wAXRRRQB//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The M mode echocardiographic scan (from the left ventricular apex to aortic root) from a patient with Chagas' cardiomopathy shows a dilated left ventricle (LV) and left atrium (LA) and the posterior wall (PW) shows very little systolic thickening while the septal (S) motion is exaggerated. There is significant mitral valve (MV)-S separation. This picture is somewhat similar to that encountered in patients with inferior infarction and mitral regurgitation.",
"    <div class=\"footnotes\">",
"     Ao: aortic root.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_0_28678=[""].join("\n");
var outline_f28_0_28678=null;
var title_f28_0_28679="Femoral hernia on computed tomography";
var content_f28_0_28679=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RADIOL%2F87219&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RADIOL%2F87219&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 483px\">",
"   <div class=\"ttl\">",
"    Femoral hernia on computed tomography",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 463px; height: 581px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Computed tomography (CT) scan through the femoral heads (A) shows a fat-filled localized mass (white arrow) lateral to the pubic tubercle (white arrowhead) associated with compression of the left femoral vein (white dashed arrow). These findings are consistent with a femoral hernia. The pear-shaped hernia sac is better appreciated in the coronal view (B), which is magnified in (C). There is no evidence of bowel obstruction.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_0_28679=[""].join("\n");
var outline_f28_0_28679=null;
var title_f28_0_28680="ECG Monomorphic VT tutorial";
var content_f28_0_28680=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F63176&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F63176&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1078px;\">",
"  <div class=\"figure\" style=\"width: 508px\">",
"   <div class=\"ttl\">",
"    Single lead electrocardiogram (ECG) showing monomorphic ventricular tachycardia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 488px; height: 150px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Three or more successive ventricular beats are defined as ventricular tachycardia (VT). This VT is monomorphic since all of the QRS complexes have an identical appearance. Although the P waves are not distinct, they can be seen altering the QRS complex and ST-T waves in an irregular fashion, indicating the absence of a relationship between the P waves and the QRS complexes, ie, AV dissociation is present.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal rhythm strip",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 165px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Normal rhythm strip in lead II. The PR interval is 0.15 sec and the QRS duration is 0.08 sec. Both the P and T waves are upright.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Morton F Arnsdorf, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_0_28680=[""].join("\n");
var outline_f28_0_28680=null;
var title_f28_0_28681="Genetics of congenital and acquired long QT syndrome";
var content_f28_0_28681=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"0\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Genetics of congenital and acquired long QT syndrome",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/0/28681/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/0/28681/contributors\">",
"     Peter J Zimetbaum, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/0/28681/contributors\">",
"     Mark E Josephson, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/0/28681/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/0/28681/contributors\">",
"     John K Triedman, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/0/28681/contributors\">",
"     Benjamin A Raby, MD, MPH",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/0/28681/contributors\">",
"     Samuel Asirvatham, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/0/28681/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/0/28681/contributors\">",
"     Brian C Downey, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?28/0/28681/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 19, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The long QT syndrome (LQTS) is the phenotypic description of a group of disorders characterized by a prolonged QT interval in association with a characteristic arrhythmia, polymorphic ventricular tachycardia. The LQTS can be inherited or acquired as an adverse response to medication, metabolic abnormalities, or bradyarrhythmias. Torsades de pointes (TdP) or \"twisting of points\" is the specific type of polymorphic ventricular tachycardia (VT) associated with either form of the LQTS. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/9/2202?source=see_link\">",
"     \"Clinical features of congenital long QT syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/55/23418?source=see_link\">",
"     \"Acquired long QT syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Modern molecular biological techniques have permitted the identification and analysis of the genes responsible for almost all patients with a congenital long QT syndrome (",
"    <a class=\"graphic graphic_figure graphicRef63732 \" href=\"UTD.htm?0/57/927\">",
"     figure 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef58937 \" href=\"UTD.htm?42/34/43565\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/1-7\">",
"     1-7",
"    </a>",
"    ]. Hundreds of mutations in more than ten genes have thus far been identified [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/8\">",
"     8",
"    </a>",
"    ]. Distinct genetic types have been designated LQT1 through LQT10 and additional genetic types have been identified.",
"   </p>",
"   <p>",
"    Long QT syndrome can also be an acquired disorder, most often due to drugs (",
"    <a class=\"graphic graphic_table graphicRef57431 \" href=\"UTD.htm?2/48/2830\">",
"     table 2",
"    </a>",
"    ). In some patients, drug-associated LQTS appears to represent a \"forme fruste\" of congenital LQTS in which a mutation or polymorphism in one of the LQTS genes is clinically inapparent until the patient is exposed to a particular drug or other predisposing factor. (See",
"    <a class=\"local\" href=\"#H20\">",
"     'Mutations in acquired LQTS'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The genetics of congenital and acquired LQTS will be reviewed here. The clinical features and criteria used to make the diagnosis of congenital long QT syndrome and the characteristics of acquired LQTS are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/9/2202?source=see_link\">",
"     \"Clinical features of congenital long QT syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/6/33897?source=see_link\">",
"     \"Diagnosis of congenital long QT syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/55/23418?source=see_link\">",
"     \"Acquired long QT syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h2\">",
"     Phenotypes of congenital LQTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Two clinical phenotypes have been described in congenital LQTS that vary with the type of inheritance and the presence or absence of sensorineural hearing loss: the Romano-Ward syndrome and the less common Jervell and Lange-Nielsen syndrome.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The Romano-Ward syndrome is transmitted as an autosomal dominant trait and is characterized clinically by LQTS without deafness (cardiac phenotype); it may result from any of the underlying mutations thus far found in LQTS or other as yet unidentified mutations (",
"      <a class=\"graphic graphic_table graphicRef58151 \" href=\"UTD.htm?31/27/32189\">",
"       table 3",
"      </a>",
"      )&nbsp;[",
"      <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/2-4,6,9\">",
"       2-4,6,9",
"      </a>",
"      ]. A recessive form of the Romano-Ward syndrome has been described in one family of individuals homozygous for mutations in the KVLQT1 gene [",
"      <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/10\">",
"       10",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The Jervell and Lange-Nielsen syndrome is transmitted as an autosomal recessive trait and is characterized clinically by LQTS and sensorineural deafness. It has only been described with mutations in KCNQ1 (LQT1) or KCNE1 (LQT5) that are described below [",
"      <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/2,6,11\">",
"       2,6,11",
"      </a>",
"      ]. These encode the alpha and beta subunits of the slowly acting component of the outward-rectifying potassium current (IKs). This variant has been associated with a more malignant course. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?2/9/2202?source=see_link&amp;anchor=H21#H21\">",
"       \"Clinical features of congenital long QT syndrome\", section on 'Congenital sensorineural deafness'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     TYPES OF CONGENITAL LQTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;At least thirteen types of congenital LQTS have been identified [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/12\">",
"     12",
"    </a>",
"    ]. LQT1 accounts for approximately 30 to 35 percent of LQTS, LQT2 for 25 to 40 percent, and LQT3 for 5 to 10 percent, with the remaining 10 types accounting for &lt;5 percent of LQTS [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     LQT type 1",
"    </span>",
"    &nbsp;&mdash;&nbsp;The first association between a chromosomal marker and congenital LQTS was identified by analysis of a Utah family with a high prevalence of this disorder [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/13\">",
"     13",
"    </a>",
"    ]. Linkage was found between the LQTS phenotype and a marker on the short arm of chromosome 11. Investigators using positional cloning techniques identified the involved gene and named it KVLQT1 (also called KCNQ1) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    LQT1 accounts for 30 to 35 percent of cases of the LQTS [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/12\">",
"     12",
"    </a>",
"    ]. Most patients with this defect show paradoxical prolongation of the QT interval after an infusion of epinephrine, which can also be used to unmask latent mutation carriers [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. In a 14-year old boy who arrested during exercise, the QTc was initially borderline; the administration of epinephrine markedly increased the QTc (442 to 585 msec) and led to a spontaneously terminating TdP [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The protein product of KVLQT1 (alpha-subunit), when coexpressed with the cardiac protein minK (IsK or beta-subunit, which is encoded by KCNE1), forms the slowly acting component of the outward-rectifying potassium current (IKs) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/16-18\">",
"     16-18",
"    </a>",
"    ]. Suppression of IKs by mutations in the KVLQT1 gene, in the absence or presence of minK, can be correlated with and likely underlie prolongation of human ventricular action potentials [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/19\">",
"     19",
"    </a>",
"    ]. Mutations in the gene for minK (LQT5), produces a similar defect in IKs (see",
"    <a class=\"local\" href=\"#H10\">",
"     'LQT type 5'",
"    </a>",
"    below). Gain-of-function mutations in KVLQT1 have been associated with familial atrial fibrillation [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/20\">",
"     20",
"    </a>",
"    ] and with the congenital short QT syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/21\">",
"     21",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/12/15559?source=see_link&amp;anchor=H9#H9\">",
"     \"Sudden cardiac arrest in the absence of apparent structural heart disease\", section on 'Short QT syndrome'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/54/28522?source=see_link&amp;anchor=H262710391#H262710391\">",
"     \"Epidemiology of and risk factors for atrial fibrillation\", section on 'Genetic factors'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Many missense mutations, and some other types of mutations, have been identified in KVLQT1. The severity of the clinical features of LQT1 vary with the specific mutation. In particular, mutations in the transmembrane region are associated with more frequent cardiac events (syncope, aborted cardiac arrest, or sudden cardiac death) than mutations in the C-terminal region (55 versus 21 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/22\">",
"     22",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/9/2202?source=see_link&amp;anchor=H16#H16\">",
"     \"Clinical features of congenital long QT syndrome\", section on 'Genotype'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A mutation KVLQT1-A341V (also called KCNQ1-A341V) is associated with high clinical severity independent of ethnic origin [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/23\">",
"     23",
"    </a>",
"    ]. In a study comparing 244 A341V patients with 205 non-A341V LQT1 patients at a median follow-up of approximately 30 years, A341V patients were significantly more likely to have cardiac events (75 versus 24 percent), were younger at first event (6 versus 11 years), and had a longer QTc (485&plusmn;43 versus 465&plusmn;38 msec).",
"   </p>",
"   <p>",
"    Homozygous mutations of KVLQT1 appear to cause the Jervell-Lange-Nielsen syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/24\">",
"     24",
"    </a>",
"    ]. Studies in which the KVLQT1 gene is disrupted in mice suggest that KVLQT1 is required for normal development of the inner ear [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/25\">",
"     25",
"    </a>",
"    ]. Deafness can also be induced by the loss of functional minK protein, which seems to disrupt the production of endolymph.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     LQT type 2",
"    </span>",
"    &nbsp;&mdash;&nbsp;LQT2, which accounts for 25 to 40 percent of cases of congenital LQTS [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/12,26,27\">",
"     12,26,27",
"    </a>",
"    ], is caused by a variety of mutations in a different potassium channel gene, localized to chromosome 7 [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/28-30\">",
"     28-30",
"    </a>",
"    ]. The implicated gene is called HERG (or KCNH2), the function of which is the rapidly acting component of the outward-rectifying potassium current (IKr) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/31-34\">",
"     31-34",
"    </a>",
"    ]. This current is largely responsible for repolarization and thus the QT interval duration. The HERG channel has unique electrophysiologic features that may normally protect against early afterdepolarizations (EADs) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/33\">",
"     33",
"    </a>",
"    ]. Virtually all of the drugs that cause acquired LQTS block the IKr current mediated by HERG. (See",
"    <a class=\"local\" href=\"#H20\">",
"     'Mutations in acquired LQTS'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The mutations may involve the pore or the nonpore region of the HERG channel [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/30,35\">",
"     30,35",
"    </a>",
"    ]. In a study of 201 patients, those with mutations at the pore region had a significantly greater risk of a cardiac event (74 versus 35 percent with mutations in the nonpore region) and of SCD or aborted cardiac arrest (15 versus 6 percent); these manifestations occurred at an earlier age in the patients with mutations in the pore region [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/30\">",
"     30",
"    </a>",
"    ]. With multivariate analysis, patients with the pore mutation had a significantly greater risk of a cardiac event at a QTc of 500 ms (hazard ratio 11); each 10 ms change in the QTc above or below 500 ms increases or decreases the risk by 16 percent.",
"   </p>",
"   <p>",
"    In some reports, nonpore mutations are more likely to be associated with TdP in the presence of hypokalemia [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/35\">",
"     35",
"    </a>",
"    ]. However, a malignant phenotype has been described in a family with a novel mutation in the nonpore region [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Short QT syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;A mutation in the HERG gene that increases IKr has been identified in two families with the congenital short QT syndrome. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/12/15559?source=see_link&amp;anchor=H9#H9\">",
"     \"Sudden cardiac arrest in the absence of apparent structural heart disease\", section on 'Short QT syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     LQT type 3",
"    </span>",
"    &nbsp;&mdash;&nbsp;LQT3, which accounts for 5 to 10 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/12,26,27\">",
"     12,26,27",
"    </a>",
"    ], is caused by mutations in the sodium channel gene (SCN5A) located on chromosome 3 at location 21-24; six mutations have been associated with LQT3 [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/37,38\">",
"     37,38",
"    </a>",
"    ]. Mutations in at least two families involve a nine base pair deletion in a region of the sodium channel gene that causes impaired inactivation of the channel [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/37\">",
"     37",
"    </a>",
"    ]. The abnormal sodium channel fails to inactivate only 3.5 percent of the time, suggesting that even infrequent dysfunction can result in the clinical phenotype [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/39\">",
"     39",
"    </a>",
"    ]. Impaired sodium channel inactivation keeps the membrane slightly depolarized through slow leakage of sodium current into the cell, possibly resulting in membrane instability and early afterdepolarizations (EADs).",
"   </p>",
"   <p>",
"    Sporadic (de novo) SCN5A mutations have also been described in which neither parent had either the mutation or a long QT interval. In contrast to the heritable mutations, one of these mutations resulted in a prolonged opening and early reopening of the sodium channel and therefore a threefold prolongation of sodium current decay [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/40\">",
"     40",
"    </a>",
"    ]. Mutations in SCN5A have been associated with sudden infant death syndrome, at least some of which are sporadic [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/41-43\">",
"     41-43",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/9/2202?source=see_link&amp;anchor=H22#H22\">",
"     \"Clinical features of congenital long QT syndrome\", section on 'Sudden infant death syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Other SCN5A mutations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Different mutations in SCN5A can also cause a variety of other cardiac abnormalities including Brugada syndrome, a related disorder, the sudden unexpected nocturnal death syndrome, an isolated familial AV conduction defect, congenital sick sinus syndrome, and familial dilated cardiomyopathy with conduction defects and susceptibility to atrial fibrillation. In addition, some mutations are associated with both LQT3 and the Brugada syndrome with or without a conduction block [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/44,45\">",
"     44,45",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The differences in clinical manifestations are probably due to differences in the electrophysiologic abnormalities induced by the specific mutations [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/46,47\">",
"     46,47",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/37/28250?source=see_link&amp;anchor=H12#H12\">",
"     \"Brugada syndrome\", section on 'Genetics'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/16/32007?source=see_link&amp;anchor=H8#H8\">",
"     \"Etiology of atrioventricular block\", section on 'Familial disease'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/41/39576?source=see_link\">",
"     \"Genetics of dilated cardiomyopathy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/12/15559?source=see_link&amp;anchor=H8#H8\">",
"     \"Sudden cardiac arrest in the absence of apparent structural heart disease\", section on 'Brugada syndrome'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/31/22008?source=see_link&amp;anchor=H6106301#H6106301\">",
"     \"Manifestations and causes of the sick sinus syndrome\", section on 'Childhood and familial disease'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Further support for an overlap between Brugada syndrome and long QT syndrome type 3 comes from a report of 13 patients with long QT syndrome type 3 who received intravenous",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/30/30182?source=see_link\">",
"     flecainide",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/48\">",
"     48",
"    </a>",
"    ]. Although shortening of repolarization and the QT interval occurred in 12 of these patients, 6 (46 percent) developed ST segment elevation in V1 through V3, compatible with Brugada syndrome.",
"   </p>",
"   <p>",
"    A specific polymorphism in SCN5A (referred to as both Y1102 and S1103Y) is present in approximately 13 percent of African Americans [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/49\">",
"     49",
"    </a>",
"    ]. It is associated with accelerated sodium channel activation, produces only a small increase in arrhythmia risk, and most affected subjects never develop arrhythmia. However, they may be at risk for long QT syndrome and potentially life-threatening arrhythmia if other factors are superimposed such as hypokalemia or certain drugs (",
"    <a class=\"graphic graphic_table graphicRef57431 \" href=\"UTD.htm?2/48/2830\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    In addition, it seems likely that at least some individuals with this polymorphism are at increased risk for sudden death independent of other risk factors. This was illustrated in a review of 189 sudden deaths in African Americans, all of whom had autopsies and genetic analysis performed [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/50\">",
"     50",
"    </a>",
"    ]. The following findings were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      117 had significant structural heart disease, 40 had only mild to moderate left ventricular hypertrophy, and 25 had no cardiac structural abnormalities.",
"     </li>",
"     <li>",
"      Among the patients with a clear cardiac explanation for SCD, 4.3 percent were heterozygotes for the Y1102 allele. The incidence was significantly higher in the patients with mild to moderate or no structural heart disease (20 and 28 percent, respectively).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This mutation has also been associated with an elevated risk of sudden infant death syndrome in African Americans [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/51\">",
"     51",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/9/2202?source=see_link&amp;anchor=H22#H22\">",
"     \"Clinical features of congenital long QT syndrome\", section on 'Sudden infant death syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     LQT type 4",
"    </span>",
"    &nbsp;&mdash;&nbsp;LQT4 is caused by a loss-of-function mutation of the ankyrin-B (ANK2) gene on chromosome 4q25-27 [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/52,53\">",
"     52,53",
"    </a>",
"    ]. Ankyrin-B is a plasma membrane protein that physically links the lipid bilayer to the membrane skeleton; it is the first protein associated with LQTS that is not an ion channel or channel subunit. Individuals with this mutation have marked sinus node dysfunction, sinus bradycardia or junctional escape rhythm, and episodes of atrial fibrillation. Sudden death occurs after physical exertion or emotional stress.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     LQT type 5",
"    </span>",
"    &nbsp;&mdash;&nbsp;LQT5 results from a mutation in the minK (KCNE1) gene on chromosome 21q22.1-22.2 [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/6,18\">",
"     6,18",
"    </a>",
"    ]. As noted above, this protein, when combined with the product of the KVLQT1 gene, forms the slowly acting component of the outward-rectifying potassium current. Homozygous mutations in KCNE1 have been reported to cause the Jervell-Lange-Nielsen syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     LQT type 6",
"    </span>",
"    &nbsp;&mdash;&nbsp;LQT6 is the result of a mutation in the minK related peptide 1 (MiRP1 or KCNE2) gene on chromosome 21q22.1-22.2 [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/55\">",
"     55",
"    </a>",
"    ]. This small membrane peptide is thought to assemble with HERG to alter its function, affecting IKr. Three missense mutations associated with LQTS and ventricular fibrillation have been identified in MiRP1; mutants form channels that open slowly and close rapidly, decreasing the potassium current. One polymorphism in MiRP1, which is present in approximately 1.6 percent of the general population, can be clinically silent but appears to predispose to drug-induced LQTS at therapeutic levels of sulfamethoxazole [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/56\">",
"     56",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H20\">",
"     'Mutations in acquired LQTS'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     LQT type 7",
"    </span>",
"    &nbsp;&mdash;&nbsp;LQT7 results from a mutation in the KCNJ2 gene on chromosome 17 that encodes Kir2.1, the inward rectifier potassium channel expressed in cardiac and skeletal muscle [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/7,57\">",
"     7,57",
"    </a>",
"    ]. The mutation appears to prolong the terminal phase of the myocardial action potential and, in the presence of low extracellular potassium, can induce Na-Ca exchanger-dependent delayed afterpotentials [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/57\">",
"     57",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Affected patients with this rare autosomal dominant disorder, called Andersen syndrome or Andersen-Tawil syndrome, can develop periodic paralysis, skeletal developmental abnormalities, and long QT syndrome with ventricular arrhythmias that are exacerbated by hypokalemia [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/57\">",
"     57",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/9/2202?source=see_link&amp;anchor=H24#H24\">",
"     \"Clinical features of congenital long QT syndrome\", section on 'Andersen syndrome'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/62/9193?source=see_link&amp;anchor=H14#H14\">",
"     \"Hypokalemic periodic paralysis\", section on 'Andersen syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     LQT type 8",
"    </span>",
"    &nbsp;&mdash;&nbsp;LQT8 results from a mutation in CACNA1C, the gene encoding the L-type calcium channel (CaV 1.2). The mutation, which leads to an increase in calcium current, underlies Timothy syndrome, a multisystem disorder with major phenotypic abnormalities including syndactyly, dysmorphic features, cognitive deficits, autism and arrhythmias [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/58\">",
"     58",
"    </a>",
"    ]. The disorder is rare, with case reports including 17 children. Severe QT prolongation is a common feature (QTc &gt;650 msec), and malignant arrhythmias have been documented in 12 of the 17 cases.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Compound mutations",
"    </span>",
"    &nbsp;&mdash;&nbsp;In different large series, 4.5 and 7.9 percent of unrelated individuals who were each the first in their families to be diagnosed with LQTS (probands) had two disease-causing mutations [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/59,60\">",
"     59,60",
"    </a>",
"    ]. This unexpectedly high incidence of compound mutations could be a reflection of selection bias since such individuals would be more likely to develop clinical disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/9/2202?source=see_link&amp;anchor=H2#H2\">",
"     \"Clinical features of congenital long QT syndrome\", section on 'Epidemiology'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Consistent with this hypothesis is the observation in one of the studies that patients with two mutations, compared to those with only one mutation, had significantly longer QT intervals (QTc 527 versus 489 msec) and were more likely to have a history of cardiac arrest (56 versus 27 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/60\">",
"     60",
"    </a>",
"    ]. The increased severity of compound mutations was recapitulated at the cellular level; electrophysiologic studies of IKs channels expressed in Xenopus oocytes demonstrated that the effects of two mutations on potassium current were equivalent to the additive effects of each of the mutations alone.",
"   </p>",
"   <p>",
"    The presence of two mutations can affect the success of genetic testing. (See",
"    <a class=\"local\" href=\"#H19\">",
"     'Genetic testing'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Rett syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;With the exception of LQT4, the other six types of congenital LQTS involve an ion channel. QT prolongation and sudden cardiac death are also part of another genetic disorder called Rett syndrome. Rett syndrome is a neurodevelopmental disease that almost exclusively affects females but is not due to a mutation in an ion channel. It results from mutations in the MECP2 gene. How this leads to QT prolongation is not well understood. One possibility is autonomic nervous system dysfunction with increased sympathetic tone. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/29/32218?source=see_link\">",
"     \"Rett syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Other genes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately 25 to 30 percent of patients with LQTS syndrome do not have one of the identified genetic abnormalities. Additional genetic defects that may cause LQTS have been identified and are undergoing further study. These include a mutation in AKAP9 which is associated with decreased outward-rectifying potassium current (IKs) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/61\">",
"     61",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     VARIABILITY OF CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical features of congenital LQTS are described in detail elsewhere. It is useful here to briefly review the variability according to the specific genetic mutation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/9/2202?source=see_link\">",
"     \"Clinical features of congenital long QT syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    LQT1, LQT2, and LQT3 account for over 90 percent of cases of congenital LQTS [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/26,27\">",
"     26,27",
"    </a>",
"    ]. In addition to their genetic differences, there are certain clinical differences that may suggest one of these disorders [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/27,62\">",
"     27,62",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Triggers of arrhythmia vary with the LQTS type (",
"      <a class=\"graphic graphic_figure graphicRef64239 \" href=\"UTD.htm?9/27/9662\">",
"       figure 2",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/27\">",
"       27",
"      </a>",
"      ]. In a review of 670 symptomatic patients, events triggered by exercise were much more common in LQT1 (62 versus 13 percent in types 2 and 3), while events occurring at rest or during sleep were most often seen in LQT3 (36 versus 13 versus 29 percent). The sensitivity of patients with LQT1 to exercise may be related to exaggerated prolongation of the QT interval during and after exercise (compared to LQT2 and LQT3), primarily due to increased transmural dispersion of repolarization [",
"      <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/63\">",
"       63",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?2/9/2202?source=see_link&amp;anchor=H9#H9\">",
"       \"Clinical features of congenital long QT syndrome\", section on 'Triggers of arrhythmia'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Events before age 10 are common only in LQT1 (40 versus 16 and 2 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/62\">",
"       62",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Beta blockers are most likely to prevent events in LQT1. This was illustrated in an observational study of 670 patients of known genotype [",
"      <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/27\">",
"       27",
"      </a>",
"      ]. Patients with LQT1 were highly likely to be free from recurrence and had a very low SCD rate (81 and 4 percent, respectively) with beta blocker therapy; these events were more common with beta blockers in patients with LQT2 (59 and 4 percent) and LQT3 (50 and 17 percent). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/3/26682?source=see_link\">",
"       \"Prognosis and management of congenital long QT syndrome\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?10/9/10389?source=see_link\">",
"       Mexiletine",
"      </a>",
"      is highly likely to shorten the QT interval in LQT3 with little or no effect in types 1 and 2 [",
"      <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/62\">",
"       62",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    There are conflicting data as to the impact of genotype on prognosis. In two studies, the LQTS genotype was determined and compared with the frequency of cardiac events (syncope, aborted cardiac arrest, or SCD) through age 40 and prior to any medical treatment. In one series, the event rate was highest for those with LQT1 [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/64\">",
"     64",
"    </a>",
"    ], while in the other, the event rate was highest for those with LQT2 [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/65\">",
"     65",
"    </a>",
"    ]. Why these differences might occur is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/3/26682?source=see_link\">",
"     \"Prognosis and management of congenital long QT syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     GENETIC TESTING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Genetic testing is available to identify specific mutations that result in LQTS [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/1,9,66,67\">",
"     1,9,66,67",
"    </a>",
"    ]. However, such testing is subject to limitations given the complexity and heterogeneity of the disorder. It has been estimated that a specific mutation in one of the three major genes (KCNQ1, KCNH2, and SCN5A) can be identified in approximately 75 percent of patients presenting with LQTS and that a mutation can be identified in as many as 80 percent patients when testing includes all known disease-associated genes that have been included in commercial disease gene panels [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/12\">",
"     12",
"    </a>",
"    ]. Approximately 4 percent of controls have a rare variant of uncertain significance which represents a lower point estimate for the false positive rate for genetic testing.",
"   </p>",
"   <p>",
"    In a series of 541 unrelated patients from the Mayo Clinic, the overall yield of genetic testing was also approximately 50 percent and correlated with clinical measures of disease severity [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/68\">",
"     68",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The likelihood of identifying a mutation increased progressively with increasing QTc, ranging from 0 to 62 percent as the QTc increased from the lowest (&lt;400 msec) to the highest (&gt;480 msec) category.",
"     </li>",
"     <li>",
"      A clinical LQTS diagnostic tool, the Schwartz LQTS score is derived from QTc, symptoms, and family history, and predicts the likelihood of LQTS [",
"      <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/69\">",
"       69",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/6/33897?source=see_link&amp;anchor=H16#H16\">",
"       \"Diagnosis of congenital long QT syndrome\", section on 'LQTS score'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Patients with a score &ge;4, suggesting a strong probability of LQTS, had with a mutation identified more frequently than those with a score &lt;4 (72 versus 44 percent). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/6/33897?source=see_link&amp;anchor=H16#H16\">",
"     \"Diagnosis of congenital long QT syndrome\", section on 'LQTS score'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A higher yield from genetic testing may be available with more sophisticated and creative strategies. This was demonstrated in a report of 430 probands with Romano-Ward syndrome evaluated at a referral center [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/59\">",
"     59",
"    </a>",
"    ]. The entire coding regions for LQT 1, 2, 3, 5, and 6 (KCNQ1, KCNH2, SCN5A, KCNE1, and KCNE2) were analyzed in each patient. Mutations were defined as any nucleotide change that altered the protein product and that was not present in 400 controls. The following results were reported:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      310 probands (72 percent) were identified as carriers of 235 distinct mutations.",
"     </li>",
"     <li>",
"      138 of these mutations had not been reported previously.",
"     </li>",
"     <li>",
"      64 codons of KCNQ1, KCNH2, and SCN5A were identified as frequent sites of mutations. 58 percent of the mutations occurred in these codons, although they represent less than 4 percent of the codons in these genes.",
"     </li>",
"     <li>",
"      Defining LQTS as a QTc &gt;440 msec in men and 460 msec in women, the average QTc penetrance in genetically affected family members was 60 percent.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Thus, this exhaustive evaluation yielded a high percentage of genetic diagnoses and uncovered a large number of novel mutations. However, the authors acknowledge that this approach may be impractical in clinical settings. As a result, they suggested a multitiered approach, with progressively more comprehensive genetic testing in three stages:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Initial testing would focus on the smaller number of genetic sites with frequent mutations, and testing could stop once a defect was found. For example, in suspected cases of LQTS, the 64 frequently mutated codons should be genotyped, which could yield diagnoses in 40 to 50 percent of cases.",
"     </li>",
"     <li>",
"      If no mutations were found in the initial stage, the entire coding region of KCNQ1 and KCNH2 (LQT 1 and 2) should be screened, since these account for more than 80 percent of cases if LQTS.",
"     </li>",
"     <li>",
"      For patients who test negative in the second stage, full genotyping for less common mutations in SCN5A, KCNE1 and KCNE2 could be done.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    An important limitation of this multitiered approach is that 4.5 percent of the probands in this study and 7.9 percent in another had mutations in two LQTS genes [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/59,60\">",
"     59,60",
"    </a>",
"    ]. In such cases, if one mutation is identified in an early stage, the second would not be detected. This could alter management recommendations for the affected patient. Furthermore, since family screening is limited to an identified disease-causing gene, the failure to identify a second locus could prevent detection of affected family members. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'Compound mutations'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    In patients with a confirmed or suspected clinical diagnosis of LQTS, genetic diagnosis could have important implications for both management decisions and family members.",
"   </p>",
"   <p>",
"    We agree with the 2011 Heart Rhythm",
"    <span class=\"nowrap\">",
"     Society/European",
"    </span>",
"    Heart Rhythm Association",
"    <span class=\"nowrap\">",
"     (HRS/EHRA)",
"    </span>",
"    expert consensus statement recommendations for genetic testing [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/12\">",
"     12",
"    </a>",
"    ]. Genetic testing is recommended in the following settings:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Comprehensive or LQT1-3 (KCNQ1, KCNH2, and SCN5A) targeted LQTS genetic testing is recommended for any patient in whom a cardiologist has established a strong clinical index of suspicion for LQTS based on examination of the patient&rsquo;s clinical history, family history, and expressed electrocardiographic (resting 12-lead ECGs",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      provocative stress testing with exercise or catecholamine infusion) phenotype.",
"     </li>",
"     <li>",
"      Comprehensive or LQT1-3 targeted LQTS genetic testing is recommended for any asymptomatic patient with QT prolongation in the absence of other clinical conditions that might prolong the QT interval (such as electrolyte abnormalities, hypertrophy, bundle branch block, etc.) on serial 12-lead ECGs defined as QTc&gt;480 ms (prepuberty) or &gt;500 ms (adults).",
"     </li>",
"     <li>",
"      Mutation-specific genetic testing is recommended for family members and other appropriate relatives subsequently following the identification of the LQTS-causative mutation in an index case.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition, the consensus statement notes that comprehensive or LQT1-3 targeted LQTS genetic testing may be considered for any asymptomatic patient with otherwise idiopathic QTc values &gt;460 ms (prepuberty) or &gt;480 ms (adults) on serial 12-lead ECGs.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     MUTATIONS IN ACQUIRED LQTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Long QT syndrome can also be an acquired disorder, most often due to drugs (",
"    <a class=\"graphic graphic_table graphicRef57431 \" href=\"UTD.htm?2/48/2830\">",
"     table 2",
"    </a>",
"    ). Virtually all of the drugs that produce LQTS act by blocking the IKr current mediated by the potassium channel encoded by the HERG gene. As noted above, mutations in HERG are responsible for LQT2. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/55/23418?source=see_link&amp;anchor=H5#H5\">",
"     \"Acquired long QT syndrome\", section on 'Importance of HERG blockade'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In some patients, drug-associated LQTS appears to represent a \"forme fruste\" of congenital LQTS in which a mutation or polymorphism in one of the LQTS genes is clinically inapparent until the patient is exposed to a particular drug or other predisposing factor [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/1,55,70,71\">",
"     1,55,70,71",
"    </a>",
"    ]. It has been suggested that there is a redundancy in repolarizing currents that has been called repolarization reserve [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/72\">",
"     72",
"    </a>",
"    ]. This could explain why a given mutation might be associated with clinical disease only when another insult, such as a drug, hypokalemia, or hypomagnesemia, is superimposed.",
"   </p>",
"   <p>",
"    The frequency with which patients with drug-associated LQTS and TdP have an underlying predisposition to such events was evaluated in a series of 92 patients [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/71\">",
"     71",
"    </a>",
"    ]. The culprit drugs were antiarrhythmic drugs (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/48/777?source=see_link\">",
"     quinidine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/13/21721?source=see_link\">",
"     sotalol",
"    </a>",
"    ) in 77 percent and nonantiarrhythmics in 23 percent (",
"    <a class=\"graphic graphic_table graphicRef57431 \" href=\"UTD.htm?2/48/2830\">",
"     table 2",
"    </a>",
"    ). Genetic screening was performed for LQTS types 1, 2, 3, 5, and 6. Mutations in LQT1, LQT2, or LQT3 were identified in five patients (5.4 percent) and gene polymorphisms that might contribute to risk were identified in another 5 to 10 percent. In addition, all but 10 patients had an underlying risk factor for TdP (heart failure, left ventricular hypertrophy, hypokalemia, and hypomagnesemia). It was estimated that 1 in 1000 to 3000 individuals is a carrier of an LQTS mutation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/55/23418?source=see_link\">",
"     \"Acquired long QT syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other reports have also identified a genetic predisposition to drug-induced TdP due to mutations or polymorphisms in the genes responsible for LQT1 [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/22,73\">",
"     22,73",
"    </a>",
"    ], LQT3 [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/74,75\">",
"     74,75",
"    </a>",
"    ], and LQT6 [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/55,56\">",
"     55,56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Unaffected family members may carry silent mutations on LQTS genes (ie, they are carriers of mutated genes with low penetrance) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/22,70,76,77\">",
"     22,70,76,77",
"    </a>",
"    ]. This was illustrated in a study of nine families with sporadic cases of LQTS; 15 of 46 family members (33 percent) who were felt to be unaffected based upon clinical criteria were gene carriers [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/76\">",
"     76",
"    </a>",
"    ]. In such individuals, the LQTS mutations may produce an alteration in repolarizing currents that is insufficient to prolong the QT interval at rest. However, these silent gene carriers and their affected offspring might be at risk for unexpected TdP if exposed to drugs that can prolong the QT interval.",
"   </p>",
"   <p>",
"    In addition, common genetic variations associated with modest changes in QT interval duration have been identified. As examples, common variants of the KCNH2 gene encoding the alpha subunit of the HERG channel are associated with 3 to 4 msec increases in QT interval [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/78\">",
"     78",
"    </a>",
"    ], and common variants of the NOS1AP myocardial repolarization gene are associated with an approximately 7 msec increase in QT interval [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28681/abstract/79,80\">",
"     79,80",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19875495\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      At least 13 types of congenital LQTS have been identified (",
"      <a class=\"graphic graphic_table graphicRef58937 \" href=\"UTD.htm?42/34/43565\">",
"       table 1",
"      </a>",
"      ). LQT1, LQT2, and LQT3 account for approximately 75 percent of cases of congenital LQTS, with the remaining 10 types accounting for &lt;5 percent of LQTS. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Types of congenital LQTS'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H18\">",
"       'Variability of clinical features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      LQT1 accounts for 30 to 35 percent of cases of the LQTS and is caused by mutations in the KVLQT1 (also called KCNQ1). Most patients with this defect show paradoxical prolongation of the QT interval after an infusion of epinephrine, which can also be used to unmask latent mutation carriers. Events triggered by exercise are characteristic of (but not specific for) LQT1. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'LQT type 1'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H18\">",
"       'Variability of clinical features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      LQT2, which accounts for 25 to 40 percent of cases of congenital LQTS, is caused by a variety of mutations in the HERG (also known as KCNH2) potassium channel gene, localized to chromosome 7. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'LQT type 2'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      LQT3, which accounts for 5 to 10 percent of cases, is caused by mutations in the sodium channel gene (SCN5A) located on chromosome 3 at location 21-24. Events occurring at rest or during sleep are characteristic of (but not specific for) LQT3. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'LQT type 3'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H18\">",
"       'Variability of clinical features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Genetic testing is available in to identify specific mutations that result in LQTS. However, such testing is subject to limitations given the complexity and heterogeneity of the disorder. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Genetic testing'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In some patients, drug-associated LQTS appears to represent a \"forme fruste\" of congenital LQTS in which a mutation or polymorphism in one of the LQTS genes is clinically inapparent until the patient is exposed to a particular drug or other predisposing factor. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Mutations in acquired LQTS'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/1\">",
"      Wehrens XH, Vos MA, Doevendans PA, Wellens HJ. Novel insights in the congenital long QT syndrome. Ann Intern Med 2002; 137:981.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/2\">",
"      Chiang CE, Roden DM. The long QT syndromes: genetic basis and clinical implications. J Am Coll Cardiol 2000; 36:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/3\">",
"      Keating MT. The long QT syndrome. A review of recent molecular genetic and physiologic discoveries. Medicine (Baltimore) 1996; 75:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/4\">",
"      Vincent GM. Heterogeneity in the inherited long QT syndrome. J Cardiovasc Electrophysiol 1995; 6:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/5\">",
"      Wang Q, Curran ME, Splawski I, et al. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet 1996; 12:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/6\">",
"      Duggal P, Vesely MR, Wattanasirichaigoon D, et al. Mutation of the gene for IsK associated with both Jervell and Lange-Nielsen and Romano-Ward forms of Long-QT syndrome. Circulation 1998; 97:142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/7\">",
"      Plaster NM, Tawil R, Tristani-Firouzi M, et al. Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome. Cell 2001; 105:511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/8\">",
"      Roden DM. Clinical practice. Long-QT syndrome. N Engl J Med 2008; 358:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/9\">",
"      Priori SG, Barhanin J, Hauer RN, et al. Genetic and molecular basis of cardiac arrhythmias: impact on clinical management parts I and II. Circulation 1999; 99:518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/10\">",
"      Priori SG, Schwartz PJ, Napolitano C, et al. A recessive variant of the Romano-Ward long-QT syndrome? Circulation 1998; 97:2420.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/11\">",
"      Huang L, Bitner-Glindzicz M, Tranebjaerg L, Tinker A. A spectrum of functional effects for disease causing mutations in the Jervell and Lange-Nielsen syndrome. Cardiovasc Res 2001; 51:670.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/12\">",
"      Ackerman MJ, Priori SG, Willems S, et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Heart Rhythm 2011; 8:1308.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/13\">",
"      Jackman WM, Friday KJ, Anderson JL, et al. The long QT syndromes: a critical review, new clinical observations and a unifying hypothesis. Prog Cardiovasc Dis 1988; 31:115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/14\">",
"      Ackerman MJ, Khositseth A, Tester DJ, et al. Epinephrine-induced QT interval prolongation: a gene-specific paradoxical response in congenital long QT syndrome. Mayo Clin Proc 2002; 77:413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/15\">",
"      Shimizu W, Noda T, Takaki H, et al. Epinephrine unmasks latent mutation carriers with LQT1 form of congenital long-QT syndrome. J Am Coll Cardiol 2003; 41:633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/16\">",
"      Barhanin J, Lesage F, Guillemare E, et al. K(V)LQT1 and lsK (minK) proteins associate to form the I(Ks) cardiac potassium current. Nature 1996; 384:78.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/17\">",
"      Sanguinetti MC, Curran ME, Zou A, et al. Coassembly of K(V)LQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel. Nature 1996; 384:80.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/18\">",
"      Splawski I, Tristani-Firouzi M, Lehmann MH, et al. Mutations in the hminK gene cause long QT syndrome and suppress IKs function. Nat Genet 1997; 17:338.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/19\">",
"      Shalaby FY, Levesque PC, Yang WP, et al. Dominant-negative KvLQT1 mutations underlie the LQT1 form of long QT syndrome. Circulation 1997; 96:1733.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/20\">",
"      Chen YH, Xu SJ, Bendahhou S, et al. KCNQ1 gain-of-function mutation in familial atrial fibrillation. Science 2003; 299:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/21\">",
"      Bellocq C, van Ginneken AC, Bezzina CR, et al. Mutation in the KCNQ1 gene leading to the short QT-interval syndrome. Circulation 2004; 109:2394.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/22\">",
"      Shimizu W, Horie M, Ohno S, et al. Mutation site-specific differences in arrhythmic risk and sensitivity to sympathetic stimulation in the LQT1 form of congenital long QT syndrome: multicenter study in Japan. J Am Coll Cardiol 2004; 44:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/23\">",
"      Crotti L, Spazzolini C, Schwartz PJ, et al. The common long-QT syndrome mutation KCNQ1/A341V causes unusually severe clinical manifestations in patients with different ethnic backgrounds: toward a mutation-specific risk stratification. Circulation 2007; 116:2366.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/24\">",
"      Splawski I, Timothy KW, Vincent GM, et al. Molecular basis of the long-QT syndrome associated with deafness. N Engl J Med 1997; 336:1562.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/25\">",
"      Lee MP, Ravenel JD, Hu RJ, et al. Targeted disruption of the Kvlqt1 gene causes deafness and gastric hyperplasia in mice. J Clin Invest 2000; 106:1447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/26\">",
"      Splawski I, Shen J, Timothy KW, et al. Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2. Circulation 2000; 102:1178.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/27\">",
"      Schwartz PJ, Priori SG, Spazzolini C, et al. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation 2001; 103:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/28\">",
"      Jiang C, Atkinson D, Towbin JA, et al. Two long QT syndrome loci map to chromosomes 3 and 7 with evidence for further heterogeneity. Nat Genet 1994; 8:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/29\">",
"      Furutani M, Trudeau MC, Hagiwara N, et al. Novel mechanism associated with an inherited cardiac arrhythmia: defective protein trafficking by the mutant HERG (G601S) potassium channel. Circulation 1999; 99:2290.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/30\">",
"      Moss AJ, Zareba W, Kaufman ES, et al. Increased risk of arrhythmic events in long-QT syndrome with mutations in the pore region of the human ether-a-go-go-related gene potassium channel. Circulation 2002; 105:794.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/31\">",
"      Curran ME, Splawski I, Timothy KW, et al. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 1995; 80:795.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/32\">",
"      Sanguinetti MC, Jiang C, Curran ME, Keating MT. A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel. Cell 1995; 81:299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/33\">",
"      Miller C. The inconstancy of the human heart. Nature 1996; 379:767.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/34\">",
"      Tseng GN. I(Kr): the hERG channel. J Mol Cell Cardiol 2001; 33:835.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/35\">",
"      Berthet M, Denjoy I, Donger C, et al. C-terminal HERG mutations: the role of hypokalemia and a KCNQ1-associated mutation in cardiac event occurrence. Circulation 1999; 99:1464.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/36\">",
"      Rossenbacker T, Mubagwa K, Jongbloed RJ, et al. Novel mutation in the Per-Arnt-Sim domain of KCNH2 causes a malignant form of long-QT syndrome. Circulation 2005; 111:961.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/37\">",
"      Wang Q, Shen J, Splawski I, et al. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell 1995; 80:805.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/38\">",
"      Wei J, Wang DW, Alings M, et al. Congenital long-QT syndrome caused by a novel mutation in a conserved acidic domain of the cardiac Na+ channel. Circulation 1999; 99:3165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/39\">",
"      Bennett PB, Yazawa K, Makita N, George AL Jr. Molecular mechanism for an inherited cardiac arrhythmia. Nature 1995; 376:683.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/40\">",
"      Kambouris NG, Nuss HB, Johns DC, et al. Phenotypic characterization of a novel long-QT syndrome mutation (R1623Q) in the cardiac sodium channel. Circulation 1998; 97:640.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/41\">",
"      Schwartz PJ, Priori SG, Dumaine R, et al. A molecular link between the sudden infant death syndrome and the long-QT syndrome. N Engl J Med 2000; 343:262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/42\">",
"      Wedekind H, Smits JP, Schulze-Bahr E, et al. De novo mutation in the SCN5A gene associated with early onset of sudden infant death. Circulation 2001; 104:1158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/43\">",
"      Ackerman MJ, Siu BL, Sturner WQ, et al. Postmortem molecular analysis of SCN5A defects in sudden infant death syndrome. JAMA 2001; 286:2264.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/44\">",
"      Grant AO, Carboni MP, Neplioueva V, et al. Long QT syndrome, Brugada syndrome, and conduction system disease are linked to a single sodium channel mutation. J Clin Invest 2002; 110:1201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/45\">",
"      Clancy CE, Rudy Y. Na(+) channel mutation that causes both Brugada and long-QT syndrome phenotypes: a simulation study of mechanism. Circulation 2002; 105:1208.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/46\">",
"      Desch&ecirc;nes I, Baroudi G, Berthet M, et al. Electrophysiological characterization of SCN5A mutations causing long QT (E1784K) and Brugada (R1512W and R1432G) syndromes. Cardiovasc Res 2000; 46:55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/47\">",
"      Clancy CE, Kass RS. Defective cardiac ion channels: from mutations to clinical syndromes. J Clin Invest 2002; 110:1075.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/48\">",
"      Priori SG, Napolitano C, Schwartz PJ, et al. The elusive link between LQT3 and Brugada syndrome: the role of flecainide challenge. Circulation 2000; 102:945.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/49\">",
"      Splawski I, Timothy KW, Tateyama M, et al. Variant of SCN5A sodium channel implicated in risk of cardiac arrhythmia. Science 2002; 297:1333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/50\">",
"      Burke A, Creighton W, Mont E, et al. Role of SCN5A Y1102 polymorphism in sudden cardiac death in blacks. Circulation 2005; 112:798.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/51\">",
"      Plant LD, Bowers PN, Liu Q, et al. A common cardiac sodium channel variant associated with sudden infant death in African Americans, SCN5A S1103Y. J Clin Invest 2006; 116:430.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/52\">",
"      Mohler PJ, Schott JJ, Gramolini AO, et al. Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death. Nature 2003; 421:634.",
"     </a>",
"    </li>",
"    <li>",
"     CIrculation 2007 115:432.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/54\">",
"      Schulze-Bahr E, Wang Q, Wedekind H, et al. KCNE1 mutations cause jervell and Lange-Nielsen syndrome. Nat Genet 1997; 17:267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/55\">",
"      Abbott GW, Sesti F, Splawski I, et al. MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia. Cell 1999; 97:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/56\">",
"      Sesti F, Abbott GW, Wei J, et al. A common polymorphism associated with antibiotic-induced cardiac arrhythmia. Proc Natl Acad Sci U S A 2000; 97:10613.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/57\">",
"      Tristani-Firouzi M, Jensen JL, Donaldson MR, et al. Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome). J Clin Invest 2002; 110:381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/58\">",
"      Splawski I, Timothy KW, Sharpe LM, et al. Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell 2004; 119:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/59\">",
"      Napolitano C, Priori SG, Schwartz PJ, et al. Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice. JAMA 2005; 294:2975.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/60\">",
"      Westenskow P, Splawski I, Timothy KW, et al. Compound mutations: a common cause of severe long-QT syndrome. Circulation 2004; 109:1834.",
"     </a>",
"    </li>",
"    <li>",
"     Proc Natl Acad Sci U S A 2007; 104:20990.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/62\">",
"      Wilde AA, Roden DM. Predicting the long-QT genotype from clinical data: from sense to science. Circulation 2000; 102:2796.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/63\">",
"      Takenaka K, Ai T, Shimizu W, et al. Exercise stress test amplifies genotype-phenotype correlation in the LQT1 and LQT2 forms of the long-QT syndrome. Circulation 2003; 107:838.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/64\">",
"      Zareba W, Moss AJ, Schwartz PJ, et al. Influence of genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group. N Engl J Med 1998; 339:960.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/65\">",
"      Priori SG, Schwartz PJ, Napolitano C, et al. Risk stratification in the long-QT syndrome. N Engl J Med 2003; 348:1866.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/66\">",
"      Li H, Fuentes-Garcia J, Towbin JA. Current concepts in long QT syndrome. Pediatr Cardiol 2000; 21:542.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/67\">",
"      Priori SG, Barhanin J, Hauer RN, et al. Genetic and molecular basis of cardiac arrhythmias: impact on clinical management part III. Circulation 1999; 99:674.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/68\">",
"      Tester DJ, Will ML, Haglund CM, Ackerman MJ. Effect of clinical phenotype on yield of long QT syndrome genetic testing. J Am Coll Cardiol 2006; 47:764.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/69\">",
"      Schwartz PJ, Moss AJ, Vincent GM, Crampton RS. Diagnostic criteria for the long QT syndrome. An update. Circulation 1993; 88:782.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/70\">",
"      Roden DM. Drug-induced prolongation of the QT interval. N Engl J Med 2004; 350:1013.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/71\">",
"      Yang P, Kanki H, Drolet B, et al. Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes. Circulation 2002; 105:1943.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/72\">",
"      Roden DM. Taking the \"idio\" out of \"idiosyncratic\": predicting torsades de pointes. Pacing Clin Electrophysiol 1998; 21:1029.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/73\">",
"      Napolitano C, Schwartz PJ, Brown AM, et al. Evidence for a cardiac ion channel mutation underlying drug-induced QT prolongation and life-threatening arrhythmias. J Cardiovasc Electrophysiol 2000; 11:691.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/74\">",
"      Piippo K, Holmstr&ouml;m S, Swan H, et al. Effect of the antimalarial drug halofantrine in the long QT syndrome due to a mutation of the cardiac sodium channel gene SCN5A. Am J Cardiol 2001; 87:909.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/75\">",
"      Makita N, Horie M, Nakamura T, et al. Drug-induced long-QT syndrome associated with a subclinical SCN5A mutation. Circulation 2002; 106:1269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/76\">",
"      Priori SG, Napolitano C, Schwartz PJ. Low penetrance in the long-QT syndrome: clinical impact. Circulation 1999; 99:529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/77\">",
"      Vincent GM, Timothy KW, Leppert M, Keating M. The spectrum of symptoms and QT intervals in carriers of the gene for the long-QT syndrome. N Engl J Med 1992; 327:846.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/78\">",
"      Newton-Cheh C, Guo CY, Larson MG, et al. Common genetic variation in KCNH2 is associated with QT interval duration: the Framingham Heart Study. Circulation 2007; 116:1128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/79\">",
"      Arking DE, Pfeufer A, Post W, et al. A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization. Nat Genet 2006; 38:644.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28681/abstract/80\">",
"      Aarnoudse AJ, Newton-Cheh C, de Bakker PI, et al. Common NOS1AP variants are associated with a prolonged QTc interval in the Rotterdam Study. Circulation 2007; 116:10.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1009 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-122.72.76.133-042A3B073A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_0_28681=[""].join("\n");
var outline_f28_0_28681=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H19875495\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      Phenotypes of congenital LQTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      TYPES OF CONGENITAL LQTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      LQT type 1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      LQT type 2",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Short QT syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      LQT type 3",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Other SCN5A mutations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      LQT type 4",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      LQT type 5",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      LQT type 6",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      LQT type 7",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      LQT type 8",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Compound mutations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Rett syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Other genes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      VARIABILITY OF CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      GENETIC TESTING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      MUTATIONS IN ACQUIRED LQTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19875495\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/1009\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/1009|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?0/57/927\" title=\"figure 1\">",
"      Molecular basis of LQTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?9/27/9662\" title=\"figure 2\">",
"      Trigger event vs LQTS genotype",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/1009|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?42/34/43565\" title=\"table 1\">",
"      Long-QT syndrome genes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?2/48/2830\" title=\"table 2\">",
"      Causes of long QT syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?31/27/32189\" title=\"table 3\">",
"      Genetic abnormalities LQTS",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/55/23418?source=related_link\">",
"      Acquired long QT syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/37/28250?source=related_link\">",
"      Brugada syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/9/2202?source=related_link\">",
"      Clinical features of congenital long QT syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/6/33897?source=related_link\">",
"      Diagnosis of congenital long QT syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/54/28522?source=related_link\">",
"      Epidemiology of and risk factors for atrial fibrillation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/16/32007?source=related_link\">",
"      Etiology of atrioventricular block",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/41/39576?source=related_link\">",
"      Genetics of dilated cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/62/9193?source=related_link\">",
"      Hypokalemic periodic paralysis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/31/22008?source=related_link\">",
"      Manifestations and causes of the sick sinus syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/3/26682?source=related_link\">",
"      Prognosis and management of congenital long QT syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/29/32218?source=related_link\">",
"      Rett syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/12/15559?source=related_link\">",
"      Sudden cardiac arrest in the absence of apparent structural heart disease",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f28_0_28682="Depression in pregnant women: Management";
var content_f28_0_28682=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Depression in pregnant women: Management",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/0/28682/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/0/28682/contributors\">",
"     Shaila Misri, MD, FRCPC",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/0/28682/contributors\">",
"     Shari I Lusskin, MD, FAPA",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/0/28682/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/0/28682/contributors\">",
"     Peter P Roy-Byrne, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/0/28682/contributors\">",
"     Charles J Lockwood, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/0/28682/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/0/28682/contributors\">",
"     David Solomon, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?28/0/28682/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 13, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinicians caring for pregnant and postpartum women should be able to recognize the symptoms of mental illness and, ideally, make a diagnosis and assess the severity of the disorder. Maternal psychiatric illness should be treated, as appropriate, because untreated or inadequately treated disease will result in maternal suffering and could lead to poor compliance with prenatal care; poor nutrition; use of alcohol, cigarettes, or",
"    <span class=\"nowrap\">",
"     drugs/substances",
"    </span>",
"    that could be harmful; and disturbed relationships between the mother and her infant or other family members [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/1\">",
"     1",
"    </a>",
"    ]. However, pregnant and postpartum women are less likely to utilize mental health services than nonpregnant women [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Nonpsychiatric clinicians may prescribe psychotropic medication for depression and anxiety disorders; however, more severely ill patients should be managed by a psychiatrist, who can consult with the obstetrical care provider regarding appropriate use of medications in pregnancy.",
"   </p>",
"   <p>",
"    This topic reviews the management of depression during pregnancy. The clinical features and consequences of depression during pregnancy and the clinical features and management of postpartum depression are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/2/29735?source=see_link\">",
"     \"Depression in pregnant women: Clinical features and consequences\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/11/20666?source=see_link\">",
"     \"Postpartum blues and depression\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     GENERAL APPROACH",
"    </span>",
"    &nbsp;&mdash;&nbsp;Maintaining euthymic mood in the mother throughout the pregnancy and preventing postpartum decompensation are the most important goals of treatment. A biopsychosocial approach is the ideal model for management of a pregnant woman with a mood disorder. Treatment will vary depending upon the type of psychiatric disorder, the severity of the symptoms, and prior history of treatment and response [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Management of the pregnant woman with a mood disorder should address biological and psychosocial factors. Psychotherapy, using interpersonal psychotherapy or cognitive-behavioral techniques, is suggested for the initial treatment of mild-to-moderate symptoms of anxiety disorders and depression in the drug-naive patient who is not suicidal [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/4,5\">",
"     4,5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Women with a prior history of a good response to medications and women with moderate-to-severe symptoms are best managed with psychotropic medications as the first line of treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/6\">",
"     6",
"    </a>",
"    ]. In this population, psychotherapy is an adjunctive treatment and is also used to address psychosocial factors, such as relationship difficulties, financial strain, and living conditions.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PSYCHOTHERAPY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13804399\">",
"    <span class=\"h2\">",
"     Cognitive-behavioral therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cognitive-behavioral therapy (CBT) for major depression is a structured, manual based treatment that combines cognitive therapy and behavioral therapy. Cognitive therapy attempts to modify dysfunctional thoughts and illness beliefs; one technique is cognitive restructuring, which involves reframing distorted thoughts by empirically testing them and considering more benign explanations. Behavioral therapy aims to change problematic behavioral responses to symptoms, dysfunctional thoughts, and environmental stimuli; specific techniques include behavioral activation (counteracting inertia and avoidance by assigning rewarding activities for patients to complete between treatment sessions), problem solving (identifying the problem, generating multiple solutions, considering the consequences of each solution, choosing one solution, and acting upon it), progressive muscle relaxation, abdominal breathing exercises, and physical exercise. &nbsp;",
"   </p>",
"   <p>",
"    Cognitive-behavioral therapy can be useful in pregnant and postpartum patients [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. As an example, a 16 week randomized trial compared cognitive-behavioral therapy (12 individual sessions, each lasting 50 minutes) with standard care (feedback about depression status, educational material about perinatal depression, and referrals for psychotherapy) in 55 low income, perinatal outpatients with unipolar major depression who were attending obstetric clinics [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/9\">",
"     9",
"    </a>",
"    ]. The active treatment was modified to address the needs of perinatal patients, and included efforts to increase adherence, such as telephone calls, letters, and home visits by therapists. Improvement was greater with cognitive-behavioral therapy than standard care, and treatment gains persisted at the three month follow-up assessment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13804406\">",
"    <span class=\"h2\">",
"     Interpersonal psychotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The focus of interpersonal psychotherapy in pregnant and postpartum women is on role transitions and the acquisition of new skills applicable to motherhood. An interpersonal psychotherapy technique that is particularly useful for these women is psychoeducation, which involves providing information on the nature and course of mood disorders during or after pregnancy and on child care and child development [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/10\">",
"     10",
"    </a>",
"    ]. Preliminary studies of interpersonal psychotherapy in pregnant and postpartum women have produced encouraging results, including improvement in mood and better mother-child interactions [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/10-21\">",
"     10-21",
"    </a>",
"    ]. Group therapy also appears to be effective in reducing the degree of depression in both pregnant and postpartum women [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]. Interpersonal psychotherapy is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/16/17674?source=see_link\">",
"     \"Interpersonal Psychotherapy (IPT) for depressed adults: Indications, theoretical foundation, general concepts, and efficacy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/20/4425?source=see_link\">",
"     \"Interpersonal Psychotherapy (IPT) for depressed adults: Specific interventions and techniques\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13804413\">",
"    <span class=\"h2\">",
"     Family therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Marital and family problems are common in the course of mood disorders, and even more common when dealing specifically with perinatal mood disorders. The roles of the partner and family are particularly important when the mother is afflicted with a mood disorder. A stable marital relationship helps new parents adapt to the competing demands of marriage, the infant, and the family [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/22\">",
"     22",
"    </a>",
"    ]. In contrast, a poor marital relationship is one of the most consistent psychosocial predictors of perinatal depression and anxiety [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/11,15\">",
"     11,15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    During the evaluation, the woman should be evaluated individually (to assure privacy, particularly when screening for domestic violence), and again with her partner to assess any relationship discord. Family or marital therapy may be considered as a primary or adjunctive approach to treatment for",
"    <span class=\"nowrap\">",
"     couples/families",
"    </span>",
"    in which troubled interpersonal relationships are contributing to the mood disorder. Family and couples therapy is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/38/18025?source=see_link\">",
"     \"Family and couples therapy for treating depressed adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     PHARMACOTHERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The approach to drug therapy of depression is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/8/40074?source=see_link\">",
"     \"Initial treatment of depression in adults\"",
"    </a>",
"    .) Specific pregnancy issues are reviewed below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Overview",
"    </span>",
"    &nbsp;&mdash;&nbsp;The decision to medicate is based upon the severity of depression, the number and frequency of depressive episodes (the higher the number of previous depressive episodes, the more likely a relapse will occur in pregnancy), and the history of response to medication (relapses tend to become progressively harder to treat). In 2003, as many as 13 percent of women enrolled in Tennessee Medicaid filled a prescription for an antidepressant drug at some time during pregnancy; most of these prescriptions were for SSRIs [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The potential risks of in utero exposure to antidepressant medications depend on numerous factors, including the gestational age and duration of exposure, and comorbid factors [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/24\">",
"     24",
"    </a>",
"    ]. The risks of exposure to medications must be weighed against the risks of untreated psychiatric illness, which affects both mother and child [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/16,24,25\">",
"     16,24,25",
"    </a>",
"    ]. All psychotropic medications cross the placenta, thus exposing the developing fetus to these drugs. Pharmacokinetic, pharmacodynamic, and pharmacogenetic research is aimed at improving our ability to select drugs that will be most effective and well-tolerated for both the mother and the child [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/18-21\">",
"     18-21",
"    </a>",
"    ]. Since the degree of maternal depression plays a significant role in child development, maintaining euthymic mood in the mother throughout the pregnancy and preventing postpartum decompensation remain the most important goals of treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Prior to using any medication during pregnancy or lactation, it is important to have a thorough discussion with the patient, and, if possible, the partner or a supportive family member [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/25\">",
"     25",
"    </a>",
"    ]. The discussion should include the risks and benefits of treatment with the particular medication, including, but not limited to, potential risks of [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/27-31\">",
"     27-31",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      No treatment",
"     </li>",
"     <li>",
"      Teratogenicity",
"     </li>",
"     <li>",
"      Miscarriage",
"     </li>",
"     <li>",
"      Reduction in birth weight and preterm birth",
"     </li>",
"     <li>",
"      Poor neonatal adaptation or neonatal behavioral syndromes",
"     </li>",
"     <li>",
"      Neurobehavioral effects",
"     </li>",
"     <li>",
"      Maternal relapse (if medication is ineffective, or if dosing is suboptimal)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    After a diagnosis has been made, selection of a psychotropic medication in pregnancy is based upon:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The woman's prior response to psychotropic medications",
"     </li>",
"     <li>",
"      Family history of response (especially in the drug-na&iuml;ve patient)",
"     </li>",
"     <li>",
"      Anticipated efficacy and response in the individual woman",
"     </li>",
"     <li>",
"      Side effect profile in each individual woman",
"     </li>",
"     <li>",
"      Concurrent medications and risk of interactions",
"     </li>",
"     <li>",
"      Potential adverse effects of the medication for the woman and her fetus",
"     </li>",
"     <li>",
"      Whether the woman plans to breastfeed",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Ideally, the choice of medication in pregnancy will consider the safety of the drug during breastfeeding, even if the woman is not currently planning to breastfeed as her feelings about this may change. It is rarely advisable to switch medications postpartum if the woman is stable, even if there is better safety data in lactation for a different drug.",
"   </p>",
"   <p>",
"    Maternal and fetal systems of drug absorption, distribution, metabolism, and elimination change throughout pregnancy and following delivery. Some of these variations require an increase or decrease in dose of a specific medication, thus potentially increasing or decreasing drug exposure of the fetus [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/32,33\">",
"     32,33",
"    </a>",
"    ]. These changes in dosing can be complex and are influenced by the trimester of exposure. Therefore, the patient's clinical status must be closely monitored throughout pregnancy and postpartum, with medication doses adjusted as necessary to both maintain remission and avoid excessive dosing.",
"   </p>",
"   <p>",
"    Strategies to minimize drug exposure during the most sensitive periods of pregnancy include [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/34\">",
"     34",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      As in nonpregnant women, using the lowest effective dose and the fewest number of medications that will give a therapeutic response. Importantly, however, there is no evidence that lowering the dose of antidepressants at term is either safe or effective in reducing any risk of neonatal complications. In fact, many women require a dosage increase to maintain euthymia.",
"     </li>",
"     <li>",
"      Choosing a medication that is known to result in the lowest",
"      <span class=\"nowrap\">",
"       fetal/neonatal",
"      </span>",
"      exposure whenever possible. Data on placental passage of antidepressants are limited; more data are available on transfer to the infant by breastfeeding.",
"     </li>",
"     <li>",
"      Avoiding use of recently released medications until a body of information is available regarding the effects of the medication in human pregnancy unless the clinical situation demands it. As an example, the patient may have conceived accidentally and the risk of relapse is too high to warrant discontinuation",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      switching medications.",
"     </li>",
"     <li>",
"      In women who conceive while on medications but wish to discontinue them, slowly tapering (eg, by 25 percent every one to two weeks), rather than abruptly stopping is advised [",
"      <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/24\">",
"       24",
"      </a>",
"      ]. This will diminish the risk of drug withdrawal symptoms and allow for better clinical monitoring for relapse.",
"     </li>",
"     <li>",
"      Prior to instituting any drug therapy in pregnant or lactating women, current implications for use in these populations should be researched using both literature searches and drug databases.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Risks of suboptimal dosing and discontinuing therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Failing to treat adequately the anxious or depressed mother may lead to worsening of symptoms and compromise maternal and fetal health, maternal-infant bonding, and infant care in the postpartum period. Multiple observational studies have documented the risks associated with suboptimal dosing [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/35,36\">",
"     35,36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the largest of these series, 201 women with a history of major depression were prospectively followed across pregnancy using monthly psychiatric assessments (Structured Clinical Interview, Hamilton Rating Scale for Depression, Clinical Global Impressions Scale) [",
"      <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/35\">",
"       35",
"      </a>",
"      ]. All of the women were recruited by 16 weeks of gestation, euthymic for at least three months prior to conception, and currently or recently on antidepressant therapy. Half of the participants had a greater than 15-year history of depression, 44 percent had had at least five prior episodes, and 18 percent had had a prior suicide attempt, thus the group was largely comprised of women with chronic major depression at high risk of recurrence.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Relapse of major depression during pregnancy was common (43 percent) and occurred significantly more often in women who discontinued their medication just prior to conception or in early pregnancy",
"    <span class=\"nowrap\">",
"     (44/65",
"    </span>",
"    [68 percent]) than in those who maintained their medication throughout pregnancy",
"    <span class=\"nowrap\">",
"     (21/82",
"    </span>",
"    [26 percent]). Women who decreased but did not discontinue their medication were at intermediate risk of relapse",
"    <span class=\"nowrap\">",
"     (12/34",
"    </span>",
"    [35 percent]). The occurrence of relapse by trimester of pregnancy was first trimester (51 percent), second trimester (36 percent), and third trimester (13 percent).",
"   </p>",
"   <p>",
"    Sixty percent of women who discontinued antidepressant treatment at the beginning of pregnancy restarted it during pregnancy. Reintroduction of antidepressants in the second trimester (by women who wished to avoid first trimester exposure) lowered the risk of relapse, but not to the level in women who maintained antidepressant therapy. Women who relapsed and resumed medications did not necessarily achieve remission during the pregnancy. These findings highlight the maternal risk of discontinuing antidepressant medication in pregnant women with a history of major depression, but do not address the risk in women with minor depression.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     SSRIS AND SNRIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The selective serotonin reuptake inhibitors (SSRI) and the serotonin-norepinephrine reuptake inhibitor (SNRI) classes of antidepressants are highly effective in the treatment of anxiety and depression. Issues relating to the safety and administration of these drugs in pregnancy are reviewed below. Use of these drugs for treatment of depressive symptoms is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/28/5578?source=see_link\">",
"     \"Serotonin-norepinephrine reuptake inhibitors (SNRIs): Pharmacology, administration, and side effects\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Pregnancy complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Data on pregnancy complications of SSRIs come from observational studies, the results of which should be interpreted with caution due to methodologic limitations (eg, lack of control for use of tobacco, alcohol, or illicit substances). Many studies suggest that first trimester exposure to SSRIs does not increase rates of prematurity, stillbirth, or low birth weight [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/37-43\">",
"     37-43",
"    </a>",
"    ]. However, other studies have found that SSRI exposure was associated with perinatal complications [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/44\">",
"     44",
"    </a>",
"    ]; low birth weight [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/45,46\">",
"     45,46",
"    </a>",
"    ]; preterm birth and stillbirth [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/45\">",
"     45",
"    </a>",
"    ]; lower gestational age at birth and preterm birth [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/47\">",
"     47",
"    </a>",
"    ]; and infant mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/46\">",
"     46",
"    </a>",
"    ]. Most studies did not show an increased risk of miscarriage, but this remains controversial [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/29,41,48\">",
"     29,41,48",
"    </a>",
"    ]. An association between depression",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    use of SSRIs and preeclampsia or gestational hypertension has also been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/49-51\">",
"     49-51",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the largest study (N = 1,633,877 singleton births, including 6054 stillbirths, 3609 neonatal deaths, and 1578 postnatal deaths), use of SSRIs during pregnancy did not appear to increase the risk of stillbirth or infant mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/52\">",
"     52",
"    </a>",
"    ]. Nationwide registries from five countries were linked to obtain information from 1996 to 2007 about prescriptions, maternal characteristics, pregnancy outcomes, and neonatal outcomes; more than 29,000 mothers had filled a prescription for an SSRI. After accounting for maternal factors such as age, smoking, diabetes, hypertension, and hospitalization for psychiatric illness, the risks of stillbirth and infant mortality were comparable for women who used or did not use SSRIs. In a separate study that appeared to draw upon comparable registry data from one of the countries (N = 920,620 births), in utero exposure to SSRIs (N = 12,425) was not associated with an elevated risk of perinatal death [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/53\">",
"     53",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Teratogenicity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most studies have found no increase in congenital malformations associated with in-utero",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/49/15130?source=see_link\">",
"     fluoxetine",
"    </a>",
"    exposure, nor have animal studies identified any consistent pattern of defects. However, some studies have reported a small increased risk of congenital malformations following exposure to other SSRIs, [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/54-56\">",
"     54-56",
"    </a>",
"    ]. These studies are limited by a number of factors, including (but not limited to) biases inherent in retrospective observational studies, the small number of affected and exposed infants, the possibility of chance associations from performing multiple comparisons, issues with ascertainment and classification of birth defects, the inability to confirm fetal exposure to the drug (as well as use of over-the-counter drugs), and the inability to separate the effects of maternal SSRI use from those related to depression.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     SSRI composite data",
"    </span>",
"    &nbsp;&mdash;&nbsp;As different SSRIs have different pharmacologic properties, studies conducted on SSRIs as a group are less useful for evaluating teratogenicity than studies of individual drugs. However, many composite studies have been conducted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pregnancy outcomes after exposure to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?43/3/44089?source=see_link\">",
"       sertraline",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?14/50/15146?source=see_link\">",
"       paroxetine",
"      </a>",
"      , and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?28/50/29481?source=see_link\">",
"       fluvoxamine",
"      </a>",
"      , were described in a prospective series from nine teratology information centers in Canada and the United States [",
"      <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/41\">",
"       41",
"      </a>",
"      ]. In this report, 147 women were exposed to sertraline, 97 to paroxetine, and 26 to fluvoxamine during pregnancy. SSRI exposure was not associated with an increased risk of major congenital malformations.",
"     </li>",
"     <li>",
"      The National Birth Defects Prevention Study of infants delivered in the United States from 1997 to 2002 is an ongoing case control study of birth defect risk factors; the cases are ascertained from birth defects surveillance systems in eight US states [",
"      <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/54\">",
"       54",
"      </a>",
"      ]. Adjusted analyses showed that women who took an SSRI were more likely than those who were not exposed to have an infant with omphalocele (181 affected, 11 exposed to SSRIs; OR 2.8, 95% CI 1.3-5.7), anencephaly (214 affected, 9 exposed; OR 2.4, 95% CI 1.1-5.5), and craniosynostosis (432 affected, 24 exposed; OR 2.5, 95% CI 1.5-4.0). The absolute risk of having any of the three birth defects was small.",
"     </li>",
"     <li>",
"      The Sloane Epidemiologic Center Birth Defects Study also evaluated the risk of birth defects after antenatal exposure to SSRIs [",
"      <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/55\">",
"       55",
"      </a>",
"      ]. Overall use of SSRIs was not associated with significantly increased risks of craniosynostosis (115 affected, 2 exposed to SSRIs; OR 0.8, 95% CI 0.2-3.5), omphalocele (127 affected, 3 exposed; OR 1.4; 95% CI 0.4-4.5), or heart defects overall (3724 affected, 100 exposed; OR 1.2; 95% CI 0.9-1.6).",
"      <br/>",
"      <br/>",
"      An editorial accompanying these two studies [",
"      <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/54,55\">",
"       54,55",
"      </a>",
"      ] concluded that although these data suggest in-utero exposure to SSRIs confers a very low absolute risk of having a child with a specific birth defect, SSRIs are not major teratogens [",
"      <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/57\">",
"       57",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The Swedish Medical Birth Register prospectively collected data on over 5000 women exposed to SSRIs in early pregnancy [",
"      <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/56\">",
"       56",
"      </a>",
"      ]. The overall risk of congenital malformations was not significantly increased with any SSRI.",
"     </li>",
"     <li>",
"      A population-based cohort study from Denmark compared the risk of congenital malformations in 1370 infants of women who redeemed a prescription for SSRls from 28 days before conception to the end of the first trimester versus infants of women with no SSRI prescriptions during this period (over 490,000 infants) [",
"      <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/58\">",
"       58",
"      </a>",
"      ]. The combined prevalence of major malformations (OR 1.21, 95% CI 0.91-1.62) or noncardiac malformations (OR 1.12, 95% CI 0.79-1.59) was not significantly higher among exposed children, but SSRI use was associated with an increased prevalence of septal heart defects (OR 1.99, 95% CI 1.13-3.53). The absolute increase in the prevalence of malformations was low, septal heart defects occurred in 0.5 percent",
"      <span class=\"nowrap\">",
"       (2315/493",
"      </span>",
"      113) of unexposed children, 0.9 percent",
"      <span class=\"nowrap\">",
"       (12/1370)",
"      </span>",
"      of children whose mothers were prescribed any SSRI, and 2.1 percent",
"      <span class=\"nowrap\">",
"       (4/193)",
"      </span>",
"      of children whose mothers were prescribed more than one type of SSRI. When outcomes were examined for individual drugs,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/56/13193?source=see_link\">",
"       citalopram",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?43/3/44089?source=see_link\">",
"       sertraline",
"      </a>",
"      were associated with a significant increase in risk of septal defects, and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?14/49/15130?source=see_link\">",
"       fluoxetine",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?14/50/15146?source=see_link\">",
"       paroxetine",
"      </a>",
"      were not, although the number of infants with malformations was small (one to five infants) for individual drugs. A limitation of prescription events monitoring studies is the inability to confirm fetal exposure to the drug or other substances.",
"     </li>",
"     <li>",
"      In a community sample of pregnant women with clinically relevant depression who were treated with SSRIs (N = 99), and pregnant women with few or no depressive symptoms (N = 7027; control group), head circumference at birth was reduced in children exposed in utero to SSRIs compared to controls by approximately 5.88 mm [",
"      <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/59\">",
"       59",
"      </a>",
"      ]. In addition, preterm birth occurred in more children exposed to SSRIs than controls (10 versus 5 percent).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Fluoxetine",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/49/15130?source=see_link\">",
"     Fluoxetine",
"    </a>",
"    is the best studied SSRI in terms of safety and efficacy in pregnancy and lactation [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/60\">",
"     60",
"    </a>",
"    ]. Over 1500 in-utero exposures have been reported without evidence of teratogenicity. The average fluoxetine dose is 20 mg, but some patients require doses of up to 60 mg per day. A dose increase in the third trimester may be necessary.",
"   </p>",
"   <p>",
"    Although the pregnancy safety profile of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/49/15130?source=see_link\">",
"     fluoxetine",
"    </a>",
"    is reassuring, if the patient has had a good response to another SSRI either prior to or during pregnancy, we do not recommend switching to fluoxetine solely on this basis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Paroxetine",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/50/15146?source=see_link\">",
"     Paroxetine",
"    </a>",
"    has been associated with an increase in congenital heart defects, particularly ventricular septal defects, but these findings have not been consistent. Several studies, including a study in 2008 which analyzed data from eight teratogen information centers, have not shown an excess risk of congenital anomalies with paroxetine use [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/61\">",
"     61",
"    </a>",
"    ]. The following four studies suggested an association and led to the addition of a warning on the product label.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A retrospective epidemiological study of 3581 pregnant women exposed to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?14/50/15146?source=see_link\">",
"       paroxetine",
"      </a>",
"      or other antidepressants during the first trimester showed an increased overall risk of major congenital malformations for paroxetine compared to other antidepressants (OR 2.20; 95% CI 1.34-3.63) (absolute risk 4 versus 2 percent); there was no comparison with unexposed controls [",
"      <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/62\">",
"       62",
"      </a>",
"      ]. Paroxetine use was also associated with an increased risk of cardiovascular malformations compared to other antidepressants (OR 2.08; 95% CI 1.03-4.23) (absolute risk 1.5 versus 1 percent); 10 of the 14 infants with cardiovascular malformations had ventricular septal defects.",
"     </li>",
"     <li>",
"      A study based on Swedish Medical Birth Registry data noted",
"      <a class=\"drug drug_general\" href=\"UTD.htm?14/50/15146?source=see_link\">",
"       paroxetine",
"      </a>",
"      exposure was associated with an increased risk of congenital heart disease (OR 2.22, 95% CI 1.39-3.55; absolute risk 2 versus 1 percent); most of these normalities were ventricular or atrial septal defects [",
"      <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/56\">",
"       56",
"      </a>",
"      ]. An increased risk of congenital heart disease was also found for",
"      <a class=\"drug drug_general\" href=\"UTD.htm?42/20/43336?source=see_link\">",
"       clomipramine",
"      </a>",
"      (OR 1.87, 95% CI 1.16-2.99), which is also a potent serotonergic antidepressant. The severity of these defects was not reported.",
"     </li>",
"     <li>",
"      The Sloane Epidemiologic Center Birth Defects Study also found",
"      <a class=\"drug drug_general\" href=\"UTD.htm?14/50/15146?source=see_link\">",
"       paroxetine",
"      </a>",
"      exposure was associated with an increased risk of right ventricular outflow tract obstruction defects, but not septal defects (363 affected and 6 exposed; OR 3.3, 95% CI 1.3-8.8) [",
"      <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/55\">",
"       55",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The National Birth Defects Prevention Study [",
"      <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/54\">",
"       54",
"      </a>",
"      ] found no association between",
"      <a class=\"drug drug_general\" href=\"UTD.htm?14/50/15146?source=see_link\">",
"       paroxetine",
"      </a>",
"      and septal defects, but did detect an association with right ventricular outflow defects (seven exposed infants; adjusted odds ratio, 2.5; 95% CI 1.0-6.0).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In contrast, the population-based Danish study cited above did not find a significant association between potential",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/50/15146?source=see_link\">",
"     paroxetine",
"    </a>",
"    exposure (299 fetuses) and any congenital anomaly, including cardiac defects [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/58\">",
"     58",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A meta-analysis concluded that while",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/50/15146?source=see_link\">",
"     paroxetine",
"    </a>",
"    use is associated with an increased risk of cardiac malformations (odds ratio 1.72, 95% CI 1.22-2.42), this increase may be related to a detection bias; women who took SSRIs during pregnancy underwent 30 percent more prenatal ultrasound examinations than women not on antidepressants, and infants who had been exposed during pregnancy had twice as many echocardiograms in the first year of life than unexposed infants [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/63\">",
"     63",
"    </a>",
"    ]. Thus, the rate of detection of both persistent and transient septal defects may have been higher than in the non-exposed population.",
"   </p>",
"   <p>",
"    Due to the controversy, we do not recommend",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/50/15146?source=see_link\">",
"     paroxetine",
"    </a>",
"    as a first line choice in pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/1\">",
"     1",
"    </a>",
"    ]; however, we do not discontinue paroxetine to initiate another agent in women who have become pregnant while taking paroxetine. Some women, after considering the data discussed above, will choose to remain on paroxetine (both prior to conception and during pregnancy) because it has been effective for them. We do not recommend that these women switch to another drug.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Sertraline",
"    </span>",
"    &nbsp;&mdash;&nbsp;As noted in the composite data, a prospective teratogen information service study found no increased risk of birth defects after in-utero",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/3/44089?source=see_link\">",
"     sertraline",
"    </a>",
"    exposure [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/41\">",
"     41",
"    </a>",
"    ]. In contrast, the Sloane Epidemiologic Center Birth Defects Study (discussed above) found sertraline exposure was associated with an increased risk of omphalocele (127 affected and 3 exposed; OR 5.7, 95% CI 1.6-20.7) and septal defects (1161 affected and 13 exposed; OR 2.0, 95% CI 1.2-4.0) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/55\">",
"     55",
"    </a>",
"    ]. A population-based Danish study also reported an association with septal defects (259 potentially exposed fetuses, 4 infants with septal defects; OR 3.25, 95% CI 1.21-8.75) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/58\">",
"     58",
"    </a>",
"    ]. These findings merit further study. We do not discontinue sertraline to initiate another agent in women who have become pregnant while taking this drug.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Citalopram and escitalopram",
"    </span>",
"    &nbsp;&mdash;&nbsp;Data from five studies including a total of over 1000 early pregnancy",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/56/13193?source=see_link\">",
"     citalopram",
"    </a>",
"    exposures did not find a significantly increased risk of any congenital malformation in the drug exposed group compared to the expected rate in the general population [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/42,43,54,55,64\">",
"     42,43,54,55,64",
"    </a>",
"    ], but a population-based Danish study reported an association with septal defects (460 potentially exposed fetuses, 5 infants with septal defects; OR 2.53, 95% CI 1.04-6.10) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/58\">",
"     58",
"    </a>",
"    ]. Use of citalopram was associated with an increased risk of the pooled group of birth defects (comprising anencephaly, omphalocele, and craniosynostosis) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/54\">",
"     54",
"    </a>",
"    ]. Further studies are needed to clarify the association. As with other agents, we do not recommend switching to another medication if the patient becomes pregnant while taking citalopram.",
"   </p>",
"   <p>",
"    There are no data on the effects of isolated exposure to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/56/25481?source=see_link\">",
"     escitalopram",
"    </a>",
"    , which is the s-enantiomer of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/56/13193?source=see_link\">",
"     citalopram",
"    </a>",
"    (a racemic mixture), although a single case report described necrotizing enterocolitis in an infant exposed during pregnancy and through breastfeeding [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/65\">",
"     65",
"    </a>",
"    ]. The safety data on citalopram are considered to be applicable to escitalopram.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Venlafaxine",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/45/22233?source=see_link\">",
"     Venlafaxine",
"    </a>",
"    is a SNRI; prospective cohort data are limited to one series of 150 patients that did not show an increased risk of congenital anomalies in exposed offspring [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/66\">",
"     66",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Duloxetine",
"    </span>",
"    &nbsp;&mdash;&nbsp;A pooled analysis of eight randomized trials that compared",
"    <a class=\"drug drug_general\" href=\"UTD.htm?36/62/37864?source=see_link\">",
"     duloxetine",
"    </a>",
"    (40 to 120 mg per day) with placebo for eight or nine weeks in 1916 patients with unipolar major depression identified 28 pregnancies exposed to duloxetine during the first trimester (despite exclusion criteria for pregnant women and women of childbearing potential not using a medically accepted means of contraception) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/67\">",
"     67",
"    </a>",
"    ]. There were no reports of malformations. Three subsequent case reports also described no teratogenic effects from prenatal exposure to duloxetine [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/68-70\">",
"     68-70",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Neonatal issues",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Poor neonatal adaptation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The terms \"poor neonatal adaptation\" and \"neonatal behavioral syndromes\" have been used to describe a variety of neonatal complications that appear to be associated with third trimester exposure to serotonergic antidepressants. These complications have ranged from the benign, such as mild tremors or mild tachypnea, to the rare but severe, such as persistent pulmonary hypertension of the newborn. The true incidence and prevalence of neonatal complications related to",
"    <span class=\"nowrap\">",
"     SSRI/SNRI",
"    </span>",
"    exposure has not been well-defined [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/16,20,27,47,60,71-79\">",
"     16,20,27,47,60,71-79",
"    </a>",
"    ]. Likewise, the mechanisms that may account for these complications have yet to be elucidated. They may be multifactorial, with the severity of maternal mental illness playing a major role, or they may reflect side effects of perinatal medication exposure. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/29/11736?source=see_link\">",
"     \"Infants with antenatal exposure to serotonin reuptake inhibitors\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In 2004, the drug information labeling for",
"    <span class=\"nowrap\">",
"     SSRI/SNRIs",
"    </span>",
"    was changed to include a warning that neonates exposed to these agents in the late third trimester have developed adverse events [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/80,81\">",
"     80,81",
"    </a>",
"    ]. However, this warning should not be regarded as a definitive barrier to treating women in the third trimester with medication. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/2/29735?source=see_link\">",
"     \"Depression in pregnant women: Clinical features and consequences\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Neurodevelopmental effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;The long-term neurodevelopment of SSRI-exposed infants has only been minimally reported, but the available evidence suggests that these drugs do not affect the attainment of developmental milestones in exposed offspring. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/29/11736?source=see_link&amp;anchor=H10#H10\">",
"     \"Infants with antenatal exposure to serotonin reuptake inhibitors\", section on 'Neurodevelopmental outcome'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Persistent pulmonary hypertension",
"    </span>",
"    &nbsp;&mdash;&nbsp;Concerns have been raised about the possibility that maternal use of SSRIs in the latter half of pregnancy may be associated with persistent pulmonary hypertension of the newborn (PPHN) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/82\">",
"     82",
"    </a>",
"    ]. This has led the United States Food and Drug Administration to issue a Drug Safety Communication, which states that &ldquo;given the conflicting results from different studies, it is premature to reach any conclusion about a possible link between SSRI use in pregnancy and PPHN&rdquo; [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/83\">",
"     83",
"    </a>",
"    ]. The studies that have examined the risk of PPHN in newborns with intrapartum exposure to SSRIs are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/29/11736?source=see_link&amp;anchor=H8#H8\">",
"     \"Infants with antenatal exposure to serotonin reuptake inhibitors\", section on 'Persistent pulmonary hypertension'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Discussion",
"    </span>",
"    &nbsp;&mdash;&nbsp;In all cases, patients and doctors must assess the potential risks of medication exposure in the context of the risks of untreated illness.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/3/44089?source=see_link\">",
"     Sertraline",
"    </a>",
"    , with its very low serum levels in breastfed infants, is a reasonable first line pharmacotherapeutic choice for pregnant and postpartum women, despite controversy regarding teratogenicity.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/49/15130?source=see_link\">",
"     Fluoxetine",
"    </a>",
"    is the best studied drug in pregnancy, and the SSRI with the largest amount of long-term follow-up of exposed infants; however, it has a long half-life which predisposes to accumulation in the neonate, and the rate of transfer to the baby through breastfeeding is higher than for other SSRIs. For these reasons, and because of the controversy over",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/50/15146?source=see_link\">",
"     paroxetine",
"    </a>",
"    , we recommend sertraline as a first line antidepressant in pregnancy rather than fluoxetine or paroxetine. Some women on paroxetine or fluoxetine may wish to attempt a trial of sertraline prior to pregnancy but if the patient is already pregnant and doing well she should not switch antidepressants.",
"   </p>",
"   <p>",
"    Thus far, there is no evidence that tapering or discontinuing antidepressant medication near term is necessary, safe, or effective in terms of preventing transient neonatal complications. Such an approach would, however, increase the risk of perinatal relapse for the mother. Discontinuation is particularly dangerous in women with severe depression, such as those with suicide attempts, functional incapacitation or weight loss, thus these women should continue pharmacotherapy [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/24\">",
"     24",
"    </a>",
"    ]. Some women on antidepressants will need to have the dose increased in the third trimester in order to maintain euthymia [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/84\">",
"     84",
"    </a>",
"    ]",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     TRICYCLIC ANTIDEPRESSANTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Changes in hepatic metabolism, protein binding, and gastrointestinal motility during pregnancy may necessitate increases in TCA doses to maintain a therapeutic level.",
"   </p>",
"   <p>",
"    Most studies have not shown an association between TCAs and congenital anomalies [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/31,85\">",
"     31,85",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    As with SSRIs, peripartum exposure to TCAs may result in significant, although transient, neonatal withdrawal symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/86-88\">",
"     86-88",
"    </a>",
"    ]. Long-term studies of fetuses exposed to TCAs in-utero have reported normal motor and behavioral development in these children at three years of age and no difference in global IQ, language development, temperament, mood, arousability, activity level, distractibility, or behavior problems compared to unexposed children [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/26,86,89\">",
"     26,86,89",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Use of TCAs for treatment of depressive symptoms is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/20/36169?source=see_link\">",
"     \"Unipolar depression in adults and tricyclic and tetracyclic drugs: Pharmacology, administration, and side effects\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Desipramine, nortriptyline",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/14/39144?source=see_link\">",
"     Desipramine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/21/30040?source=see_link\">",
"     nortriptyline",
"    </a>",
"    are the preferred TCAs due to fewer sedative, gastrointestinal, cardiac, and hypotensive side effects in the fetus.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Imipramine, amitriptyline",
"    </span>",
"    &nbsp;&mdash;&nbsp;The more sedating medications,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/41/41624?source=see_link\">",
"     imipramine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?26/30/27112?source=see_link\">",
"     amitriptyline",
"    </a>",
"    , may be useful for treatment of insomnia, especially in low doses of 10 to 20 mg at bedtime. Sometimes they are used to treat insomnia secondary to treatment with SSRIs. It is not known whether combination therapy will increase the risk of neonatal complications.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Clomipramine",
"    </span>",
"    &nbsp;&mdash;&nbsp;The tricyclic antidepressant",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/20/43336?source=see_link\">",
"     clomipramine",
"    </a>",
"    is frequently used for the treatment of obsessive-compulsive disorder and depression. A prospective study including 1029 women who used clomipramine in early pregnancy found a statistically significant association between clomipramine use and congenital heart disease (OR 1.87, 95% CI 1.16-2.99) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/56\">",
"     56",
"    </a>",
"    ]. Poor neonatal adaptation has been described in case reports, but the prevalence is not known [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/87,88\">",
"     87,88",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     ATYPICAL ANTIDEPRESSANTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The newer atypical antidepressants include",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/29/26073?source=see_link\">",
"     bupropion",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/41/32408?source=see_link\">",
"     mirtazapine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/0/2057?source=see_link\">",
"     nefazodone",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/0/24584?source=see_link\">",
"     trazodone",
"    </a>",
"    . The general treatment of major depression with these drugs is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/28/5578?source=see_link\">",
"     \"Serotonin-norepinephrine reuptake inhibitors (SNRIs): Pharmacology, administration, and side effects\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Trazodone and Nefazodone",
"    </span>",
"    &nbsp;&mdash;&nbsp;A study including 58 women with first trimester exposure to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/0/24584?source=see_link\">",
"     trazodone",
"    </a>",
"    and 89 women with first trimester exposure to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/0/2057?source=see_link\">",
"     nefazodone",
"    </a>",
"    reported two infants born with major malformations, which is within the expected baseline risk (1 to 3 percent) of congenital anomalies [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/90\">",
"     90",
"    </a>",
"    ]. Fifty-two women took their medication throughout pregnancy; neonatal outcome was similar to that in controls. Long-term follow-up data are not available.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Mirtazapine",
"    </span>",
"    &nbsp;&mdash;&nbsp;Data on pregnancy outcomes after exposure to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/41/32408?source=see_link\">",
"     mirtazapine",
"    </a>",
"    are limited [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/91-97\">",
"     91-97",
"    </a>",
"    ]. A prescription events monitoring study reported on 41 cases of first trimester exposure [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/93\">",
"     93",
"    </a>",
"    ]. There were four premature births (26 to 36 weeks of gestation), eight therapeutic terminations, and eight spontaneous miscarriages; one outcome was not known; presumably the other 20 babies were healthy and delivered at term. The study limitations included a lack of control groups, and incomplete information on diagnoses, doses, and duration of treatment. Mirtazapine has also been used in the first and second trimesters for the treatment of hyperemesis gravidarum as described in two small case series and a case report [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/92,95,96\">",
"     92,95,96",
"    </a>",
"    ]. All of the babies were reportedly normal at delivery except for one case of mild pulmonary hypertension.",
"   </p>",
"   <p>",
"    A collaborative teratogen information center study described the outcomes of 104 pregnancies exposed to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/41/32408?source=see_link\">",
"     mirtazapine",
"    </a>",
"    , 95 percent of the exposures were in the first trimester [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/97\">",
"     97",
"    </a>",
"    ]. Two major malformations (patent ductus arteriosus and a midline facial defect) were reported. The study did not include data on neonatal complications or neurodevelopmental outcomes.",
"   </p>",
"   <p>",
"    The use of an alternative medication whose effects have been evaluated more extensively is recommended, whenever possible.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Bupropion",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/29/26073?source=see_link\">",
"     Bupropion",
"    </a>",
"    is used both for depression and smoking cessation. Data on bupropion exposure during pregnancy are available from the manufacturer's registry [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/98\">",
"     98",
"    </a>",
"    ]. Outcome data are available on 724 first trimester exposures and show 579 live borns without congenital anomalies, 17 live born infants with congenital anomalies, 90 spontaneous abortions, and 30 induced abortions (six abortuses had birth defects). One fetal death of an anomalous fetus was reported. The registry's Advisory Committee noted the repeated occurrence of cardiac defects among the collected reports. However, data in the registry were not sufficient to determine whether this agent increases the risk of cardiac (or other) congenital defects. The manufacturer continues to enroll patients in the registry (1-800-336-2176 or 910-256-0549).",
"   </p>",
"   <p>",
"    Two controlled studies used an insurance company database and a medical record review of pregnant women who filled a prescription for",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/29/26073?source=see_link\">",
"     bupropion",
"    </a>",
"    in an attempt to evaluate this issue [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/99,100\">",
"     99,100",
"    </a>",
"    ]. Women who filled other antidepressant prescriptions were used as the comparator group. The authors found no significant increase in total malformations or cardiovascular defects associated with prescription of bupropion in the first trimester.",
"   </p>",
"   <p>",
"    A prospective study including 136 women exposed to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/29/26073?source=see_link\">",
"     bupropion",
"    </a>",
"    for depression or smoking cessation during the first trimester of pregnancy also looked at this issue [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/101\">",
"     101",
"    </a>",
"    ]. Control groups consisted of women taking other antidepressants and women with what the authors considered to be trivial exposures. The groups were matched for maternal age at conception, gestational age at first contact, chronic conditions, and self-reported alcohol and tobacco use, but it is not known whether the groups were contemporaneous. The sample size was adequate to detect a tripling of the overall birth defect rate, but not to detect a meaningful increase in individual malformations. There were no major malformations and no increase in preterm birth or low birth weight in exposed pregnancies compared with controls. However, there was a statistically significant increase in the rate of miscarriage in the bupropion-exposed group compared to the trivial exposure group. These results are not conclusive given the methodologic limitations of the study (eg, the rate of spontaneous abortion in the control group was lower than expected, actual nicotine use was not measured, and severity of depression was not assessed).",
"   </p>",
"   <p>",
"    No long-term neurodevelopmental data are available and information on breastfeeding is limited.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/29/26073?source=see_link\">",
"     Bupropion",
"    </a>",
"    is not a first line choice in a pregnant woman, but may be useful for patients who have attention deficit disorder, have not responded to other medications, or want to use it for smoking cessation. If a woman is uniquely responsive to bupropion, or becomes pregnant on bupropion, switching to another medication is not recommended.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h1\">",
"     MONOAMINE OXIDASE INHIBITORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Monoamine oxidase inhibitors (MAOIs) (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/42/20135?source=see_link\">",
"     phenelzine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/29/32215?source=see_link\">",
"     tranylcypromine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/54/25448?source=see_link\">",
"     selegiline",
"    </a>",
"    ) are",
"    <strong>",
"     not",
"    </strong>",
"    recommended for use in pregnant women because animal studies have shown that MAOI exposure in pregnancy is associated with fetal growth restriction; there is a paucity of human data [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/85,102,103\">",
"     85,102,103",
"    </a>",
"    ]. In postpartum nonlactating women, MAOIs may exacerbate hypertension and can interact with many different medications and foods to cause a hypertensive crisis, further complicating treatment. Clinicians may encounter MAOI use more frequently as a transdermal preparation of selegiline has been released in the United States. Use of these drugs for the general treatment of major depression is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/25/7574?source=see_link\">",
"     \"Monoamine oxidase inhibitors (MAOIs) for treating depressed adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H89203454\">",
"    <span class=\"h1\">",
"     POSTNATAL EFFECTS OF ANTIDEPRESSANTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is not clear if antidepressants affect postnatal development:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A prospective observational study that controlled for maternal psychiatric status and other variables found no significant difference in neuromotor performance (eg, posture, muscle tone, and reflexes) six months postpartum in babies with prenatal antidepressant exposure (N = 202) compared to babies with no prenatal psychotropic exposure (N = 85) [",
"      <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/104\">",
"       104",
"      </a>",
"      ]. In addition, information processing and learning were comparable for the two groups. The neurodevelopmental effects of selective serotonin reuptake inhibitors (SSRIs) are discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/29/11736?source=see_link&amp;anchor=H10#H10\">",
"       \"Infants with antenatal exposure to serotonin reuptake inhibitors\", section on 'Neurodevelopmental outcome'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A population-based case control study in the United States evaluated whether treatment with an SSRI during pregnancy was associated with an increased risk of autism spectrum disorders, using maternal prescription databases and medical records of 298 case children and 1507 control children [",
"      <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/105\">",
"       105",
"      </a>",
"      ]. First trimester exposure was associated with an increased risk after controlling for various factors including maternal mental illness (OR 3.5, 95% CI 1.5-7.9). No increase in risk was found for children of mothers with a prior history of mental health treatment who were not treated with SSRIs during pregnancy. However, actual ingestion of medication was not confirmed, and the study did not control for exposure to illicit drugs, ethanol, or tobacco, or for paternal psychiatric illness.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h1\">",
"     BENZODIAZEPINES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The benzodiazepine medications are commonly used in combination with an SSRI antidepressant for the treatment of depression with secondary anxiety, for panic disorder, and for generalized anxiety disorder. Women with anxiety disorders are vulnerable to relapse or exacerbation of symptoms in the setting of premature labor, surgical procedures, placental abruption, induction of labor, and cesarean delivery.",
"   </p>",
"   <p>",
"    The benzodiazepine is often added at the beginning of pharmacotherapy specifically to treat and prevent worsening of anxiety symptoms, and is gradually tapered once the antidepressant begins to take effect. Given the risk of addiction, and the possibly increased risk of neonatal complications [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/16\">",
"     16",
"    </a>",
"    ], we suggest not using benzodiazepines for more than two weeks, if possible. However, the clinical situation often warrants continued use to achieve remission of symptoms.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/45/26328?source=see_link\">",
"     Clonazepam",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/8/8329?source=see_link\">",
"     lorazepam",
"    </a>",
"    are generally preferred over",
"    <a class=\"drug drug_general\" href=\"UTD.htm?30/31/31224?source=see_link\">",
"     alprazolam",
"    </a>",
"    because the latter has a very short half life, which can result in rebound anxiety. However, the intermediate length half-lives of clonazepam and lorazepam may predispose to accumulation in the infant. While",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/46/16105?source=see_link\">",
"     diazepam",
"    </a>",
"    is the best studied drug [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/34,106,107\">",
"     34,106,107",
"    </a>",
"    ], it tends to be very sedating, and its long half-life means that it more likely to persist in the infant than drugs with shorter half lives. Thus, it is not the first choice in the pregnant woman unless she is uniquely responsive to it. Effects on the",
"    <span class=\"nowrap\">",
"     fetus/neonate",
"    </span>",
"    are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/0/32776?source=see_link\">",
"     \"Generalized anxiety disorder: Epidemiology, pathogenesis, clinical manifestations, course, assessment, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h1\">",
"     ANTIPSYCHOTIC MEDICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with psychotic depression are treated with a combination of antidepressant and antipsychotic agents. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/0/4105?source=see_link\">",
"     \"Unipolar major depression with psychotic features: Acute treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The issues regarding the use of antipsychotic medications during pregnancy are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/61/11226?source=see_link&amp;anchor=H1561506#H1561506\">",
"     \"Bipolar disorder in adults: Teratogenic and postnatal risks of pharmacotherapy\", section on 'Antipsychotics'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h1\">",
"     MOOD STABILIZERS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with mood swings and a strong family history of bipolar disorder may meet criteria for bipolar II disorder, and should be treated with a mood stabilizing drug. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/8/40074?source=see_link&amp;anchor=H30#H30\">",
"     \"Initial treatment of depression in adults\", section on 'Mood stabilizers'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The issues regarding the use of mood stabilizers during pregnancy are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/61/11226?source=see_link\">",
"     \"Bipolar disorder in adults: Teratogenic and postnatal risks of pharmacotherapy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h1\">",
"     ELECTROCONVULSIVE THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Electroconvulsive therapy (ECT) is generally regarded as effective and safe for treating unipolar major depression during pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/108\">",
"     108",
"    </a>",
"    ]. The indications, efficacy, adverse maternal and fetal effects, and reproductive safety of ECT are discussed separately, as is the technique for performing ECT during pregnancy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/28/41416?source=see_link&amp;anchor=H7#H7\">",
"     \"Unipolar major depression in adults: Indications for and efficacy of electroconvulsive therapy (ECT)\", section on 'Efficacy'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/16/4362?source=see_link&amp;anchor=H4605992#H4605992\">",
"     \"Bipolar disorder in pregnant women: Treatment of mania, hypomania, and mixed episodes\", section on 'Electroconvulsive therapy'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/61/11226?source=see_link&amp;anchor=H1561541#H1561541\">",
"     \"Bipolar disorder in adults: Teratogenic and postnatal risks of pharmacotherapy\", section on 'Electroconvulsive therapy'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/52/13128?source=see_link&amp;anchor=H13734882#H13734882\">",
"     \"Technique for performing electroconvulsive therapy (ECT) in adults\", section on 'Pregnancy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H88319019\">",
"    <span class=\"h1\">",
"     LIGHT THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Light therapy may be helpful for depression during pregnancy. One randomized trial compared 7000 lux fluorescent bright white light with 70 lux dim red (placebo) light in 27 pregnant women with non-seasonal unipolar major depression [",
"    <a class=\"abstract\" href=\"UTD.htm?28/0/28682/abstract/109\">",
"     109",
"    </a>",
"    ]. Remission occurred in significantly more patients who received bright light than placebo (69 versus 36 percent).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H35\">",
"    <span class=\"h1\">",
"     POSTPARTUM AND BREASTFEEDING ISSUES",
"    </span>",
"    &nbsp;&mdash;&nbsp;These issues are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/53/38745?source=see_link\">",
"     \"Use of psychotropic medications in breastfeeding women\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/11/20666?source=see_link\">",
"     \"Postpartum blues and depression\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5th to 6th grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10th to 12th grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?6/21/6483?source=see_link\">",
"       \"Patient information: Reducing the costs of medicines (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?19/41/20116?source=see_link\">",
"       \"Patient information: Depression in adults (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?31/61/32726?source=see_link\">",
"       \"Patient information: Reducing the costs of medicines (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H37\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For the drug-na&iuml;ve patient who is not suicidal, we suggest cognitive behavioral or interpersonal psychotherapy as the initial treatment of mild-to-moderate symptoms of anxiety disorders and depression (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'General approach'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H3\">",
"       'Psychotherapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For women with a prior history of a good response to medication and women with moderate-to-severe symptoms, we suggest psychotropic medications for first line treatment of depression (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'General approach'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H4\">",
"       'Pharmacotherapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The overall risk of birth defects following SSRI exposure appears to be low. Several studies have, however, reported an association between",
"      <a class=\"drug drug_general\" href=\"UTD.htm?14/50/15146?source=see_link\">",
"       paroxetine",
"      </a>",
"      exposure and cardiovascular defects. These findings remain controversial and await confirmation by other studies. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Teratogenicity'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Maintaining euthymic mood in the mother throughout the pregnancy and preventing postpartum decompensation are the most important goals of treatment. Untreated, or undertreated, maternal depression poses significant risks to both the mother and child. These risks often outweigh the risks associated with pharmacotherapy. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Pharmacotherapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The risk of relapse of depression is high in untreated women, but is also substantial for women on medications, especially if the dose is subtherapeutic. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Risks of suboptimal dosing and discontinuing therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The SSRIs, as well as other antidepressants, have been associated with transient neonatal effects. The risk of pregnancy complications such as miscarriage, stillbirth, preterm birth, shorter gestation, and low birth weight appears to be low, but this is controversial. SSRIs (",
"      <a class=\"drug drug_general\" href=\"UTD.htm?14/49/15130?source=see_link\">",
"       fluoxetine",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?14/50/15146?source=see_link\">",
"       paroxetine",
"      </a>",
"      , and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?43/3/44089?source=see_link\">",
"       sertraline",
"      </a>",
"      ) have been associated with an increased risk of persistent pulmonary hypertension of the newborn. Any increased risk is probably small and needs to be considered in the context of the potentially greater risk to the mother and child that may result from the mother's depression remaining untreated. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'SSRIs and SNRIs'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Treatment of depression in pregnancy must be individualized. As in other medical conditions (eg, hypertension and epilepsy), it is unreasonable to expect a single drug to work for everyone. It is also unreasonable to do nothing if the preferred drug is not effective or not well-tolerated. In all cases, patients and doctors must assess the potential risks of medication exposure in the context of the risks of untreated illness.",
"     </li>",
"     <li>",
"      We suggest",
"      <a class=\"drug drug_general\" href=\"UTD.htm?43/3/44089?source=see_link\">",
"       sertraline",
"      </a>",
"      as a first-line drug treatment of depression in pregnancy, despite the controversy regarding teratogenicity (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Sertraline'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Although",
"      <a class=\"drug drug_general\" href=\"UTD.htm?14/49/15130?source=see_link\">",
"       fluoxetine",
"      </a>",
"      is the best studied drug in pregnancy, and the SSRI with the largest amount of long-term follow-up of exposed infants, it has a long half-life, which predisposes it to accumulation in the neonate, and the rate of transfer to the baby through breastfeeding is higher than for other SSRIs. For pregnant patients, we suggest avoiding fluoxetine as a first-line antidepressant in pregnancy (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Fluoxetine'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Although",
"      <a class=\"drug drug_general\" href=\"UTD.htm?14/50/15146?source=see_link\">",
"       paroxetine",
"      </a>",
"      is transferred at a low rate through breast milk, it is not recommended as a first-line antidepressant in pregnancy because of the controversy over teratogenicity (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Prior to pregnancy, some women may attempt to switch to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?43/3/44089?source=see_link\">",
"       sertraline",
"      </a>",
"      , but a woman who is already pregnant on paroxetine should remain on the drug if it is effective.(See",
"      <a class=\"local\" href=\"#H12\">",
"       'Paroxetine'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest",
"      <a class=\"drug drug_general\" href=\"UTD.htm?25/29/26073?source=see_link\">",
"       bupropion",
"      </a>",
"      for patients who have attention deficit disorder, have not responded to other medications, or want to use it for smoking cessation (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H29\">",
"       'Bupropion'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/1\">",
"      ACOG Committee on Practice Bulletins--Obstetrics. ACOG Practice Bulletin: Clinical management guidelines for obstetrician-gynecologists number 92, April 2008 (replaces practice bulletin number 87, November 2007). Use of psychiatric medications during pregnancy and lactation. Obstet Gynecol 2008; 111:1001.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/2\">",
"      Vesga-L&oacute;pez O, Blanco C, Keyes K, et al. Psychiatric disorders in pregnant and postpartum women in the United States. Arch Gen Psychiatry 2008; 65:805.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/3\">",
"      Misri S, Kendrick K. Treatment of perinatal mood and anxiety disorders: a review. Can J Psychiatry 2007; 52:489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/4\">",
"      Spinelli MG, Endicott J. Controlled clinical trial of interpersonal psychotherapy versus parenting education program for depressed pregnant women. Am J Psychiatry 2003; 160:555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/5\">",
"      Stewart DE. Clinical practice. Depression during pregnancy. N Engl J Med 2011; 365:1605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/6\">",
"      Hendrick V, Altshuler L. Management of major depression during pregnancy. Am J Psychiatry 2002; 159:1667.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/7\">",
"      Misri S, Reebye P, Corral M, Milis L. The use of paroxetine and cognitive-behavioral therapy in postpartum depression and anxiety: a randomized controlled trial. J Clin Psychiatry 2004; 65:1236.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/8\">",
"      Misri S. Suffering in silence: the burden of perinatal depression. Can J Psychiatry 2007; 52:477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/9\">",
"      O'Mahen H, Himle JA, Fedock G, et al. A PILOT RANDOMIZED CONTROLLED TRIAL OF COGNITIVE BEHAVIORAL THERAPY FOR PERINATAL DEPRESSION ADAPTED FOR WOMEN WITH LOW INCOMES. Depress Anxiety 2013.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/10\">",
"      Stuart S, O'Hara MW. Treatment of postpartum depression with interpersonal psychotherapy. Arch Gen Psychiatry 1995; 52:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/11\">",
"      O'Hara MW. Social support, life events, and depression during pregnancy and the puerperium. Arch Gen Psychiatry 1986; 43:569.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/12\">",
"      O'Hara MW, Stuart S, Gorman LL, Wenzel A. Efficacy of interpersonal psychotherapy for postpartum depression. Arch Gen Psychiatry 2000; 57:1039.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/13\">",
"      Meager I, Milgrom J. Group treatment for postpartum depression: a pilot study. Aust N Z J Psychiatry 1996; 30:852.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/14\">",
"      Zlotnick C, Johnson SL, Miller IW, et al. Postpartum depression in women receiving public assistance: pilot study of an interpersonal-therapy-oriented group intervention. Am J Psychiatry 2001; 158:638.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/15\">",
"      Affonso, DD, Lovett, S, Paul, S, et al. Predictors of depression symptoms during pregnancy and postpartum. J Psychosomatic Obstet Gynaecol 1991; 12:255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/16\">",
"      Misri S, Oberlander TF, Fairbrother N, et al. Relation between prenatal maternal mood and anxiety and neonatal health. Can J Psychiatry 2004; 49:684.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/17\">",
"      Use of psychoactive medication during pregnancy and possible effects on the fetus and newborn. Committee on Drugs. American Academy of Pediatrics. Pediatrics 2000; 105:880.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/18\">",
"      Hendrick V, Stowe ZN, Altshuler LL, et al. Placental passage of antidepressant medications. Am J Psychiatry 2003; 160:993.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/19\">",
"      Hostetter A, Ritchie JC, Stowe ZN. Amniotic fluid and umbilical cord blood concentrations of antidepressants in three women. Biol Psychiatry 2000; 48:1032.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/20\">",
"      Laine K, Heikkinen T, Ekblad U, Kero P. Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations. Arch Gen Psychiatry 2003; 60:720.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/21\">",
"      Laine K, Kyt&ouml;l&auml; J, Bertilsson L. Severe adverse effects in a newborn with two defective CYP2D6 alleles after exposure to paroxetine during late pregnancy. Ther Drug Monit 2004; 26:685.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/22\">",
"      Misri S, Kostaras X, Fox D, Kostaras D. The impact of partner support in the treatment of postpartum depression. Can J Psychiatry 2000; 45:554.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/23\">",
"      Sharma A, Feldman JG, Golub ET, et al. Live birth patterns among human immunodeficiency virus-infected women before and after the availability of highly active antiretroviral therapy. Am J Obstet Gynecol 2007; 196:541.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/24\">",
"      Yonkers KA, Wisner KL, Stewart DE, et al. The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. Obstet Gynecol 2009; 114:703.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/25\">",
"      Wisner KL, Zarin DA, Holmboe ES, et al. Risk-benefit decision making for treatment of depression during pregnancy. Am J Psychiatry 2000; 157:1933.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/26\">",
"      Nulman I, Rovet J, Stewart DE, et al. Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study. Am J Psychiatry 2002; 159:1889.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/27\">",
"      Moses-Kolko EL, Bogen D, Perel J, et al. Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications. JAMA 2005; 293:2372.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/28\">",
"      Einarson TR, Einarson A. Newer antidepressants in pregnancy and rates of major malformations: a meta-analysis of prospective comparative studies. Pharmacoepidemiol Drug Saf 2005; 14:823.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/29\">",
"      Hemels ME, Einarson A, Koren G, et al. Antidepressant use during pregnancy and the rates of spontaneous abortions: a meta-analysis. Ann Pharmacother 2005; 39:803.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/30\">",
"      Oberlander TF, Warburton W, Misri S, et al. Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data. Arch Gen Psychiatry 2006; 63:898.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/31\">",
"      Simon GE, Cunningham ML, Davis RL. Outcomes of prenatal antidepressant exposure. Am J Psychiatry 2002; 159:2055.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/32\">",
"      Hostetter A, Stowe ZN, Strader JR Jr, et al. Dose of selective serotonin uptake inhibitors across pregnancy: clinical implications. Depress Anxiety 2000; 11:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/33\">",
"      Ohman I, Vitols S, Tomson T. Lamotrigine in pregnancy: pharmacokinetics during delivery, in the neonate, and during lactation. Epilepsia 2000; 41:709.",
"     </a>",
"    </li>",
"    <li>",
"     Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation, 8th ed, Lippincott Williams &amp; Wilkins, Philadelphia, PA 2008.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/35\">",
"      Cohen LS, Altshuler LL, Harlow BL, et al. Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA 2006; 295:499.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/36\">",
"      Marcus SM, Flynn HA, Blow F, Barry K. A screening study of antidepressant treatment rates and mood symptoms in pregnancy. Arch Womens Ment Health 2005; 8:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/37\">",
"      Goldstein DJ, Corbin LA, Sundell KL. Effects of first-trimester fluoxetine exposure on the newborn. Obstet Gynecol 1997; 89:713.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/38\">",
"      McElhatton PR, Garbis HM, El&eacute;fant E, et al. The outcome of pregnancy in 689 women exposed to therapeutic doses of antidepressants. A collaborative study of the European Network of Teratology Information Services (ENTIS). Reprod Toxicol 1996; 10:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/39\">",
"      Heikkinen T, Ekblad U, Kero P, et al. Citalopram in pregnancy and lactation. Clin Pharmacol Ther 2002; 72:184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/40\">",
"      Einarson A, Selby P, Koren G. Abrupt discontinuation of psychotropic drugs during pregnancy: fear of teratogenic risk and impact of counselling. J Psychiatry Neurosci 2001; 26:44.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/41\">",
"      Kulin NA, Pastuszak A, Sage SR, et al. Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study. JAMA 1998; 279:609.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/42\">",
"      Ericson A, K&auml;ll&eacute;n B, Wiholm B. Delivery outcome after the use of antidepressants in early pregnancy. Eur J Clin Pharmacol 1999; 55:503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/43\">",
"      Malm H, Klaukka T, Neuvonen PJ. Risks associated with selective serotonin reuptake inhibitors in pregnancy. Obstet Gynecol 2005; 106:1289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/44\">",
"      Chambers CD, Johnson KA, Dick LM, et al. Birth outcomes in pregnant women taking fluoxetine. N Engl J Med 1996; 335:1010.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/45\">",
"      Wen SW, Yang Q, Garner P, et al. Selective serotonin reuptake inhibitors and adverse pregnancy outcomes. Am J Obstet Gynecol 2006; 194:961.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/46\">",
"      Colvin L, Slack-Smith L, Stanley FJ, Bower C. Early morbidity and mortality following in utero exposure to selective serotonin reuptake inhibitors: a population-based study in Western Australia. CNS Drugs 2012; 26:e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/47\">",
"      Suri R, Altshuler L, Hellemann G, et al. Effects of antenatal depression and antidepressant treatment on gestational age at birth and risk of preterm birth. Am J Psychiatry 2007; 164:1206.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/48\">",
"      Pastuszak A, Schick-Boschetto B, Zuber C, et al. Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac). JAMA 1993; 269:2246.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/49\">",
"      Qiu C, Sanchez SE, Lam N, et al. Associations of depression and depressive symptoms with preeclampsia: results from a Peruvian case-control study. BMC Womens Health 2007; 7:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/50\">",
"      Toh S, Mitchell AA, Louik C, et al. Selective serotonin reuptake inhibitor use and risk of gestational hypertension. Am J Psychiatry 2009; 166:320.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/51\">",
"      Kurki T, Hiilesmaa V, Raitasalo R, et al. Depression and anxiety in early pregnancy and risk for preeclampsia. Obstet Gynecol 2000; 95:487.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/52\">",
"      Stephansson O, Kieler H, Haglund B, et al. Selective serotonin reuptake inhibitors during pregnancy and risk of stillbirth and infant mortality. JAMA 2013; 309:48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/53\">",
"      Jimenez-Solem E, Andersen JT, Petersen M, et al. SSRI Use During Pregnancy and Risk of Stillbirth and Neonatal Mortality. Am J Psychiatry 2013; 170:299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/54\">",
"      Alwan S, Reefhuis J, Rasmussen SA, et al. Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects. N Engl J Med 2007; 356:2684.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/55\">",
"      Louik C, Lin AE, Werler MM, et al. First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects. N Engl J Med 2007; 356:2675.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/56\">",
"      K&auml;ll&eacute;n BA, Otterblad Olausson P. Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformations. Birth Defects Res A Clin Mol Teratol 2007; 79:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/57\">",
"      Greene MF. Teratogenicity of SSRIs--serious concern or much ado about little? N Engl J Med 2007; 356:2732.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/58\">",
"      Pedersen LH, Henriksen TB, Vestergaard M, et al. Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study. BMJ 2009; 339:b3569.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/59\">",
"      El Marroun H, Jaddoe VW, Hudziak JJ, et al. Maternal use of selective serotonin reuptake inhibitors, fetal growth, and risk of adverse birth outcomes. Arch Gen Psychiatry 2012; 69:706.",
"     </a>",
"    </li>",
"    <li>",
"     National Toxicology Program and Center for the Evaluation of Risks to Human Reproduction (CERHR). Expert panel report on the reproductive and developmental toxicity of fluoxetine. NTP-CERHR-Fluoxetine-04. April 2004. p. 144. Available at: file://cerhr.niehs.nih.gov/news/fluoxetine/fluoxetine_final.pdf.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/61\">",
"      Einarson A, Pistelli A, DeSantis M, et al. Evaluation of the risk of congenital cardiovascular defects associated with use of paroxetine during pregnancy. Am J Psychiatry 2008; 165:749.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/62\">",
"      Cole JA, Ephross SA, Cosmatos IS, Walker AM. Paroxetine in the first trimester and the prevalence of congenital malformations. Pharmacoepidemiol Drug Saf 2007; 16:1075.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/63\">",
"      Bar-Oz B, Einarson T, Einarson A, et al. Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors. Clin Ther 2007; 29:918.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/64\">",
"      Sivojelezova A, Shuhaiber S, Sarkissian L, et al. Citalopram use in pregnancy: prospective comparative evaluation of pregnancy and fetal outcome. Am J Obstet Gynecol 2005; 193:2004.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/65\">",
"      Potts AL, Young KL, Carter BS, Shenai JP. Necrotizing enterocolitis associated with in utero and breast milk exposure to the selective serotonin reuptake inhibitor, escitalopram. J Perinatol 2007; 27:120.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/66\">",
"      Einarson A, Fatoye B, Sarkar M, et al. Pregnancy outcome following gestational exposure to venlafaxine: a multicenter prospective controlled study. Am J Psychiatry 2001; 158:1728.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/67\">",
"      Hudson JI, Wohlreich MM, Kajdasz DK, et al. Safety and tolerability of duloxetine in the treatment of major depressive disorder: analysis of pooled data from eight placebo-controlled clinical trials. Hum Psychopharmacol 2005; 20:327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/68\">",
"      Briggs GG, Ambrose PJ, Ilett KF, et al. Use of duloxetine in pregnancy and lactation. Ann Pharmacother 2009; 43:1898.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/69\">",
"      Boyce PM, Hackett LP, Ilett KF. Duloxetine transfer across the placenta during pregnancy and into milk during lactation. Arch Womens Ment Health 2011; 14:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/70\">",
"      Eyal R, Yaeger D. Poor neonatal adaptation after in utero exposure to duloxetine. Am J Psychiatry 2008; 165:651.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/71\">",
"      Stiskal JA, Kulin N, Koren G, et al. Neonatal paroxetine withdrawal syndrome. Arch Dis Child Fetal Neonatal Ed 2001; 84:F134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/72\">",
"      Costei AM, Kozer E, Ho T, et al. Perinatal outcome following third trimester exposure to paroxetine. Arch Pediatr Adolesc Med 2002; 156:1129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/73\">",
"      Nordeng H, Lindemann R, Perminov KV, Reikvam A. Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitors. Acta Paediatr 2001; 90:288.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/74\">",
"      Cohen LS, Heller VL, Bailey JW, et al. Birth outcomes following prenatal exposure to fluoxetine. Biol Psychiatry 2000; 48:996.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/75\">",
"      Casper RC, Fleisher BE, Lee-Ancajas JC, et al. Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy. J Pediatr 2003; 142:402.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/76\">",
"      Zeskind PS, Stephens LE. Maternal selective serotonin reuptake inhibitor use during pregnancy and newborn neurobehavior. Pediatrics 2004; 113:368.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/77\">",
"      Oberlander TF, Misri S, Fitzgerald CE, et al. Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure. J Clin Psychiatry 2004; 65:230.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/78\">",
"      Sanz EJ, De-las-Cuevas C, Kiuru A, et al. Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis. Lancet 2005; 365:482.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/79\">",
"      Levinson-Castiel R, Merlob P, Linder N, et al. Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants. Arch Pediatr Adolesc Med 2006; 160:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/80\">",
"      SSRI pregnancy exposure risks should be communicated to patients - Cmte. The Pink Sheet 2004; 66:39.",
"     </a>",
"    </li>",
"    <li>",
"     U.S. Food and Drug Administration Center for Drug Evaluation and Research. Summary Minutes of the Pediatrics Subcommittee of the Anti-Infective Drugs Advisory Committee. www.fda.gov/ohrms/dockets/ac/04/minutes/2004-4050M1.pdf (Accessed 3/10/05).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/82\">",
"      Kieler H, Artama M, Engeland A, et al. Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countries. BMJ 2012; 344:d8012.",
"     </a>",
"    </li>",
"    <li>",
"     FDA Drug Safety Communication: Selective serotonin reuptake inhibitor (SSRI) antidepressant use during pregnancy and reports of a rare heart and lung condition in newborn babies. file://www.fda.gov/Drugs/DrugSafety/ucm283375.htm#data (Accessed on December 15, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/84\">",
"      Sit DK, Perel JM, Helsel JC, Wisner KL. Changes in antidepressant metabolism and dosing across pregnancy and early postpartum. J Clin Psychiatry 2008; 69:652.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/85\">",
"      Altshuler LL, Cohen L, Szuba MP, et al. Pharmacologic management of psychiatric illness during pregnancy: dilemmas and guidelines. Am J Psychiatry 1996; 153:592.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/86\">",
"      Misri S, Sivertz K. Tricyclic drugs in pregnancy and lactation: a preliminary report. Int J Psychiatry Med 1991; 21:157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/87\">",
"      Schimmell MS, Katz EZ, Shaag Y, et al. Toxic neonatal effects following maternal clomipramine therapy. J Toxicol Clin Toxicol 1991; 29:479.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/88\">",
"      Cowe L, Lloyd DJ, Dawling S. Neonatal convulsions caused by withdrawal from maternal clomipramine. Br Med J (Clin Res Ed) 1982; 284:1837.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/89\">",
"      Nulman I, Rovet J, Stewart DE, et al. Neurodevelopment of children exposed in utero to antidepressant drugs. N Engl J Med 1997; 336:258.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/90\">",
"      Einarson A, Bonari L, Voyer-Lavigne S, et al. A multicentre prospective controlled study to determine the safety of trazodone and nefazodone use during pregnancy. Can J Psychiatry 2003; 48:106.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/91\">",
"      Kesim M, Yaris F, Kadioglu M, et al. Mirtazapine use in two pregnant women: is it safe? Teratology 2002; 66:204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/92\">",
"      Saks, BR. Mirtazapine: treatment of depression, anxiety, and hyperemesis gravidarum in the pregnant patient. A report of 7 cases. Arch Women's Ment Health 2001; 3:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/93\">",
"      Biswas PN, Wilton LV, Shakir SA. The pharmacovigilance of mirtazapine: results of a prescription event monitoring study on 13554 patients in England. J Psychopharmacol 2003; 17:121.",
"     </a>",
"    </li>",
"    <li>",
"     Simhandl, C, Zhoglami, A., Pinder, R.: Pregnancy During Use of Mirtazapine: Abstract PM02098, in Abstracts of the 21st C.I.N.P. Congress. Glasgow, Scotland 1998.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/95\">",
"      Rohde A, Dembinski J, Dorn C. Mirtazapine (Remergil) for treatment resistant hyperemesis gravidarum: rescue of a twin pregnancy. Arch Gynecol Obstet 2003; 268:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/96\">",
"      Guclu S, Gol M, Dogan E, Saygili U. Mirtazapine use in resistant hyperemesis gravidarum: report of three cases and review of the literature. Arch Gynecol Obstet 2005; 272:298.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/97\">",
"      Djulus J, Koren G, Einarson TR, et al. Exposure to mirtazapine during pregnancy: a prospective, comparative study of birth outcomes. J Clin Psychiatry 2006; 67:1280.",
"     </a>",
"    </li>",
"    <li>",
"     Glaxo Wellcome Bupropion Pregnancy Registry Interim Report 9/1/97 to 2/28/06 Research Park, Wilmington, North Carolina, Issued June 2006.",
"    </li>",
"    <li>",
"     file://ctr.gsk.co.uk/Summary/bupropion/studylist.asp. (Accessed July 10, 2006).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/100\">",
"      Cole JA, Modell JG, Haight BR, et al. Bupropion in pregnancy and the prevalence of congenital malformations. Pharmacoepidemiol Drug Saf 2007; 16:474.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/101\">",
"      Chun-Fai-Chan B, Koren G, Fayez I, et al. Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study. Am J Obstet Gynecol 2005; 192:932.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/102\">",
"      Gracious BL, Wisner KL. Phenelzine use throughout pregnancy and the puerperium: case report, review of the literature, and management recommendations. Depress Anxiety 1997; 6:124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/103\">",
"      Pavy TJ, Kliffer AP, Douglas MJ. Anaesthetic management of labour and delivery in a woman taking long-term MAOI. Can J Anaesth 1995; 42:618.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/104\">",
"      Johnson KC, LaPrairie JL, Brennan PA, et al. Prenatal antipsychotic exposure and neuromotor performance during infancy. Arch Gen Psychiatry 2012; 69:787.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/105\">",
"      Croen LA, Grether JK, Yoshida CK, et al. Antidepressant use during pregnancy and childhood autism spectrum disorders. Arch Gen Psychiatry 2011; 68:1104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/106\">",
"      Ornoy A, Arnon J, Shechtman S, et al. Is benzodiazepine use during pregnancy really teratogenic? Reprod Toxicol 1998; 12:511.",
"     </a>",
"    </li>",
"    <li>",
"     Friedman, J, Polifka, JE. Teratogenic effects of drugs: a resource for clinicians (TERIS), 2nd ed, Johns Hopkins University Press, Baltimore, MD 2000.",
"    </li>",
"    <li>",
"     American Psychiatric Association. Use of electroconvulsive therapy in special populations. In: The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training, and Privileging, Second Edition, American Psychiatric Association, Washington, DC 2001. p.31.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/0/28682/abstract/109\">",
"      Wirz-Justice A, Bader A, Frisch U, et al. A randomized, double-blind, placebo-controlled study of light therapy for antepartum depression. J Clin Psychiatry 2011; 72:986.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1703 Version 18.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.248-E01451B0F0-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_0_28682=[""].join("\n");
var outline_f28_0_28682=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H37\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      GENERAL APPROACH",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PSYCHOTHERAPY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13804399\">",
"      Cognitive-behavioral therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13804406\">",
"      Interpersonal psychotherapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13804413\">",
"      Family therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      PHARMACOTHERAPY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Overview",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Risks of suboptimal dosing and discontinuing therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      SSRIS AND SNRIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Pregnancy complications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Teratogenicity",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - SSRI composite data",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Fluoxetine",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Paroxetine",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Sertraline",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Citalopram and escitalopram",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Venlafaxine",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Duloxetine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Neonatal issues",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Poor neonatal adaptation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Neurodevelopmental effects",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Persistent pulmonary hypertension",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Discussion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      TRICYCLIC ANTIDEPRESSANTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Desipramine, nortriptyline",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Imipramine, amitriptyline",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Clomipramine",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      ATYPICAL ANTIDEPRESSANTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Trazodone and Nefazodone",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Mirtazapine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Bupropion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      MONOAMINE OXIDASE INHIBITORS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H89203454\">",
"      POSTNATAL EFFECTS OF ANTIDEPRESSANTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      BENZODIAZEPINES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      ANTIPSYCHOTIC MEDICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      MOOD STABILIZERS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      ELECTROCONVULSIVE THERAPY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H88319019\">",
"      LIGHT THERAPY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H35\">",
"      POSTPARTUM AND BREASTFEEDING ISSUES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H37\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/61/11226?source=related_link\">",
"      Bipolar disorder in adults: Teratogenic and postnatal risks of pharmacotherapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/16/4362?source=related_link\">",
"      Bipolar disorder in pregnant women: Treatment of mania, hypomania, and mixed episodes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/2/29735?source=related_link\">",
"      Depression in pregnant women: Clinical features and consequences",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/38/18025?source=related_link\">",
"      Family and couples therapy for treating depressed adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/0/32776?source=related_link\">",
"      Generalized anxiety disorder: Epidemiology, pathogenesis, clinical manifestations, course, assessment, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/29/11736?source=related_link\">",
"      Infants with antenatal exposure to serotonin reuptake inhibitors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/8/40074?source=related_link\">",
"      Initial treatment of depression in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/16/17674?source=related_link\">",
"      Interpersonal Psychotherapy (IPT) for depressed adults: Indications, theoretical foundation, general concepts, and efficacy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/20/4425?source=related_link\">",
"      Interpersonal Psychotherapy (IPT) for depressed adults: Specific interventions and techniques",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/25/7574?source=related_link\">",
"      Monoamine oxidase inhibitors (MAOIs) for treating depressed adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?19/41/20116?source=related_link\">",
"      Patient information: Depression in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?31/61/32726?source=related_link\">",
"      Patient information: Reducing the costs of medicines (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?6/21/6483?source=related_link\">",
"      Patient information: Reducing the costs of medicines (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/11/20666?source=related_link\">",
"      Postpartum blues and depression",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/28/5578?source=related_link\">",
"      Serotonin-norepinephrine reuptake inhibitors (SNRIs): Pharmacology, administration, and side effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/52/13128?source=related_link\">",
"      Technique for performing electroconvulsive therapy (ECT) in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/20/36169?source=related_link\">",
"      Unipolar depression in adults and tricyclic and tetracyclic drugs: Pharmacology, administration, and side effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/28/41416?source=related_link\">",
"      Unipolar major depression in adults: Indications for and efficacy of electroconvulsive therapy (ECT)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/0/4105?source=related_link\">",
"      Unipolar major depression with psychotic features: Acute treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/53/38745?source=related_link\">",
"      Use of psychotropic medications in breastfeeding women",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f28_0_28683="Cryosurg BCC contraindications";
var content_f28_0_28683=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F74682&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F74682&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Cryosurgery for BCC: contraindications",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Tumor characteristics",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Clinical features",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Indistinct borders*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Recurrent tumor*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Tumor",
"location - overlying nerves, corners of the mouth, vermillion border,",
"inner canthi, lid margin, and the free margin of the nasal alae, and",
"the auditory canal*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Size greater than 1 cm on the face",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Pathologic features",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Morpheaform, sclerosing, infiltrative, perineural invasion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Patient Characteristics",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Dark skin type",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cosmetically-sensitive patient*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Previous poor response to cryotherapy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Unable to care for wound",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cold urticaria, Raynauds phenomenon (selected sites), cold intolerance, cryofibrinogenemia, or cryoglobulinema*",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Absolute contraindication.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_0_28683=[""].join("\n");
var outline_f28_0_28683=null;
var title_f28_0_28684="Definitions major bleeding";
var content_f28_0_28684=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F71353&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F71353&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Definitions of major bleeding",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        <p>",
"         TIMI",
"        </p>",
"        <p>",
"         (1988)",
"        </p>",
"       </td>",
"       <td class=\"subtitle1\">",
"        <p>",
"         GUSTO",
"        </p>",
"        <p>",
"         (1997)",
"        </p>",
"       </td>",
"       <td class=\"subtitle1\">",
"        <p>",
"         ISAR trials*",
"        </p>",
"        <p>",
"         (2000-05)",
"        </p>",
"       </td>",
"       <td class=\"subtitle1\">",
"        <p>",
"         ACUITY",
"        </p>",
"        <p>",
"         (2006)",
"        </p>",
"       </td>",
"       <td class=\"subtitle1\">",
"        <p>",
"         REPLACE-2",
"        </p>",
"        <p>",
"         (2007)",
"        </p>",
"       </td>",
"       <td class=\"subtitle1\">",
"        <p>",
"         HORIZONS AMI",
"        </p>",
"        <p>",
"         (2009)",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Intracranial bleed",
"       </td>",
"       <td>",
"        Intracranial bleed",
"       </td>",
"       <td>",
"        Intracranial bleed",
"       </td>",
"       <td>",
"        Intracranial or intraocular",
"       </td>",
"       <td>",
"        Intracranial, intraocular, or retroperitoneal",
"       </td>",
"       <td>",
"        Intracranial or intraocular",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hgb &darr; &gt;5 g/dl or Hct &darr; &gt;15 percent",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        Hgb &darr; &gt;5 g/dl or Hct &darr; &gt;15 percent",
"       </td>",
"       <td>",
"        <p>",
"         Hgb &darr; &ge;3 g/dl with overt bleeding",
"        </p>",
"        <p>",
"         Any Hgb &darr; &ge;4 g/dl",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         Hgb &darr; &ge;3 g/dl with overt bleeding",
"        </p>",
"        <p>",
"         Any Hgb &darr; &ge;4 g/dl",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         Hgb &darr; &ge;3 g/dl with overt bleeding",
"        </p>",
"        <p>",
"         Any Hgb &darr; &ge;4 g/dl",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        Any transfusion",
"       </td>",
"       <td>",
"        Transfusion &ge;2 units of PRBCs",
"       </td>",
"       <td>",
"        Any transfusion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        Hemodynamic compromise requiring intervention",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        <p>",
"         Access site bleeding requiring intervention",
"        </p>",
"        <p>",
"         Hematoma &ge;5 cm",
"        </p>",
"        <p>",
"         Reoperation for bleeding",
"        </p>",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        <p>",
"         Access site bleeding requiring intervention",
"        </p>",
"        <p>",
"         Hematoma &ge;5 cm",
"        </p>",
"        <p>",
"         Reoperation for bleeding",
"        </p>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    TIMI and GUSTO were trials of fibrinolytic therapy for acute myocardial infarction. The remaining studies examined adjunctive pharmacology during percutaneous coronary intervention.",
"    <div class=\"footnotes\">",
"     * ISAR-REACT, ISAR-SWEET, ISAR-SMART, ISAR-REACT 2.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_0_28684=[""].join("\n");
var outline_f28_0_28684=null;
var title_f28_0_28685="Contents: Dermatologic surgery";
var content_f28_0_28685=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?2/59/3006\">",
"       Dermatology",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Dermatologic surgery",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Dermatologic surgery",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/15/18679\">",
"           Anatomic danger zones in cutaneous surgery of the head and neck",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/63/17400\">",
"           Mohs surgery",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/0/36869\">",
"           Nail biopsy: Indications and techniques",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/29/12758\">",
"           Nail surgery",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/51/38713\">",
"           Principles and overview of nail surgery",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/20/40264\">",
"           Skin biopsy techniques",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0505-95.154.198.148-CF566127C8-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f28_0_28685=[""].join("\n");
var outline_f28_0_28685=null;
var title_f28_0_28686="Rx post MI ischemia DANAMI";
var content_f28_0_28686=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F58727&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F58727&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Revascularization in patients with inducible ischemia after thrombolysis improves outcome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 383px; height: 433px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The DANAMI study randomly assigned 1008 postinfarction patients with spontaneous or exercise induced ischemia after thrombolytic therapy for acute myocardial infarction (MI) to conservative therapy or invasive therapy with revascularization, if appropriate, based upon anatomy. The invasive strategy significantly reduced the incidence of reinfarction, death, or admission for unstable angina; 44 versus 32 percent at four years (upper panel) but did not affect total mortality (lower panel).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Madsen JK, Grande P, Saunamaki K, et al, on behalf of the DANAMI Study Group, Circulation 1997; 96:748.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_0_28686=[""].join("\n");
var outline_f28_0_28686=null;
var title_f28_0_28687="Calcified pleural plaque CT I";
var content_f28_0_28687=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F78150&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F78150&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Malignant lung nodule and pleural plaques",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 288px; height: 284px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Solitary pulmonary nodule with scalloped borders in a patient with known asbestos exposure and a visible parietal pleural plaques.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_0_28687=[""].join("\n");
var outline_f28_0_28687=null;
